
<html lang="en"     class="pb-page"  data-request-id="3a78dd05-4288-4d1c-b97a-cbd6de0c705e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm900097m;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-13"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume" /></meta><meta name="dc.Creator" content="John J.  Acton, III" /></meta><meta name="dc.Creator" content="Taro E.  Akiyama" /></meta><meta name="dc.Creator" content="Ching H.  Chang" /></meta><meta name="dc.Creator" content="Lawrence  Colwell" /></meta><meta name="dc.Creator" content="Sheryl  Debenham" /></meta><meta name="dc.Creator" content="Thomas  Doebber" /></meta><meta name="dc.Creator" content="Monica  Einstein" /></meta><meta name="dc.Creator" content="Kun  Liu" /></meta><meta name="dc.Creator" content="Margaret E.  McCann" /></meta><meta name="dc.Creator" content="David E.  Moller" /></meta><meta name="dc.Creator" content="Eric S.  Muise" /></meta><meta name="dc.Creator" content="Yugen  Tan" /></meta><meta name="dc.Creator" content="John R.  Thompson" /></meta><meta name="dc.Creator" content="Kenny K.  Wong" /></meta><meta name="dc.Creator" content="Margaret  Wu" /></meta><meta name="dc.Creator" content="Libo  Xu" /></meta><meta name="dc.Creator" content="Peter T.  Meinke" /></meta><meta name="dc.Creator" content="Joel P.  Berger" /></meta><meta name="dc.Creator" content="Harold B.  Wood" /></meta><meta name="dc.Description" content="Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are used to treat type 2 diabetes mellitus (T2DM). Widespread use of PPARγ agonists has been prevented due to adverse effects inclu..." /></meta><meta name="Description" content="Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are used to treat type 2 diabetes mellitus (T2DM). Widespread use of PPARγ agonists has been prevented due to adverse effects inclu..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 9, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900097m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900097m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900097m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900097m" /></link>
        
    
    

<title>Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900097m" /></meta><meta property="og:title" content="Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0008.jpeg" /></meta><meta property="og:description" content=" Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are used to treat type 2 diabetes mellitus (T2DM). Widespread use of PPARγ agonists has been prevented due to adverse effects including weight gain, edema, and increased risk of congestive heart failure. Selective PPARγ modulators (SPPARγMs) have been identified that have antidiabetic efficacy and reduced toxicity in preclinical species. In comparison with PPARγ full agonists, SPPARγM 6 (MK0533) displayed diminished maximal activity (partial agonism) in cell-based transcription activation assays and attenuated gene signatures in adipose tissue. Compound 6 exhibited comparable efficacy to rosiglitazone and pioglitazone in vivo. However, with regard to the induction of untoward events, 6 displayed no cardiac hypertrophy, attenuated increases in brown adipose tissue, minimal increases in plasma volume, and no increases in extracellular fluid volume in vivo. Further investigation of 6 is warranted to determine if the improvement in mechanism-based side effects observed in preclinical species will be recapitulated in humans." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900097m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900097m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900097m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900097m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900097m&amp;href=/doi/10.1021/jm900097m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 3846-3854</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801420y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900409x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm401718d"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (2<i>R</i>)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+J.++Acton%2C++III">John J. Acton, III</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taro+E.++Akiyama">Taro E. Akiyama</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ching+H.++Chang">Ching H. Chang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Colwell">Lawrence Colwell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheryl++Debenham">Sheryl Debenham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Doebber">Thomas Doebber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Einstein">Monica Einstein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kun++Liu">Kun Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret+E.++McCann">Margaret E. McCann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+E.++Moller">David E. Moller</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+S.++Muise">Eric S. Muise</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yugen++Tan">Yugen Tan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Thompson">John R. Thompson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenny+K.++Wong">Kenny K. Wong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret++Wu">Margaret Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Libo++Xu">Libo Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+T.++Meinke">Peter T. Meinke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel+P.++Berger">Joel P. Berger</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harold+B.++Wood">Harold B. Wood</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 732 594 7592. Fax: 732 594 9556. E-mail: <a href="/cdn-cgi/l/email-protection#442628252d361b332b2b2004292136272f6a272b29"><span class="__cf_email__" data-cfemail="88eae4e9e1fad7ffe7e7ecc8e5edfaebe3a6ebe7e5">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Current address: Lilly Research Laboratories, Lilly Corporate Center, DC 0545, Indianapolis, Indiana 46285.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900097m&amp;href=/doi/10.1021%2Fjm900097m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 3846–3854</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 9, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 January 2009</li><li><span class="item_label"><b>Published</b> online</span>9 June 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900097m" title="DOI URL">https://doi.org/10.1021/jm900097m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3846%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BJ.%2BActon%252C%2BTaro%2BE.%2BAkiyama%252C%2BChing%2BH.%2BChang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D13%26contentID%3Djm900097m%26title%3DDiscovery%2Bof%2B%25282R%2529-2-%25283-%257B3-%255B%25284-Methoxyphenyl%2529carbonyl%255D-2-methyl-6-%2528trifluoromethoxy%2529-1H-indol-1-yl%257Dphenoxy%2529butanoic%2BAcid%2B%2528MK-0533%2529%253A%2BA%2BNovel%2BSelective%2BPeroxisome%2BProliferator-Activated%2BReceptor%2B%25CE%25B3%2BModulator%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%2BMellitus%2Bwith%2Ba%2BReduced%2BPotential%2Bto%2BIncrease%2BPlasma%2Band%2BExtracellular%2BFluid%2BVolume%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3854%26publicationDate%3DJuly%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900097m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2430</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900097m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;J. Acton&quot;},{&quot;first_name&quot;:&quot;Taro&quot;,&quot;last_name&quot;:&quot;E. Akiyama&quot;},{&quot;first_name&quot;:&quot;Ching&quot;,&quot;last_name&quot;:&quot;H. Chang&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Colwell&quot;},{&quot;first_name&quot;:&quot;Sheryl&quot;,&quot;last_name&quot;:&quot;Debenham&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Doebber&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Einstein&quot;},{&quot;first_name&quot;:&quot;Kun&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;E. McCann&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;E. Moller&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;S. Muise&quot;},{&quot;first_name&quot;:&quot;Yugen&quot;,&quot;last_name&quot;:&quot;Tan&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Thompson&quot;},{&quot;first_name&quot;:&quot;Kenny&quot;,&quot;last_name&quot;:&quot;K. Wong&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Libo&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;T. Meinke&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;P. Berger&quot;},{&quot;first_name&quot;:&quot;Harold&quot;,&quot;last_name&quot;:&quot;B. Wood&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;3846-3854&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900097m&quot;},&quot;abstract&quot;:&quot;Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are used to treat type 2 diabetes mellitus (T2DM). Widespread use of PPARγ agonists has been prevented due to adverse effects including weight gain, edema, and increased risk of congestive heart failure. Selective PPARγ modulators (SPPARγMs) have been identified that have antidiabetic efficacy and reduced toxicity in preclinical species. In comparison with PPARγ full agonists, SPPARγM 6 (MK0533) displayed diminished maximal activity (partial agonism) in cell-based transcription activation assays and attenuated gene signatures in adipose tissue. Compound 6 exhibited comparable efficacy to rosiglitazone and pioglitazone in vivo. However, with regard to the induction of untoward events, 6 displayed no cardiac hypertrophy, attenuated increases in brown adipose tissue, minimal increases in plasma volume, and no increases in extracellular fluid volume in vivo. Further investigation of 6 is warranted to determine if the improvement in mechanism-based &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900097m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900097m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900097m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900097m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900097m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900097m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900097m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900097m&amp;href=/doi/10.1021/jm900097m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900097m" /></input><a href="/doi/pdf/10.1021/jm900097m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900097m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900097m%26sid%3Dliteratum%253Aachs%26pmid%3D19507861%26genre%3Darticle%26aulast%3DActon%26date%3D2009%26atitle%3DDiscovery%2Bof%2B%25282R%2529-2-%25283-%257B3-%255B%25284-Methoxyphenyl%2529carbonyl%255D-2-methyl-6-%2528trifluoromethoxy%2529-1H-indol-1-yl%257Dphenoxy%2529butanoic%2BAcid%2B%2528MK-0533%2529%253A%2BA%2BNovel%2BSelective%2BPeroxisome%2BProliferator-Activated%2BReceptor%2B%25CE%25B3%2BModulator%2Bfor%2Bthe%2BTreatment%2Bof%2BType%2B2%2BDiabetes%2BMellitus%2Bwith%2Ba%2BReduced%2BPotential%2Bto%2BIncrease%2BPlasma%2Band%2BExtracellular%2BFluid%2BVolume%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D13%26spage%3D3846%26epage%3D3854%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are used to treat type 2 diabetes mellitus (T2DM). Widespread use of PPARγ agonists has been prevented due to adverse effects including weight gain, edema, and increased risk of congestive heart failure. Selective PPARγ modulators (SPPARγMs) have been identified that have antidiabetic efficacy and reduced toxicity in preclinical species. In comparison with PPARγ full agonists, SPPARγM <b>6</b> (MK0533) displayed diminished maximal activity (partial agonism) in cell-based transcription activation assays and attenuated gene signatures in adipose tissue. Compound <b>6</b> exhibited comparable efficacy to rosiglitazone and pioglitazone in vivo. However, with regard to the induction of untoward events, <b>6</b> displayed no cardiac hypertrophy, attenuated increases in brown adipose tissue, minimal increases in plasma volume, and no increases in extracellular fluid volume in vivo. Further investigation of <b>6</b> is warranted to determine if the improvement in mechanism-based side effects observed in preclinical species will be recapitulated in humans.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type 2 diabetes mellitus (T2DM<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: PPARγ, peroxisome proliferator-activated receptor γ; T2DM, type 2 diabetes mellitus; SPPARγM, selective peroxisome proliferator-activated receptor γ modulator; TZD, thiazolidinedione; CYP, cytochrome P450; SPA, scintillation proximity assay; PV, plasma volume; ECF, extracellular fluid; TG, triglyceride; FFA, free fatty acid; HW, heart weight.</p></div> ) is a metabolic disorder characterized by insulin resistance and hyperglycemia. Historically, the disease has been associated with obesity resulting from the sedentary western lifestyle. However, the incidence of T2DM is quickly emerging as a global medical concern. If the incidence of T2DM continues unchecked at its current rate, the World Health Organization predicts there will be 300 million cases worldwide by the year 2010. While lifestyle changes would significantly ameliorate the risk or severity of this disease state, compliance with existing therapies remains a long-standing problem owing to generally poor tolerability of most T2DM targeted drugs. One class of effective chemotherapeutic agents for T2DM is the thiazolidinediones (TZDs, e.g., rosiglitazone and pioglitazone). These compounds function as sensitizers of endogenous insulin via activation of the peroxisome proliferator activated receptor gamma (PPARγ). PPARγ is a member of the nuclear hormone receptor super family. There are two PPARγ subtypes (PPARγ1/PPARg2). PPARγ1 is expressed at low levels in many tissues, while PPARγ2 is highly expressed in adipocytes. The full potential of these drugs has not been realized due to undesirable weight gain, peripheral edema, and anemia (resulting from increased plasma volume) following prolonged usage.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> These adverse effects have precluded dosing TZDs to achieve maximal clinical efficacy and ruled out their wider usages. Indeed, TZDs are contra-indicated for T2DM patients who are at risk for congestive heart failure because the fluid retention they induce can exacerbate this disease.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Similar side effects have been observed in rodents as well,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and more recently additional concerns have been raised over generally increased cardiovascular risk<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and possible loss of bone mass following TZD treatment.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">Considering the beneficial insulin sensitizing effects of TZD therapy, a significant effort has been devoted to the development of selective PPARγ modulators (SPPARγMs) that retain the desirable efficacy for type 2 diabetes but have diminished potential for, or ideally lack all together, the undesirable PPARγ mechanism-based side effects.<a onclick="showRef(event, 'ref3 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref3 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(3, 9-18)</a> Herein, we describe our efforts to identify an optimized indole-derived SPPARγM (<b>6</b>, MK-0533) that demonstrates a reduced potential to cause increases in heart weight, plasma volume, and extracellular fluid volume and is equally efficacious to rosiglitazone and pioglitazone in its ability to improve diabetes in animal models. SPPARγM <b>6</b> has an ancillary profile suitable to allow its evaluation of in man.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> In Vitro SAR and Synthesis</h3><div class="NLM_p">We recently have disclosed a preliminary summary describing a structurally novel series of SPPARγMs.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> A thorough investigation of the SAR revealed that the key features exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> were critical for SPPARγM activity. These SPPARγMs are potent partial agonists in cell-based transcriptional activity assays that, in comparison with full agonists, produce a diminished gene signature in 3T3-L1 adipocytes and display a decreased ability to induce adipogenic differentiation of cultured rodent and human preadipocytes.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The observation that full and partial agonists interact differently with PPARγ suggests that ligand−receptor complexes with SPPARγMs may show quantitatively different interactions with coactivators and corepressors, thereby providing a physical basis for their differing pharmacological profiles. However, the ancillary profiles of the compounds disclosed to date were ill suited to merit clinical investigation of these compounds in type 2 diabetic subjects. Thus, refining the search for optimized SPPARγMs with more suitable drug-like ancillary profiles was a necessary prerequisite prior to considering evaluation of the potential benefits of these compounds in type 2 diabetic subjects.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Summary of SAR of the indolyl SPPARγMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the structural elements for potent in vitro SPPARγM activity identified, we turned our attention to the optimization of the ancillary profile of these molecules. A major liability of the <i>N</i>-benzoyl indoles was significant loss of the labile anisoyl group after oral dosing in rats. This liability was exacerbated, as the resultant indole metabolites were potent CYP inhibitors and found to accumulate after multiple dosing, raising the risk for significant drug−drug interaction liabilities (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>N</i>-Acyl indoles are metabolically labile in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As the carbonyl oxygen of <b>1</b> was integral for binding potency, fused heterocycles were evaluated as possible isosteric replacements for the benzoyl group. Extensive modification of each series to maximize intrinsic activity and introduce additional desirable, drug-like properties was undertaken; the following compounds (<b>2</b>−<b>6</b>) exemplify optimal derivatives from a given cohort. For instance, a benzisoxazole proved to be a suitable replacement for the anisoyl moiety. Although the optimized <i>N</i>-benxisoxazole SPPARγM <b>2</b> was equipotent to the benzoyl indoles in vitro and in vivo, low levels of the parent indoles lacking <i>N</i>-substitution (similar to <b>1a</b>) were still detected systemically in plasma after orally dosing compounds such as <b>2</b>. Therefore, further scaffold refinements were investigated to avoid this troubling P-450 liability. 1,3-Transposition of the indole nucleus such that the benzoyl group was connected via a carbon−carbon bond at the 3-position of the indole provided analogue <b>3</b>, which is now incapable of debenzoylation in vivo. This reversed indole maintained potent partial agonist activity in vitro. However, <b>3</b> was found to have poor bioavailability, low systemic plasma exposure, high clearance, and a short half-life in preclinical species. In an effort to improve its pharmacokinetic profile, additional modification of the reversed indole platform was initiated. Hybrid analogues were synthesized in which the benzisoxazole functionality was incorporated onto the 3-position of the transposed indole core. Such analogues, typified by <b>4</b>, while demonstrating good in vitro potency with improved pharmacokinetic characteristics overall had comparatively modest efficacy in rodent models of diabetes. While in general terms, this modification was viable, hybrid analogue <b>4</b> subsequently was found to have undesirable off-target activities, primarily inhibition of simvastatin acid glucuronidation. The comparatively high systemic plasma exposures required for useful in vivo efficacy raised concerns for potential drug−drug interactions with simvastatin, therefore more scaffold optimization ensued.</div><div class="NLM_p">The reversed indole platform offered greater opportunity to probe modifications to the carbonyl/benzisoxazoyl region. Introducing an aryl ether in place of the benzoyl or benzisoxazoyl group afforded potent partial agonists in vitro and in vivo. However, 3-phenoxy indole <b>5</b> was poorly tolerated in vivo with unacceptable increases in liver enzymes (e.g., ALT and AST) detected after 2 weeks dosing in a rat tolerability assay. Ultimately, a desirable ancillary profile was realized after revisiting the reversed indole scaffold containing a 3-benzoyl substituent. An improved pharmacokinetic profile could be obtained by excising the methylene moiety and directly attaching the phenyl ring to the nitrogen of the indole ring system to yield compound <b>6</b>. Compound <b>6</b> was a potent PPARγ selective partial agonist in vitro, was not a potent inhibitor of the P-450 enzymes (>10 uM against all CYPs), was not a time-dependent inhibitor of CYP3A4, and demonstrated low irreversible protein binding in vitro (<10 pmol/mg protein in rat and human liver microsomes) and in vivo in rat (<10 pmol/mg protein in plasma and liver).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Human PPARγ Binding IC<sub>50</sub> and Transactivation EC<sub>50</sub> Values</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0003.gif" alt="" id="gr4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="center" valign="middle">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th align="center" valign="middle">% max activation</th><th align="center" valign="middle">features</th></tr></thead><tbody><tr valign="top"><td align="left">rosiglitazone</td><td align="left">∼200</td><td align="left">20−27</td><td align="left">100</td><td align="left">full agonist</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left">1</td><td align="left">2</td><td align="left">36</td><td align="left">labile benzoyl</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">6</td><td align="left">3</td><td align="left">31</td><td align="left">labile benzisoxazole</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">1</td><td align="left">1</td><td align="left">25</td><td align="left">poor PK profile</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">2</td><td align="left">3</td><td align="left">24</td><td align="left">off-target activity</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">1</td><td align="left">3</td><td align="left">20</td><td align="left">poor rodent tolerabilty</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">9</td><td align="left">2</td><td align="left">25−39%</td><td align="left">optimized scaffold</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> is measured by the complete displacement of a radio-labeled full agonist indicating competitive binding to the receptor in a SPA assay format.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">EC<sub>50</sub> is defined as the compound concentration at which 50% of a given compound’s intrinsic maximal response has been reached.</p></div></div></div><div class="NLM_p">SPPARγM <b>6</b> was evaluated in vitro in PPAR assays from multiple species and was found to be a potent ligand for hPPARγ in SPA-based assays and a partial agonist of PPARγ in cell-based transcriptional assays with high selectivity for PPARγ over PPARα (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Using the human isoforms, >600 times more selectivity was observed between PPARγ versus PPARα. In preclinical species, <b>6</b> also demonstrated good selectivity between PPARγ and PPARα (>48 times) in vitro. All the compounds described here demonstrated a high degree of selectivity over PPARδ subtype. No activity was observed for this receptor at the highest concentration tested (10 μM) in the binding assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of SPPARγM 6 and Rosiglitazone in Vitro Potencies across Species and PPARγ Activity Score Based upon Gene Expression in 3T3-L1 Adipocytes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">in vitro potencies (nM)</th><th align="center" valign="middle">SPPARgM <b>6</b></th><th align="center" valign="middle">rosiglitazone</th></tr></thead><tbody><tr valign="top"><td align="left">hPPARγ (IC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></td><td align="left">9−14</td><td align="left">∼200</td></tr><tr valign="top"><td align="left">hPPARα (IC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></td><td align="left">>50000</td><td align="left">>50000</td></tr><tr valign="top"><td align="left">hPPARγ (EC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">2−5 (42−68%)</td><td align="left">20−27</td></tr><tr valign="top"><td align="left">hPPARα (EC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">33−68% @ 3000</td><td align="left">1−4% @ 3000</td></tr><tr valign="top"><td align="left">murine PPARα (EC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">240−340 (53−64%)</td><td align="left">na</td></tr><tr valign="top"><td align="left">hamster PPARα (EC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">330−440 (52−80%)</td><td align="left">na</td></tr><tr valign="top"><td align="left">dog PPARα (EC<sub>50</sub>)<a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="left">370 (35−62%)</td><td align="left">na</td></tr><tr valign="top"><td align="left">PPARγ activity score</td><td align="left">0.6</td><td align="left">1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">PPARγ binding is similar across all species evaluated. Only human binding data is presented for clarity.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">IC<sub>50</sub> is measured by the complete displacement of a radio-labeled full agonist indicating competitive binding to the receptor in a SPA assay format.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">EC<sub>50</sub> is defined as the compound concentration at which 50% of a given compound’s intrinsic maximal response has been reached.</p></div></div></div><div class="NLM_p">We have also evaluated SPPARγM <b>6</b> in gene expression studies performed in fully differentiated 3T3-L1 adipocytes using Agilent 25K spotted microarrays. At PPARγ saturating concentrations, SPPARγM <b>6</b> showed an overall similar but attenuated gene expression profile compared with the PPARγ full agonists rosiglitazone and non-TZD carboxylic acid PPARγ agonist (COOH).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> No robust SPPARγM <b>6</b> specific signature genes were observed (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A PPARγ activity score was developed using a χ-square fitting approach and a set of 4619 reporter genes in order to provide a single relative measure of the magnitude of their expression and therefore PPARγ activation.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These 4619 reporter genes represent the intersection of the two structurally distinct PPARγ full agonists rosiglitazone and COOH at <i>p</i> < 0.01, which we believe represents a “true” PPARγ target gene signature (both directly and indirectly regulated genes) in the adipocytes. While the activity scores of full agonists were indistinguishable (both rosiglitazone and COOH have scores of 1.0), the activity score of SPPARγM <b>6</b> was 0.62 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, last entry) due to the attenuated PPARγ gene expression profile relative to that of rosiglitazone.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of rosiglitazone, COOH, and SPPARγM <b>6</b> gene expression heat map of 4619 reporter genes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SPPARγM <b>6</b> was prepared in good overall yields and high enantiopurity utilizing the route outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The core indole was prepared via a Gassman indole synthesis<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to provide <b>8</b> in 40−60% isolated yields, subsequent to removal of the undesired regioisomer. <i>N</i>-arylation of <b>8</b> with 3-bromoanisole was achieved using a catalytic Pd/ligand cocktail to afford <b>10</b> in high yields after demethylation with boron tribromide. Acylation at the 3-position with anisoyl chloride and diethyl aluminum chloride followed by a basic workup of the reaction provided intermediate <b>11</b>. Coupling the phenol with <i>tert</i>-butyl (<i>S</i>)-2-hydroxy butyrate afforded the desired acid <b>6</b> in high yields and high enantiomeric excess after removal of the <i>tert</i>-butyl ester with trifluoroacetic acid (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of SPPARγM <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Pharmacokinetics</h3><div class="NLM_p">Overall, <b>6</b> was found to have desirable pharmacokinetic characteristics in preclinical species with low to moderate plasma clearance, moderate to good oral bioavailability, and acceptable terminal half-life (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Profile of SPPARγM <b>6</b> in Preclinical Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">species</th><th align="center" valign="middle" char=".">% <i>F</i></th><th align="center" valign="middle" char=".">PO nAUC (μM·h)</th><th align="center" valign="middle" char=".">Clp (mL/min/kg)</th><th align="center" valign="middle" char="."><i>T</i><sub>1/2</sub> (h)</th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (μM)</th><th align="center" valign="middle" char=".">Vdss (L/kg)</th></tr></thead><tbody><tr valign="top"><td align="left">rat</td><td align="char" char=".">81</td><td align="char" char=".">1.6</td><td align="char" char=".">18.3</td><td align="char" char=".">1.6</td><td align="char" char=".">1.0</td><td align="char" char=".">1.4</td></tr><tr valign="top"><td align="left">dog</td><td align="char" char=".">59</td><td align="char" char=".">2.9</td><td align="char" char=".">7.5</td><td align="char" char=".">3.6</td><td align="char" char=".">2.4</td><td align="char" char=".">1.4</td></tr><tr valign="top"><td align="left">monkey</td><td align="char" char=".">25</td><td align="char" char=".">0.8</td><td align="char" char=".">10.1</td><td align="char" char=".">3.2</td><td align="char" char=".">0.5</td><td align="char" char=".">0.7</td></tr></tbody></table></div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Efficacy in <i>db</i>/<i>db</i> Mice</h3><div class="NLM_p">To evaluate its antidiabetic efficacy in vivo, SPPARγM <b>6</b> was dosed in <i>db</i>/<i>db</i> mice, an obese insulin resistant rodent model of T2DM characterized by hyperglycemia and hypertriglyceridemia.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Its in vivo efficacy was compared to rosiglitazone and pioglitazone as positive controls; the dosage of each agent was selected such that comparable efficacy was obtained in all treatment groups. After once daily oral dosing for 11 days, compound <b>6</b> produced a significant reduction in blood glucose levels (−83%). Rosiglitazone and pioglitazone performed similarly, affording glucose decrements of 75% and 50%, respectively. On the final day of dosing, the systemic plasma exposures of each compound were measured. It is noteworthy that despite the in vitro partial agonist activity in transactivation assays and attenuated gene signature in adipocytes relative to rosiglitazone, based upon the systemic plasma drug exposure, SPPARγM <b>6</b> was roughly 3−5 times more potent than pioglitazone or rosiglitazone in this diabetic animal model (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Plasma levels of adiponectin, a bona fide PPARγ target engagement biomarker, also were measured in the rosiglitzone and SPPARγM treatment groups. Significant increases in adiponectin were observed in both treatment groups.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Evaluation of SPPARγM <b>6</b> in <i>db</i>/<i>db</i> Mice and Sprague−Dawley Rats<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="4" align="center" valign="middle"><i>db</i>/<i>db</i> mouse</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">vehicle</th><th align="center" valign="middle">rosiglitazone</th><th align="center" valign="middle"><b>6</b></th><th align="center" valign="middle">pioglitazone</th></tr></thead><tbody><tr valign="top"><td align="left">dose (mpk)</td><td align="left"> </td><td align="left">10</td><td align="left">30</td><td align="left">75</td></tr><tr valign="top"><td align="left">AUC (μM·h)</td><td align="left"> </td><td align="left">320</td><td align="left">60</td><td align="left">205</td></tr><tr valign="top"><td align="left">gluc. correction (%)</td><td align="left"> </td><td align="left">−79 ± 10</td><td align="left">−83 ± 4</td><td align="left">−50 ± 11</td></tr><tr valign="top"><td align="left">adiponectin (μg/mL)</td><td align="left">14.5 ± 1.7</td><td align="left">57.3 ± 3.1<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="left">48.1 ± 6.8<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="left">n.d.<a class="ref internalNav" href="#tbl4-fn4" aria-label="d">d</a></td></tr></tbody></table><table class="table "><colgroup><col width="20%" /></col><col width="20%" /></col><col width="20%" /></col><col width="20%" /></col><col width="20%" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="4" align="center">Sprague−Dawley rat</th></tr><tr valign="top"><th align="center">compound</th><th align="center">vehicle</th><th align="center">rosiglitazone</th><th align="center"><b>6</b></th><th align="center">fenofibrate</th></tr></thead><tbody><tr valign="top"><td>dose (mpk)</td><td> </td><td>150</td><td>300</td><td>300</td></tr><tr valign="top"><td>AUC (μM·h)</td><td> </td><td>581</td><td>954</td><td>5582</td></tr><tr valign="top"><td>heart (g)</td><td>1.12 ± 0.03</td><td>1.39 ± 0.07<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td>1.10 ± 0.03</td><td>1.16 ± 0.04</td></tr><tr valign="top"><td>liver (g)</td><td>9.0 ± 0.4</td><td>10.5 ± 0.8</td><td>19.7 ± 0.9<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td>18.9 ± 0.3<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td></tr><tr valign="top"><td>BAT<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a> (mg)</td><td>263 ± 13</td><td>944 ± 145<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td>537 ± 35<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td>276 ± 41</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Values are the means of six animals/group ± the standard error of the mean.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last"><i>P</i> < 0.05 compared to vehicle controls (Dunnett’s <i>t</i> test).</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">BAT = brown adipose tissue.</p></div><div class="footnote" id="tbl4-fn4"><sup>d</sup><p class="last">nd = not determined.</p></div></div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Tolerability in Sprague−Dawley Rats</h3><div class="NLM_p last">Recently, reports have emerged that rosiglitazone causes increased risk of cardiovascular complications after prolonged usage in humans.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Also, thiazolidinediones have been associated with cardiac hypertrophy in a number of preclinical species.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> To evaluate if the partial agonist activity would translate into a different in vivo profile, SPPARγM <b>6</b> was compared head-to-head with rosiglitazone in Sprague−Dawley rats. Both agents were dosed daily for 2 weeks at dosages to achieve exposures that were about 10 times greater than the dosages administered to <i>db</i>/<i>db</i> mice in efficacy studies. In contrast to rosiglitazone, which produced the expected increases in heart weight (25%) and brown adipose tissue (BAT, 260%), there was no significant increase in heart weight observed in animals dosed with SPPARγM <b>6</b>. Another distinguishing characteristic was the diminished augmentation in BAT weight by <b>6</b> in comparison to rosiglitazone. Overall, SPPARγM <b>6</b> was well tolerated and there were no significant findings other than a nominal increase in liver weight (120%) comparable to that observed with the PPARα agonist fenofibrate, which was also included as a control. The increases in liver weight after treatment with <b>6</b> reflect the minor murine PPARα activity present with this compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Evaluation of Plasma Volume and Extracellular Fluid Volume Increases in <i>fa</i>/<i>fa</i> Zucker Rats</h3><div class="NLM_p">On the basis of its robust efficacy in <i>db</i>/<i>db</i> mice and the unique tolerability profile in Sprague−Dawley rats, further in vivo characterization of SPPARγM <b>6</b> was undertaken. To evaluate its potential for mechanism-based side effects, we examined two parameters in obese <i>fa</i>/<i>fa</i> Zucker rats, plasma volume (PV) and extracellular fluid volume (ECF) augmentation, that have previously been used as surrogate markers for induction of edema by PPARγ agonists.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Briefly, changes in plasma volume are determined by Evan’s blue dye dilution, while ECF volume changes are determined by bioelectrical impedance. Although not frankly diabetic, insulin resistant <i>fa</i>/<i>fa</i> Zucker rats are hyperinsulinemic and dyslipidemic. Therefore, the use of this model makes it possible to evaluate both the insulin sensitizing and mechanism-based side effects of PPARγ ligands in the same model.</div><div class="NLM_p">Following 7 days of treatment with either rosiglitazone or <b>6</b> in Zucker <i>fa</i>/<i>fa</i> rats, the final body weights of treatment groups were not statistically different from those of <i>fa</i>/<i>fa</i> vehicle controls. In general, body-weight gain correlated well with food consumption over the study period regardless of treatment group. Plasma glucose levels were not elevated in the vehicle control <i>fa</i>/<i>fa</i> Zucker rats and were unaffected by rosiglitazone or SPPARγM <b>6</b>. Plasma trigylcerides (TG), insulin, and free fatty acids (FFA) were significantly reduced by rosiglitazone, and SPPARγM <b>6</b> indicative of diminished insulin resistance. As shown in the graphs, rosiglitizone affords maximal reductions in plasma TG, insulin, and FFA at 10 mpk with no further decreases upon increasing the dosage to 100 mpk. Similar reductions in TG, insulin, and FFA are observed at the 30 mpk dosage of SPPARγM <b>6</b>. At the end of the study period, systemic plasma drug levels were measured at each dosage. The exposures for rosiglitazone were 9.0, 61.1, 583.7, and 6458 μM·h at 0.1, 1, 10, and 100 mg/kg, respectively. The plasma exposures for SPPARγM 6 were 6, 115.2, 1475, and 4522 μM·h at 3, 30, 100, and 150 mg/kg, respectively. Compound dose ranges were selected based upon differences in mouse and rat PK as well as the dosage needed for efficacy in <i>db</i>/<i>db</i> mouse. On an exposure basis, SPPARγM <b>6</b> is 5 times more potent that rosiglitazone when dosed to achieve maximal reductions in TG, insulin, and FFA. This is consistent with the findings in <i>db</i>/<i>db</i> mice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of TG, insulin, and FFA lowering between rosiglitazone and SPPARγM <b>6</b> in Zucker <i>fa</i>/<i>fa</i> rats. * <i>P</i> < 0.05 compared to vehicle controls (Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significant increases in PV, ECF volume, and heart weight (HW) were observed at the 10 mpk dosage of rosiglitazone, and further increases in these parameters occur at the 100 mpk dosage. After treatment with SPPARγM <b>6</b>, no significant increase in PV was observed at the 30 mpk dosage. However, there was a modest increase in PV with SPPARγM <b>6</b> at 100 mpk, but in contrast to rosiglitazone, this augmentation reached a plateau upon increasing the dosage up to 150 mpk. Furthermore, SPPARγM <b>6</b> did not produce any significant increases in ECF or HW at any dosage evaluated. On the basis of these findings, we conclude that SPPARγM <b>6</b> afforded efficacy comparable to rosiglitazone with reduced potential for mechanism-based side effects (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of PV, ECF, and HW increases between rosiglitazone and SPPARγM <b>6</b> in Zucker <i>fa</i>/<i>fa</i> rats. * <i>P</i> < 0.05, ** <i>P</i> < 0.01 compared to vehicle controls (Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein we describe the identification of a novel indole-derived SPPARγM. In contrast to full agonists, SPPARγM <b>6</b> was a partial agonist in cell-based transcriptional activity assays and produced an attenuated gene signature in 3T3-L1 adipocytes. In a widely accepted rodent model of diabetes, <i>db</i>/<i>db</i> mice, SPPARγM <b>6</b> exhibited comparable efficacy to rosiglitazone and pioglitazone. It also showed similar insulin sensitizing activity to PPARγ full agonists in insulin resistant <i>fa</i>/<i>fa</i> Zucker rats. However, with regard to the induction of adverse events, SPPARγM <b>6</b> displayed a number of important benefits vs rosiglitazone. No cardiac hypertrophy was seen, and only attenuated increases in brown adipose tissue were noted after treating Sprague−Dawley rats chronically with high dosages of <b>6</b>. In Zucker <i>fa</i>/<i>fa</i> rats, SPPARγM <b>6</b> treatment produced only a trend toward increased plasma volume that plateaued with increasing doses, while concomitant increases in extracellular fluid or heart weight were not observed. The robust preclinical antidiabetic activity and superior ancillary pharmacology of SPPARγM <b>6</b> is sufficient to merit further investigation of its properties and to determine if the improvement in mechanism-based side effects observed in preclinical species will be recapitulated in humans.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General</h3><div class="NLM_p last">All commercial chemicals and solvents were reagent grade and were used without further purification unless otherwise specified. All reported yields were isolated yields after chromatography or crystallization. NMR spectra were obtained on a Varian Inova 500 MHz NMR spectrometer equipped with either a Nalorac 3 mm probe or a Varian indirect detection 3 mm probe. All spectra run in CDCl<sub>3</sub> were referenced to residual CHCl<sub>3</sub> at δ 7.26 ppm. Standard resolution mass spectra were obtained on HP1100 LC/MS systems; all mass spectra were obtained using electrospray ionization (EI) in positive ion mode. An LCT time-of-flight mass spectrometer (Waters, Beverly MA) with LockSpray electrospray ionization source was used for exact mass analysis. Chemical purity and enantiopurity was confirmed by HLPC to be >95%. Purity was determined by HPLC analysis via gradient elution (10%−100% acetonitrile/water modified with 0.1% TFA over 3 min with a 30 s hold at 100% acetonitrile followed by a return to 10% acetonitrile/water in 30 s at 5 mL/min) on a YMC C8 column (5 μm) at λ = 220 nm. Chiral purity determined by treating (<b>6</b>) with TMS-diazomethane and isolating the methyl ester. Chiral HPLC analysis of the methyl ester was performed using 85% heptane/15% EtOH as eluent on a Chiralpak AD column (4.6 mm × 250 mm) at a flow rate of 0.75 mL/min using a photodiode array detector, plus single wavelength analysis at 254 nm. The methyl ester of racemic (<b>6</b>) was also prepared for comparison.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-Methyl-6-(trifluoromethoxy)-1<i>H</i>-indole (<b>8</b>) step 1</h3><div class="NLM_p last">To a vigorously stirred solution of 3-trifluoromethoxyaniline (<b>7</b>, 5.74 g, 0.032 mol) in methylene chloride (100 mL) at −78 °C (acetone−dry ice bath) was added dropwise a solution of <i>tert</i>-butyl hypochlorite (3.5 g, 0.032 mol) in 15 mL of the same solvent. After 10 min, a solution of methylthio-2-propanone (3.375 g, 0.032 mol) in methylene chloride (15 mL) was added slowly over 10 min. A slight exotherm was noted during the addition, resulting in a clear yellow solution. After stirring for another hour at −78 °C, during which time the intermediate azasulfonium salt precipitated to form a suspension, a solution of triethylamine (4.5 mL, 0.032 mol) in methylene chloride (15 mL) was added slowly over 5 min to give a clear solution. After an additional 10 min at −78 °C, the cooling bath was removed and the reaction was allowed to warm to room temperature. A 50 mL portion of water was added under vigorous stirring, and the organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give 8.75 g of a 2:1 mixture of the desired 6-triluoromethoxy-2-methyl-3-methylthioindole and the corresponding 4-trifluoromethoxy isomer as a yellow oil. The crude product was used in the next step without further purification. LC-MS (M + 1) 262.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Methyl-6-(trifluoromethoxy)-1<i>H</i>-indole (<b>8</b>) Step 2</h3><div class="NLM_p last">A solution of the crude product from the previous step (8.8 g, 0.032 mol) in 250 mL of absolute ethanol was placed in a 500 mL, three-necked, round-bottomed flask fitted with a mechanical stirrer. An excess of freshly washed W-2 Raney nickel (80 g, 50% slurry in water, washed twice with water and three times with ethanol) was added. The mixture was stirred for 4 h (the reaction was monitored by LC-MS). The Raney nickel was removed by filtration through celite and washing with ethanol. (CAUTION: W-2 Raney nickel may ignite spontaneously if allowed to become dry. During the filtration, a small amount of solvent must be left to cover the catalyst.) The combined ethanolic solutions were concentrated in vacuo. Purification by flash chromatography (Biotage 75 Flash, 9:1 hex/EtOAc) gave 4.05 g of the desired product as white solid (58.1%) and 2.0 g of the 4-trifluoromethoxy indole isomer as an oil (28.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.93 (br s, 1H), 7.45 (d, <i>J</i> = 8.6 Hz, 1H), 7.16 (s, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 1H), 6.23 (s, 1H), 2.45 (s, 3H). LC/MS: <i>m</i>/<i>e</i> 215.89 (M + 1). HRMS: <i>m</i>/<i>e</i> 216.0628 (M + 1) calcd (M + 1) 216.0636.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-(3-Methoxyphenyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indole (<b>9</b>)</h3><div class="NLM_p last">2-Methyl-6-(trifluoromethoxy)-1<i>H</i>-indole (<b>8</b>), 645 mg, 3.0 mmol), 3-bromoanisole (0.456 mL, 3.6 mmol), sodium <i>t</i>-butoxide (404 mg, 4.2 mmol), trisdibenzylidine dipalladium (206 mg, 0.225 mmol), and 2-di-<i>t</i>-butylphosphinobiphenyl (201 mg, 0.675 mmol) were stirred in toluene at 80 °C and monitored by TLC (3/1 hexanes/methylene chloride) or reversed phase HPLC until complete. The reaction mixture was then cooled, filtered over celite, and the filtrate evaporated to give a crude isolate, which was purified by silica gel chromatography to give the title compound (460 mg, 48% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.51 (d, Ph, <i>J</i> = 8.5 Hz, 1H), 7.45 (t, Ph, 1H), 7.02 (dd, Ph, <i>J</i> = 8.4, 2.5 Hz, 1H), 6.99 (m, Ph, 2H), 6.92 (dd, Ph, <i>J</i> = 8.3, 1.6 Hz, 1H), 6.86 (t, Ph, 1H), 6.39 (s, Ph, 1H), 3.85 (s, OCH<sub>3</sub>, 3H), 2.30 (s, 2-CH<sub>3</sub>, 3H). LC/MS: <i>m</i>/<i>e</i> 322.05 (M + 1).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 3-[2-Methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl]phenol (<b>10</b>)</h3><div class="NLM_p last">First, 460 mg (1.43 mmol) of (<b>9</b>) was dissolved in 7 mL of dichloromethane at 0 °C. Then boron tribromide (1.0 N, 2.86 mL) in dichloromethane was added, the cooling bath was removed, and the reaction was stirred at room temperature overnight. The reaction was then quenched with ice for 30 min and partitioned. The organic was washed with water and dried over sodium sulfate. After filtering the drying agent, the filtrate was evaporated and the residue purified by silica gel chromatography to give 397 mg (90%) of the title compound. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.50 (d, Ph, <i>J</i> = 8.5 Hz, 1H), 7.41 (t, Ph, 1H), 6.99 (d, Ph, <i>J</i> = 8.5 Hz, 1H), 6.97 (s, Ph, 1H), 6.94 (dd, ph, <i>J</i> = 8.2, 2.5 Hz, 1H), 6.91 (dd, Ph, <i>J</i> = 7.5, 1.4 Hz, 1H), 6.81 (t, Ph, 1H), 6.38 (s, Ph, 1H), 5.02 (s, OH, 1H), 2.30 (s, 2-CH<sub>3</sub>, 3H).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> [1-(3-Hydroxyphenyl)-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-3-yl](4-methoxyphenyl)methanone (<b>11</b>)</h3><div class="NLM_p last">First, 242 mg (0.788 mmol) of (<b>10</b>) was dissolved in methylene chloride (4 mL) and cooled to −20 °C. Then a solution of diethylaluminum chloride in toluene (1.8M, 1.23 mL) was added slowly (over 1−2 min) and stirred for 5−15 min. Then added a solution of 4-methoxybenzoyl chloride (377 mg, 2.21 mmol) in methylene chloride (1 mL) and allowed to stir overnight while slowly reaching room temperature. pH 7.0 buffer was added dropwise until gas evolution ceased and then partitioned. The aqueous layer was extracted twice more with methylene chloride, and then the combined organic layers were washed twice with saturated NaCl solution, dried over sodium sulfate, filtered, and evaporated. The crude isolate was then dissolved in methanol (5 mL), and sodium hydroxide solution (1.0 M, 1.6 mL) was added. The solution was monitored by TLC for disappearance of diacyl indole and then neutralized with HCl (1.0 M, 1.6 mL). The reaction mixture was then diluted with water and extracted with ethyl acetate. The ethyl acetate layer was dried over sodium sulfate, filtered, evaporated, and the residue purified by silica gel chromatography to give 222 mg (64% yield) of the title compound. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.83 (d, Ph, <i>J</i> = 8.8 Hz, 2H), 7.45 (t, Ph, 1H), 7.41 (d, Ph, <i>J</i> = 8.6 Hz, 1H), 7.05 (dd, Ph, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.97 (m, Ph, 3H), 6.94 (s, Ph, 1H), 6.91 (dd, Ph, <i>J</i> = 8.5, 1.4 Hz, 1H), 6.86 (t, Ph, 1H), 6.38 (s, OH, 1H), 3.91 (s, OCH3, 3H), 2.35 (s, 2-CH<sub>3</sub>, 3H). HRMS: <i>m</i>/<i>e</i> 442.1267 (M + 1) calcd (M + 1) 442.1266.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl(2<i>R</i>)-2-(3-{3-[(4-methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl}phenoxy)butanoate (<b>12</b>)</h3><div class="NLM_p last">First, 220 mg (0.500 mmol) of (<b>11</b>) was dissolved in tetrahydrofuran (2.5 mL) and cooled to 0 °C. Then triphenylphosphine (170 mg, 0.650 mmol) and <i>tert</i>-butyl (<i>S</i>)-2-hydroxybutyrate (104 mg, 0.650 mmol) were then added, followed by diethylazodicarboxylate (102 μL, 0.650 mmol). The reaction was stirred overnight and then directly purified by silica gel chromatography to give 275 mg of the title compound. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.84 (d, Ph, <i>J</i> = 8.9 Hz, 2H), 7.49 (t, Ph, 1H), 7.45 (d, Ph, <i>J</i> = 8.7 Hz, 1H), 7.05 (br, Ph, 1H), 6.97 (m, Ph, 4H), 6.89 (br, Ph, 1H), 6.87 (br t, Ph, 1H), 4.50 (t, O<u class="uu">CH</u>(CH<sub>2</sub>CH<sub>3</sub>)CO<sub>2</sub>tBu, 1H), 3.90 (s, OCH3, 3H), 2.37 (s, 2-CH<sub>3</sub>, 3H), 2.01 (m, OCH(<u class="uu">CH</u><sub>2</sub>CH<sub>3</sub>)CO<sub>2</sub>tBu, 2H), 1.47 (br s, OCH(CH<sub>2</sub>CH<sub>3</sub>)CO<sub>2</sub>t<u class="uu">Bu</u>, 9H), 1.10 (t, OCH(CH<sub>2</sub><u class="uu">CH</u><sub>3</sub>)CO<sub>2</sub>tBu, 3H). LC/MS: <i>m</i>/<i>e</i> 584.12 (M + 1).</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (2<i>R</i>)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1<i>H</i>-indol-1-yl}phenoxy)butanoic Acid (<b>6</b>)</h3><div class="NLM_p last">First, 274 mg (0.470 mol) of (<b>12</b>) was dissolved in 4.7 mL of dichloromethane. Then trifluoroacetic acid (2.4 mL, 31.1 mol) was added and the reaction was stirred until TLC monitoring showed that the reaction was complete. The volatiles were removed by rotary evaporation. The residue was dissolved twice in dichloromethane/hexanes and evaporated. The residue was pumped on high vacuum for 12 h. It was purified on a silica gel column (70/30/0.33 hexanes/ethyl acetate/acetic acid) to give clean title compound (236 mg, 95% yield) after isolation. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.84 (d, Ph, <i>J</i> = 8.7 Hz, 2H), 7.50 (t, Ph, 1H), 7.42 (br s, Ph, 1H), 7.08 (br s, Ph, 1H), 6.970 (m, Ph, 4H), 6.92 (br m, Ph, 2H), 4.67 (br m, O<u class="uu">CH</u>(CH<sub>2</sub>CH<sub>3</sub>)CO<sub>2</sub>H, 1H), 3.90 (s, OCH<sub>3</sub>, 3H), 2.38 (s, 2-CH<sub>3</sub>, 3H), 2.07 (m, OCH(<u class="uu">CH</u><sub>2</sub>CH<sub>3</sub>)CO<sub>2</sub>H, 2H), 1.13 (t, OCH(CH<sub>2</sub><u class="uu">CH</u><sub>3</sub>)CO<sub>2</sub>H, 3H). LC/MS: <i>m</i>/<i>e</i> 528 (M + 1). HRMS: <i>m</i>/<i>e</i> 528.1614 (M + 1) calcd (M + 1) 528.1644. HPLC purity 99.7% (<i>t</i><sub>R</sub> = 2.316 min). Chiral purity 99.6% <i>t</i><sub>R</sub>13.19 min, 0.1% <i>t</i><sub>R</sub> 19.24 min (racemate 50/50 at <i>t</i><sub>R</sub> 13.22 and 19.25 min, respectively).</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preparation of Recombinant PPARs and Binding Assay</h3><div class="NLM_p">Recombinant PPARs were prepared and the receptor binding assays were performed as previously described.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Briefly, the full length human cDNAs for each was subcloned into pGEX-KT expression vectors (Pharmacia, Piscataway, NJ), followed by production of purified recombinant proteins in <i>Escherichia coli</i>. Using the purified GST-hPPAR receptors, scintillation proximity assay-based receptor competitive binding assays were performed in Packard OptiPlate-96 well polystyrene microplates (Packard BioScience, Meriden, CT) using [<sup>3</sup>H<sub>2</sub>]nTZD3 for PPARγ and PPARα and [<sup>3</sup>H<sub>2</sub>]nTZD4 for PPARδ. <i>K</i><sub>i</sub>s were calculated by the equation of Cheng and Prusoff.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Four-parameter logistic equation used is shown below: <span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/jm-2009-00097m_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p last">Bottom is the <i>Y</i> value at the bottom plateau, while Top is the <i>Y</i> value at the top plateau. Log EC<sub>50</sub> is the <i>X</i> value when the response is halfway between bottom and top. HillSlope describes the steepness of the curve (GraphPad Prism version 4.00 for Windows, GraphPad Software, Inc., San Diego, CA).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cell-Based Transcriptional Activity Assays</h3><div class="NLM_p last">COS-1 cells were cultured and transactivation assays were performed as previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Briefly, cells were transfected with a pcDNA3-hPPAR/GAL4 expression vector, pUAS(5X)-tk-luc reporter vector, and pCMV-lacz as an internal control for transactivation efficiency using Lipofectamine (Invitrogen, Carlsburg, CA). After a 48 h exposure to compounds, cell lysates were produced, and luciferase and β-galactosidase activity in cell extracts were determined. Inflection points (EC<sub>50</sub>) of normalized luciferase activity were calculated by the four-parameter logistic equation.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Gene Signature Profiling in 3T3-L1 Cells</h3><div class="NLM_p last">3T3-L1 cells were grown to confluence in medium A (Dulbecco’s modified Eagle’s medium with 10% fetal calf serum, 100 units/mL penicillin, and 100 μg/mL streptomycin) at 37 °C in 5% CO<sub>2</sub> and induced to differentiate as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Briefly, differentiation was induced by incubating the cells with medium A supplemented with methylisobutylxanthine (IBMX), dexamethasone, and insulin for 2 days (days 1 to 2), followed by another 2-day incubation with medium A supplemented with insulin (days 3 to 4). The cells were further incubated in medium A for an additional 4 days to complete the adipocyte conversion (days 5 to 8). At day 8 following the initiation of differentiation, cells were incubated in medium A ± compounds for 24 h at saturating concentrations: vehicle, rosiglitazone (600nM), COOH (3870 nM), or SPPARγM6 (1075 nM). The doses were chosen to be 1.5 log the inflection point in the fatty acid binding protein adipogenesis assay performed in 3T3-L1 cells. Following treatment, total RNA was prepared from the adipocytes using Trizol reagent (Invitrogen, Carlsbad, CA) and RNeasy kits (Qiagen, Valencia, CA) according to the manufacturers’ instructions and RNA concentration was estimated from absorbance at 260 nm. Microarray processing was performed as previously described.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Briefly, labeled cRNA was hybridized for 48 h onto Agilent 60mer 2-color spotted microarrays. Individual treatment samples (including individual vehicle treatment samples) were hybridized against a vehicle treatment pool. LogRatio and <i>P</i> values were generated by averaging replicates (3 replicates per treatment) and the Rosetta Resolver v7.2 system (Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck and Co., Inc., Seattle, WA). LogRatio values represent the difference in regulation of the compound treated samples versus the vehicle treated sample where a positive value signifies up-regulation following compound treatment and vice versa. A PPARγ activity score indicative of overall adipoctye gene expression was generated using a subset of 4619 reporter genes and the χ-square fitting approach, as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This subset of reporter genes is composed of the intersection of the two PPARγ full agonists, rosiglitazone and COOH signature reporter genes with <i>P</i> < 0.01.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Glucose Measurements</h3><div class="NLM_p last"><i>db</i>/<i>db</i> mice were used as described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Adiponectin Measurements</h3><div id="sec3_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Serum/Plasma Sample Handling</h4><div class="NLM_p last">Serum 5−15 μL per sample of plasma were received. Vehicle was diluted 1:1000 μL into 5 mL of 1× assay buffer (10 mM phosphate buffer, pH 7.6 containing 0.08% sodium azide, 0.1% RIA grade BSA), and all full and partial agonists were diluted either 1:1000 or 1:5000, 1, or 5 μL into 5 mL of 1× assay buffer. Each sample was assayed in duplicate.</div></div><div id="sec3_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Assay Protocol</h4><div class="NLM_p last">The assay utilized a Mouse Adiponectin RIA kit (cat. no. MADP-60HK) purchased from LINCO Research, Inc. St. Charles, MO. The assay was performed over 2 days and utilizes <sup>125</sup>I-labeled murine adiponectin and a multispecies adiponectin rabbit antiserum to determine the level of adiponectin in serum, plasma, or tissue culture media by the double antibody/PEG technique. The adiponectin standards were prepared using recombinant mouse adiponectin and were used to determine the μg/mL circulating levels of adiponectin in plasma samples.</div></div><div id="sec3_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Adiponectin Concentration Determination</h4><div class="NLM_p last">The concentrations of adiponectin in the plasma samples were determined from the standard curve, which was linear from 1 to 100 ng/mL. Standards are fit to a one site competition equation using GraphPad Prism Software purchased from GraphPad Software, Inc., San Diego, CA.</div></div><div id="sec3_13_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Statistical Analysis</h4><div class="NLM_p last">The unknown concentrations of adiponectin determined by GraphPad Prism Software were exported to the CMG (Comparing Multiple Groups) Guidance System statistical package, provided by the Merck Biometrics Research Department. This provided all statistical data, including point and box plot graphs, along with pairwise comparison results.</div></div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Obese Zucker <i>fa</i>/<i>fa</i> Rat Studies</h3><div class="NLM_p">Nine−ten week old male Zucker <i>fa</i>/<i>fa</i> rats (Charles River Laboratories, Wilmington, MA) were housed two animals per cage and were provided food (Harlan Teklad Diet no. 7012, Madison, WI) and water ad libitum. Animals were housed in a temperature-, humidity-, and light-controlled room (21−23 °C, 47−65%, 12−12 h light−dark cycle, <i>n</i> = 8/group). Following 7 days of acclimation, rats were treated once daily for 7 days by oral gavage with vehicle (0.25% methylcellulose, 10 mL/kg), rosiglitazone (0.1, 1, 10, and 100 mg/kg), or SPPARγM 6 (3, 30, 100, and 150 mg/kg).</div><div id="sec3_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Evaluation of Insulin Sensitization</h4><div class="NLM_p last">Tail nick blood samples were collected one day before the start of dosing and one day after seventh dose and plasma glucose (Sigma glucose Trinder assay kit, St. Louis, MO), insulin (rat insulin RIA from American Laboratory Products Company, Windham, NH), free fatty acids (FFA) and triglyceride (both from Roche Diagnostics, Basel, Switzerland) concentrations were determined.</div></div><div id="sec3_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Bioelectrical Impedance Analysis for Determination of Extracellular Fluid Volume</h4><div class="NLM_p last">Twenty-four hours following the final dose, rats were anesthetized with ketamine (85 mg/kg, im) and xylazine (10 mg/kg, im). Animals were positioned on a nonconductive surface in dorsolateral recumbency and <i>extracellular fluid</i> volume was determined by bioelectrical impedance analysis, following procedures described by the manufacturer (Hydra ECF/ICF impedance analyzer model 4, Xitron, San Diego, CA) and by B. H. Cornish et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and Rutter et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A tetrapolar impedance monitor was used to measure impedance, and hence the total body water, over a frequency range of 5 kHz to 1 MHz. Source electrodes (1 cm × 26G stainless steel needles) were inserted 5 mm subcutaneously. Detector electrodes were inserted along the midline at the anterior point of the sternum and the anterior point of the penis. The distance between electrodes was measured and included for data modeling.</div></div><div id="sec3_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Plasma Volume Measurement</h4><div class="NLM_p last">After determination of <i>extracellular fluid</i> volume, plasma volume was measured in anesthetized animals using a dye dilution technique following methods described by Belcher and Harriss<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with minor modifications. Evans blue dye solution (25 mg/mL in physiological saline) was filtered through a 0.22 μm filter prior to injection into a femoral vein. Twenty minutes after injection, a heparinized blood sample (2 mL) was withdrawn from the descending aorta. Plasma was separated by centrifugation of the blood at 1100<i>g</i> for 15 min.; samples were kept at −80 °C until assayed. Absorbance of the thawed plasma was read at 620 nm, and plasma Evans blue dye concentrations were calculated according to a standard curve generated by a serial dilution of the 25 mg/mL Evans blue dye−saline solution. Plasma volume was calculated by using the dilution factors of Evans blue as shown below. <span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/jm-2009-00097m_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span></div></div><div id="sec3_14_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Heart Weight Measurements</h4><div class="NLM_p last">Animals were then euthanized by pneumothorax and exsanguination, and the heart was excised, blotted, and weighed.</div></div><div id="sec3_14_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Plasma Drug Level Measurements</h4><div class="NLM_p last">All plasma samples collected from the descending aorta were precipitated with acetonitrile and subsequently subject to LC/MS/MS for rosiglitazone and SPPARγM <b>6</b> measurements.</div></div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Animal Care and Handling</h3><div class="NLM_p last">All animal experiments and euthanasia protocols were conducted in strict accordance with the National Research Council’s <i>Guide for the Care and Use of Laboratory Animals</i>. Animal experiment protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Merck Research Laboratories. The laboratory animal facilities of Merck Research Laboratories are certified by the Association for Assessment and Accreditation of Laboratory Animal Care International.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Statistical Analysis</h3><div class="NLM_p last">Data were expressed in one of the three ways as noted in legends or footnotes: mean ± SEM, or mean ± SD. Dunnett’s <i>t</i> test was performed to determine if there were significant differences between the vehicle group and each incremental dosage group of a compound for the following parameters: plasma glucose, triglyceride, free fatty acids and insulin concentration, plasma volume, extracellular fluid volume, and hematocrit. A <i>P</i> value <0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harold B. Wood</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#52303e333b200d253d3d36123f372031397c313d3f"><span class="__cf_email__" data-cfemail="dcbeb0bdb5ae83abb3b3b89cb1b9aebfb7f2bfb3b1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John J. Acton</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taro E. Akiyama</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ching H. Chang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Colwell</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheryl Debenham</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Doebber</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Einstein</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kun Liu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret E. McCann</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David E. Moller</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric S. Muise</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yugen Tan</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Thompson</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenny K. Wong</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret Wu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Libo Xu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter T. Meinke</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel P. Berger</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories, Merck & Co., Inc., RY800-C114, P.O. Box 2000, Rahway, New Jersey 07065</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm900097m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Renee M. Chabin, Bahanu Habulihaz, the Rosetta Gene Expression Laboratory, and Neelam Sharma for additional technical support.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Plosker, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=409-438&author=G.+L.+Ploskerauthor=D.+Faulds&title=Troglitazone%3A+A+Review+of+its+Use+in+the+Management+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DTroglitazone%253A%2520A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26spage%3D409%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Balfour, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plosker, G. L.</span> <span class="citation_source-journal">Rosiglitazone Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.2165%2F00003495-199957060-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10400405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1GnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balfour%2C+J.+A.%3B+Plosker%2C+G.+L.Rosiglitazone+Drugs+1999%2C+57%2C+921%E2%80%93930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone</span></div><div class="casAuthors">Balfour, Julia A. Barman; Plosker, Greg L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">921-930</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 66 refs. Rosiglitazone, a thiazolidinedione antidiabetic agent, improves insulin resistance, a key metabolic abnormality in most patients with type 2 (non-insulin-dependent) diabetes mellitus.  In animal models of insulin resistance, rosiglitazone decreased plasma glucose, insulin and triglyceride levels and also attenuated or prevented diabetic nephropathy and pancreatic islet cell degeneration.  In contrast to troglitazone, rosiglitazone does not induce cytochrome P 4503A4 metab.  It does not interact significantly with nifedipine, oral contraceptives, metformin, digoxin, ranitidine or acarbose.  In clin. trials in patients with type 2 diabetes mellitus, rosiglitazone at 2-12 mg/day (as a single daily dose or 2 divided daily doses) improved glycemic control, as shown by decreases in fasting plasma glucose and glycosylated Hb (HbA1c).  Addn. of rosiglitazone at 2-8 mg/day to existing sulfonylurea, metformin or insulin therapy achieved further redns. in fasting plasma glucose and HbA1c.  Oral combinations improved insulin sensitivity and β-cell function according to a homeostasis model assessment.  Consistent with its mechanism of action, rosiglitazone appears to be assocd. with a low risk of hypoglycemia (<2% of patients receiving monotherapy).  There is no evidence to date that rosiglitazone shares the hepatotoxicity of troglitazone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqijoPBeWdDCbVg90H21EOLACvtfcHk0ljZi3rNr_iCtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1GnsL0%253D&md5=74eb65e8e17cb6187b6e6be22ac30d9d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F00003495-199957060-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199957060-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBalfour%26aufirst%3DJ.%2BA.%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26jtitle%3DRosiglitazone%2520Drugs%26date%3D1999%26volume%3D57%26spage%3D921%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nesto, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonow, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenkovich, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span> </span><span class="NLM_article-title">Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=256-263&author=R.+W.+Nestoauthor=D.+Bellauthor=R.+O.+Bonowauthor=V.+Fonsecaauthor=S.+M.+Grundyauthor=E.+S.+Hortonauthor=M.+L.+Winterauthor=D.+Porteauthor=C.+F.+Semenkovichauthor=S.+Smithauthor=L.+H.+Youngauthor=R.+Kahn&title=Thiazolidinedione+Use%2C+Fluid+Retention%2C+and+Congestive+Heart+Failure%3A+A+Consensus+Statement+from+the+American+Heart+Association+and+American+Diabetes+Association"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNesto%26aufirst%3DR.%2BW.%26aulast%3DBell%26aufirst%3DD.%26aulast%3DBonow%26aufirst%3DR.%2BO.%26aulast%3DFonseca%26aufirst%3DV.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DHorton%26aufirst%3DE.%2BS.%26aulast%3DWinter%26aufirst%3DM.%2BL.%26aulast%3DPorte%26aufirst%3DD.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BH.%26aulast%3DKahn%26aufirst%3DR.%26atitle%3DThiazolidinedione%2520Use%252C%2520Fluid%2520Retention%252C%2520and%2520Congestive%2520Heart%2520Failure%253A%2520A%2520Consensus%2520Statement%2520from%2520the%2520American%2520Heart%2520Association%2520and%2520American%2520Diabetes%2520Association%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D256%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pickavance, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckingham, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, J. P. H.</span><span> </span><span class="NLM_article-title">Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1038%2Fsj.bjp.0702932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10602338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXotFSit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=1570-1576&author=L.+C.+Pickavanceauthor=M.+Tadayonauthor=P.+S.+Widdowsonauthor=R.+E.+Buckinghamauthor=J.+P.+H.+Wilding&title=Therapeutic+index+for+rosiglitazone+in+dietary+obese+rats%3A+separation+of+efficacy+and+haemodilution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and hemodilution</span></div><div class="casAuthors">Pickavance, L. C.; Tadayyon, M.; Widdowson, P. S.; Buckingham, R. E.; Wilding, J. P. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1570-1576</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The blood glucose-lowering efficacy of rosiglitazone (RSG) and the mechanisms of assocd. wt. gain were detd. in dietary obese rats (DIOs).  DIO and chow-fed rats received RSG 0.3-30 mg kg-1 daily for 21 days.  In DIOs, plasma glucose and insulin concns. were reduced by RSG at dosages of 3 and 10 mg kg-1, resp.  Homeostasis model assessment (HOMA) indicated the threshold for a redn. of insulin resistance was 1 mg kg-1.  Neither glucose nor insulin levels were affected by treatment in chow-fed rats.  RSG 0.3 mg kg-1 lowered free fatty acids (FFAs) in DIOs, whereas for plasma triglycerides (TGs), the threshold was 3 mg kg-1.  By contrast, the threshold for reducing packed red cell vol. (PCV) and increasing cardiac mass was 10 mg kg-1.  Thus, the therapeutic index for RSG in DIOs was >3 and ≤10.  Energy intake and wt. gain increased in treated DIOs (by 20% and 50 g, at 30 mg kg-1) and chow-fed rats (by 25% and 35 g, at 30 mg kg-1).  In DIOs, these increases coincided with falls in plasma leptin (40% lower at 30 mg kg-1) and insulin (43% lower at 30 mg kg-1).  By contrast, in chow-fed rats, wt. gain and hyperphagia occurred without changes in either leptin or insulin.  However, redns. in FFAs below 0.4-0.3 mM were assocd. with hyperphagia and wt. gain in DIO and chow-fed rats.  We conclude that increased energy intake and body wt. did not attenuate the improved metab. evoked by RSG in DIO rats, and that insulin action was enhanced at a dose >3 fold below the threshold for causing hemodilution and cardiac hypertrophy in DIO rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgoMcAqt0bEbVg90H21EOLACvtfcHk0lh6G2O6X60gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFSit78%253D&md5=599c8b440388e50a4083e3868fceb223</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702932%26sid%3Dliteratum%253Aachs%26aulast%3DPickavance%26aufirst%3DL.%2BC.%26aulast%3DTadayon%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DWilding%26aufirst%3DJ.%2BP.%2BH.%26atitle%3DTherapeutic%2520index%2520for%2520rosiglitazone%2520in%2520dietary%2520obese%2520rats%253A%2520separation%2520of%2520efficacy%2520and%2520haemodilution%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D1570%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Richter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandeira-Echtler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S. H.</span><span> </span><span class="NLM_article-title">Rosiglitazone for type 2 diabetes mellitus</span> <span class="citation_source-journal">Cochrane Libr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=1-83&author=B.+Richterauthor=E.+Bandeira-Echtlerauthor=K.+Bergerhoffauthor=C.+Clarauthor=S.+H.+Ebrahim&title=Rosiglitazone+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DB.%26aulast%3DBandeira-Echtler%26aufirst%3DE.%26aulast%3DBergerhoff%26aufirst%3DK.%26aulast%3DClar%26aufirst%3DC.%26aulast%3DEbrahim%26aufirst%3DS.%2BH.%26atitle%3DRosiglitazone%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCochrane%2520Libr.%26date%3D2007%26volume%3D3%26spage%3D1%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’neill, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2427</span><span class="NLM_x">–</span> <span class="NLM_lpage">2443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1056%2FNEJMoa066224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=17145742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12ntrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2427-2443&author=S.+E.+Kahnauthor=S.+M.+Haffnerauthor=M.+A.+Heiseauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=N.+P.+Jonesauthor=B.+G.+Kravitzauthor=J.+M.+Lachinauthor=M.+C.+O%E2%80%99neillauthor=B.+Zinmanauthor=G.+Viberti&title=Glycemic+Durability+of+Rosiglitazone%2C+Metformin%2C+or+Glyburide+Monotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy</span></div><div class="casAuthors">Kahn, Steven E.; Haffner, Steven M.; Heise, Mark A.; Herman, William H.; Holman, Rury R.; Jones, Nigel P.; Kravitz, Barbara G.; Lachin, John M.; O'Neill, Colleen; Zinman, Bernard; Viberti, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2427-2443</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known.  METHODS: We evaluated rosiglitazone, metformin, and glyburide as initial treatment for recently diagnosed type 2 diabetes in a double-blind, randomized, controlled clin. trial involving 4360 patients.  The patients were treated for a median of 4.0 years.  The primary outcome was the time to monotherapy failure, which was defined as a confirmed level of fasting plasma glucose of more than 180 mg per dL (10.0 mmol per L), for rosiglitazone, as compared with metformin or glyburide.  Prespecified secondary outcomes were levels of fasting plasma glucose and glycated Hb, insulin sensitivity, and β-cell function.  RESULTS: Kaplan-Meier anal. showed a cumulative incidence of monotherapy failure at 5 years of 15% with rosiglitazone, 21% with metformin, and 34% with glyburide.  This represents a risk redn. of 32% for rosiglitazone, as compared with metformin, and 63%, as compared with glyburide (P < 0.001 for both comparisons).  The difference in the durability of the treatment effect was greater between rosiglitazone and glyburide than between rosiglitazone and metformin.  Glyburide was assocd. with a lower risk of cardiovascular events (including congestive heart failure) than was rosiglitazone (P < 0.05), and the risk assocd. with metformin was similar to that with rosiglitazone.  Rosiglitazone was assocd. with more wt. gain and edema than either metformin or glyburide but with fewer gastrointestinal events than metformin and with less hypoglycemia than glyburide (P < 0.001 for all comparisons).  CONCLUSIONS: The potential risks and benefits, the profile of adverse events, and the costs of these three drugs should all be considered to help inform the choice of pharmacotherapy for patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1vXiFiHU6prVg90H21EOLACvtfcHk0ljz2NRrQ7Njgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12ntrzF&md5=5d8abeaed5fabbe692d38140a6703c71</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa066224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa066224%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DJones%26aufirst%3DN.%2BP.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599neill%26aufirst%3DM.%2BC.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DGlycemic%2520Durability%2520of%2520Rosiglitazone%252C%2520Metformin%252C%2520or%2520Glyburide%2520Monotherapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2427%26epage%3D2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aftring, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Rosiglitazone-Associated Fractures in Type 2 Diabetes: An Analysis from a Diabetes Outcome Progression Trial (ADOPT)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=845-851&author=S.+E.+Kahnauthor=B.+Zinmanauthor=J.+M.+Lachinauthor=S.+M.+Haffnerauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=B.+G.+Kravitzauthor=D.+Yuauthor=M.+A.+Heiseauthor=R.+P.+Aftringauthor=G.+Viberti&title=Rosiglitazone-Associated+Fractures+in+Type+2+Diabetes%3A+An+Analysis+from+a+Diabetes+Outcome+Progression+Trial+%28ADOPT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DAftring%26aufirst%3DR.%2BP.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DRosiglitazone-Associated%2520Fractures%2520in%2520Type%25202%2520Diabetes%253A%2520An%2520Analysis%2520from%2520a%2520Diabetes%2520Outcome%2520Progression%2520Trial%2520%2528ADOPT%2529%26jtitle%3DDiabetes%2520Care%26date%3D2008%26volume%3D31%26spage%3D845%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hampton, T.</span><span> </span><span class="NLM_article-title">Diabetes Drugs Tied to Fractures in Women</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">1645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2007&pages=1645&author=T.+Hampton&title=Diabetes+Drugs+Tied+to+Fractures+in+Women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHampton%26aufirst%3DT.%26atitle%3DDiabetes%2520Drugs%2520Tied%2520to%2520Fractures%2520in%2520Women%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2007%26volume%3D297%26spage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Reginato, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krakow, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-Activated Receptor γ-Activating Properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">32679</span><span class="NLM_x">–</span> <span class="NLM_lpage">32684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32679-32684&author=M.+J.+Reginatoauthor=S.+T.+Baileyauthor=S.+L.+Krakowauthor=C.+Minamiauthor=S.+Ishiiauthor=H.+Tanakaauthor=M.+A.+Lazar&title=A+Potent+Antidiabetic+Thiazolidinedione+with+Unique+Peroxisome+Proliferator-Activated+Receptor+%CE%B3-Activating+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReginato%26aufirst%3DM.%2BJ.%26aulast%3DBailey%26aufirst%3DS.%2BT.%26aulast%3DKrakow%26aufirst%3DS.%2BL.%26aulast%3DMinami%26aufirst%3DC.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DA%2520Potent%2520Antidiabetic%2520Thiazolidinedione%2520with%2520Unique%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3-Activating%2520Properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32679%26epage%3D32684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Oberfield, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goreham, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull-Ryde, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunket, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.,</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">6102</span><span class="NLM_x">–</span> <span class="NLM_lpage">6106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1073%2Fpnas.96.11.6102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10339548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXksFKksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=6102-6106&author=J.+L.+Oberfieldauthor=J.+L.+Collinsauthor=C.+P.+Holmesauthor=D.+P.+Gorehamauthor=J.+P.+Cooperauthor=J.+E.+Cobbauthor=J.+M.+Lenhardauthor=E.+A.+Hull-Rydeauthor=C.+P.+Mohrauthor=S.+G.+Blanchardauthor=D.+J.+Parksauthor=L.+B.+Mooreauthor=J.+M.+Lehmannauthor=K.+Plunketauthor=A.+B.+Millerauthor=M.+V.+Milburnauthor=S.+A.+Kliewerauthor=T.+M.+Willson&title=A+peroxisome+proliferator-activated+receptor+%CE%B3+ligand+inhibits+adipocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation</span></div><div class="casAuthors">Oberfield, Jennifer L.; Collins, Jon L.; Holmes, Christopher P.; Goreham, Donna M.; Cooper, Joel P.; Cobb, Jeffery E.; Lenhard, James M.; Hull-Ryde, Emily A.; Mohr, Christopher P.; Blanchard, Steven G.; Parks, Derek J.; Moore, Linda B.; Lehmann, Jurgen M.; Plunket, Kelli; Miller, Ann B.; Milburn, Michael V.; Kliewer, Steven A.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6102-6106</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate glucose and lipid homeostasis.  The PPARγ subtype plays a central role in the regulation of adipogenesis and is the mol. target for the 2,4-thiazolidinedione class of antidiabetic drugs.  Structural studies have revealed that agonist ligands activate the PPARs through direct interactions with the C-terminal region of the ligand-binding domain, which includes the activation function 2 helix.  GW0072 was identified as a high-affinity PPARγ ligand that was a weak partial agonist of PPARγ transactivation.  X-ray crystallog. revealed that GW0072 occupied the ligand-binding pocket by using different epitopes than the known PPAR agonists and did not interact with the activation function 2 helix.  In cell culture, GW0072 was a potent antagonist of adipocyte differentiation.  These results establish an approach to the design of PPAR ligands with modified biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTw2RnV57krLVg90H21EOLACvtfcHk0lj7qJr2HACLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFKksrs%253D&md5=8a24d9dc837214ee27b92235410e1164</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.11.6102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.11.6102%26sid%3Dliteratum%253Aachs%26aulast%3DOberfield%26aufirst%3DJ.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DC.%2BP.%26aulast%3DGoreham%26aufirst%3DD.%2BP.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DCobb%26aufirst%3DJ.%2BE.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DHull-Ryde%26aufirst%3DE.%2BA.%26aulast%3DMohr%26aufirst%3DC.%2BP.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DPlunket%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DA%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520ligand%2520inhibits%2520adipocyte%2520differentiation%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%252C%26date%3D1999%26volume%3D96%26spage%3D6102%26epage%3D6106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klatt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-Activated Receptor γ. The Role of CYS313 in Ligand Binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=7913-7922&author=A.+Elbrechtauthor=Y.+Chenauthor=A.+Adamsauthor=J.+Bergerauthor=P.+Griffinauthor=T.+Klattauthor=B.+Zhangauthor=J.+Menkeauthor=G.+Zhouauthor=R.+G.+Smithauthor=D.+E.+Moller&title=L-764406+Is+a+Partial+Agonist+of+Human+Peroxisome+Proliferator-Activated+Receptor+%CE%B3.+The+Role+of+CYS313+in+Ligand+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKlatt%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DL-764406%2520Is%2520a%2520Partial%2520Agonist%2520of%2520Human%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3.%2520The%2520Role%2520of%2520CYS313%2520in%2520Ligand%2520Binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D27%26spage%3D7913%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shimaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikama, H.</span><span> </span><span class="NLM_article-title">The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic <i>db</i>/<i>db</i> mice</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2FS0026-0495%2800%2990440-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10726922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVeqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=411-417&author=A.+Shimayaauthor=E.+Kurosakiauthor=R.+Nakanoauthor=R.+Hirayamaauthor=M.+Shibasakiauthor=H.+Shikama&title=The+novel+hypoglycemic+agent+YM440+normalizes+hyperglycemia+without+changing+body+fat+weight+in+diabetic+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice</span></div><div class="casAuthors">Shimaya, Akiyoshi; Kurosaki, Eiji; Nakano, Ryosuke; Hirayama, Reiko; Shibasaki, Masayuki; Shikama, Hisataka</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-417</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">To det. the relationship between hypoglycemic activity and body wt. gain induced by insulin sensitizers, we compared the effects of thiazolidinedione analogs (troglitazone and pioglitazone) and the oxadiazolidinedione analog (Z)-1,4-bis{4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}but-2-ene (YM440) in diabetic db/db mice.  Oral treatment with YM440 (100 mg/kg) for 28 days decreased the blood glucose concn. (control v YM440, 418 ± 12 v 243 ± 44 mg/dL).  The hypoglycemic activity of this agent was comparable to that of troglitazone (300 mg/kg) and pioglitazone (100 mg/kg).  There were no changes in food intake among the groups.  Troglitazone and pioglitazone, but not YM440, significantly increased body wt. gain during treatment (control, 7.2 ± 0.5 g; YM440, 7.5 ± 0.8 g; troglitazone, 10.9 ± 0.8 g; and pioglitazone, 14.5 ± 1.1 g).  To further assess whether the increase in body wt. by troglitazone or pioglitazone was due to adipogenesis, the wt. of intraabdominal fat tissue (epididymal, retroperitoneal, and perirenal) was detd.  There were no differences in the total wt. of visceral fat between the control and YM440 treatment (3.53 ± 0.23 and 3.60 ± 0.16 g).  In contrast, troglitazone and pioglitazone significantly increased the fat wt. (4.31 ± 0.13 and 4.66 ± 0.19 g).  Thiazolidinediones are known as ligands for peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor responsible for adipogenesis.  Troglitazone and pioglitazone activated PPARγ and increased triglyceride accumulation and mRNA expression of fatty acid-binding protein (FABP) in 3T3-L1 cells.  However, YM440 had no effect on these indexes for adipocyte differentiation.  These results suggest that the mechanism is different for the hypoglycemic action of YM440 vs. the thiazolidinediones.  YM440 ameliorates hyperglycemia without changing PPARγ activity, adipocyte differentiation, or fat wt.  Thus, YM440 could be a useful hypoglycemic agent for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) without affecting body wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY-djP8VuqO7Vg90H21EOLACvtfcHk0lgUZjOrIJMRpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVeqtLk%253D&md5=53b8085b591bf08c35ac46e5617e4729</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2800%2990440-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252800%252990440-2%26sid%3Dliteratum%253Aachs%26aulast%3DShimaya%26aufirst%3DA.%26aulast%3DKurosaki%26aufirst%3DE.%26aulast%3DNakano%26aufirst%3DR.%26aulast%3DHirayama%26aufirst%3DR.%26aulast%3DShibasaki%26aufirst%3DM.%26aulast%3DShikama%26aufirst%3DH.%26atitle%3DThe%2520novel%2520hypoglycemic%2520agent%2520YM440%2520normalizes%2520hyperglycemia%2520without%2520changing%2520body%2520fat%2520weight%2520in%2520diabetic%2520db%252Fdb%2520mice%26jtitle%3DMetabolism%26date%3D2000%26volume%3D49%26spage%3D411%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rocchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamecq, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuquoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunket, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">A Unique PPARγ Ligand with Potent Insulin-Sensitizing Yet Weak Adipogenic Activity</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=737-747&author=S.+Rocchiauthor=F.+Picardauthor=J.+Vamecqauthor=L.+Gelmanauthor=N.+Poitierauthor=D.+Zeyerauthor=L.+Dubuquoyauthor=P.+Bacauthor=M.-F.+Champyauthor=K.+D.+Plunketauthor=L.+M.+Leesnitzerauthor=S.+G.+Blanchardauthor=P.+Desreumauxauthor=D.+Morasauthor=J.-P.+Renaudauthor=J.+Auwerx&title=A+Unique+PPAR%CE%B3+Ligand+with+Potent+Insulin-Sensitizing+Yet+Weak+Adipogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocchi%26aufirst%3DS.%26aulast%3DPicard%26aufirst%3DF.%26aulast%3DVamecq%26aufirst%3DJ.%26aulast%3DGelman%26aufirst%3DL.%26aulast%3DPoitier%26aufirst%3DN.%26aulast%3DZeyer%26aufirst%3DD.%26aulast%3DDubuquoy%26aufirst%3DL.%26aulast%3DBac%26aufirst%3DP.%26aulast%3DChampy%26aufirst%3DM.-F.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRenaud%26aufirst%3DJ.-P.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DA%2520Unique%2520PPAR%25CE%25B3%2520Ligand%2520with%2520Potent%2520Insulin-Sensitizing%2520Yet%2520Weak%2520Adipogenic%2520Activity%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D737%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Thor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beierlein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dykes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustovsson, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendeberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegurier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydow-Bachmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornstrom, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppenberg, J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3565</span><span class="NLM_x">–</span> <span class="NLM_lpage">3567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3565-3567&author=M.+Thorauthor=K.+Beierleinauthor=G.+Dykesauthor=A.-L.+Gustovssonauthor=J.+Heidrichauthor=L.+Jendebergauthor=B.+Lindqvistauthor=C.+Pegurierauthor=P.+Rousselauthor=M.+Slaterauthor=S.+Svenssonauthor=M.+Sydow-Bachmannauthor=U.+Thornstromauthor=J.+Uppenberg&title=Synthesis+and+pharmacological+evaluation+of+a+new+class+of+peroxisome+proliferator-activated+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThor%26aufirst%3DM.%26aulast%3DBeierlein%26aufirst%3DK.%26aulast%3DDykes%26aufirst%3DG.%26aulast%3DGustovsson%26aufirst%3DA.-L.%26aulast%3DHeidrich%26aufirst%3DJ.%26aulast%3DJendeberg%26aufirst%3DL.%26aulast%3DLindqvist%26aufirst%3DB.%26aulast%3DPegurier%26aufirst%3DC.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DSydow-Bachmann%26aufirst%3DM.%26aulast%3DThornstrom%26aufirst%3DU.%26aulast%3DUppenberg%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520new%2520class%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3565%26epage%3D3567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surwit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein-γ Selective Modulator</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1210%2Fme.2002-0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=12554792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=662-676&author=J.+P.+Bergerauthor=A.+E.+Petroauthor=K.+L.+McNaulauthor=L.+J.+Kellyauthor=B.+B.+Zhangauthor=K.+Richardsauthor=A.+Elbrechtauthor=B.+A.+Johnsonauthor=G.+Zhouauthor=T.+W.+Doebberauthor=C.+Biswasauthor=M.+Parikhauthor=N.+Sharmaauthor=M.+R.+Tanenauthor=G.+M.+Thompsonauthor=J.+Ventreauthor=A.+D.+Adamsauthor=R.+Mosleyauthor=R.+S.+Surwitauthor=D.+E.+Moller&title=Distinct+Properties+and+Advantages+of+a+Novel+Peroxisome+Proliferator-Activated+Protein-%CE%B3+Selective+Modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator</span></div><div class="casAuthors">Berger, Joel P.; Petro, Ann E.; Macnaul, Karen L.; Kelly, Linda J.; Zhang, Bei B.; Richards, Karen; Elbrecht, Alex; Johnson, Bruce A.; Zhou, Gaochao; Doebber, Thomas W.; Biswas, Chhabi; Parikh, Mona; Sharma, Neelam; Tanen, Michael R.; Thompson, G. Marie; Ventre, John; Adams, Alan D.; Mosley, Ralph; Surwit, Richard S.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-676</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antidiabetic thiazolidinediones (TZDs) and non-TZD compds. have been shown to serve as agonists of the peroxisome proliferator-activated receptor γ (PPARγ).  Here, we report the identification and characterization of a novel non-TZD selective PPARγ modulator (nTZDpa).  NTZDpa bound potently to PPARγ with high selectivity vs. PPARα or PPARδ.  In cell-based assays for transcriptional activation, nTZDpa served as a selective, potent PPARγ partial agonist and was able to antagonize the activity of PPARγ full agonists.  NTZDpa also displayed partial agonist effects when its ability to promote adipogenesis in 3T3-L1 cells was evaluated.  Assessment of protein conformation using protease protection or soln. NMR spectroscopy methods showed that nTZDpa produced altered PPARγ conformational stability vs. full agonists, thereby establishing a phys. basis for its obsd. partial agonism.  DNA microarray anal. of RNA from 3T3-L1 adipocytes treated with nTZDpa or several structurally diverse PPARγ full agonists demonstrated qual. differences in the affected gene expression profile for nTZDpa.  Chronic treatment of fat-fed, C57BL/6J mice with nTZDpa or a TZD full agonist ameliorated hyperglycemia and hyperinsulinemia.  However, unlike the TZD, nTZDpa caused redns. in wt. gain and adipose depot size.  Feed efficiency was also substantially diminished.  Unlike TZDs, nTZDpa did not cause cardiac hypertrophy in mice.  When a panel of PPARγ target genes was examd. in white adipose tissue, nTZDpa produced a different in vivo expression pattern vs. the full agonist.  These findings establish that novel selective PPARγ modulators can produce altered receptor conformational stability leading to distinctive gene expression profiles, reduced adipogenic cellular effects, and potentially improved in vivo biol. responses.  Such compds. may lead to preferred therapies for diabetes, obesity, or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4wmALUo6AMrVg90H21EOLACvtfcHk0li3dR_wqohg4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D&md5=d3f877b5b389d84034c98a54e3bbcf06</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0217%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DPetro%26aufirst%3DA.%2BE.%26aulast%3DMcNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DRichards%26aufirst%3DK.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DParikh%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DTanen%26aufirst%3DM.%2BR.%26aulast%3DThompson%26aufirst%3DG.%2BM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DSurwit%26aufirst%3DR.%2BS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDistinct%2520Properties%2520and%2520Advantages%2520of%2520a%2520Novel%2520Peroxisome%2520Proliferator-Activated%2520Protein-%25CE%25B3%2520Selective%2520Modulator%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D662%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Schupp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kintscher, U.</span><span> </span><span class="NLM_article-title">Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-γ Activity</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2054</span><span class="NLM_x">–</span> <span class="NLM_lpage">2057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=2054-2057&issue=17&author=M.+Schuppauthor=J.+Jankeauthor=R.+Clasenauthor=T.+Ungerauthor=U.+Kintscher&title=Angiotensin+Type+1+Receptor+Blockers+Induce+Peroxisome+Proliferator-Activated+Receptor-%CE%B3+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchupp%26aufirst%3DM.%26aulast%3DJanke%26aufirst%3DJ.%26aulast%3DClasen%26aufirst%3DR.%26aulast%3DUnger%26aufirst%3DT.%26aulast%3DKintscher%26aufirst%3DU.%26atitle%3DAngiotensin%2520Type%25201%2520Receptor%2520Blockers%2520Induce%2520Peroxisome%2520Proliferator-Activated%2520Receptor-%25CE%25B3%2520Activity%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26issue%3D17%26spage%3D2054%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Minoura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirosumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayakiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo-Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, S.</span><span> </span><span class="NLM_article-title">Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">494</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2Fj.ejphar.2004.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=15212984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2004&pages=273-281&author=H.+Minouraauthor=S.+Takeshitaauthor=M.+Itaauthor=J.+Hirosumiauthor=M.+Mabuchiauthor=I.+Kawamuraauthor=S.+Nakajimaauthor=O.+Nakayamaauthor=H.+Kayakiriauthor=T.+Okuauthor=A.+Ohkubo-Suzukiauthor=M.+Fukagawaauthor=H.+Kojoauthor=K.+Haniokaauthor=N.+Yamasakiauthor=T.+Imotoauthor=Y.+Kobayashiauthor=S.+Mutoh&title=Pharmacological+characteristics+of+a+novel+nonthiazolidinedione+insulin+sensitizer%2C+FK614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614</span></div><div class="casAuthors">Minoura, Hideaki; Takeshita, Shigeru; Ita, Makoto; Hirosumi, Jiro; Mabuchi, Miyuki; Kawamura, Ikuo; Nakajima, Satoko; Nakayama, Osamu; Kayakiri, Hiroshi; Oku, Teruo; Ohkubo-Suzuki, Akiko; Fukagawa, Masao; Kojo, Hitoshi; Hanioka, Kenichi; Yamasaki, Noritsugu; Imoto, Takafumi; Kobayashi, Yoshinori; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">273-281</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We evaluated antidiabetic effects of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide (FK614), a benzimidazole deriv. without a thiazolidinedione structure, which was obtained using C57BL/KsJ-db/db mice.  In db/db mice, the potency of FK614 for hypoglycemic effect was comparable to that of rosiglitazone and approx. 15-fold greater than that of pioglitazone.  FK614 also showed a potent attenuating effect on hypertriglyceridemia in db/db mice, as well as rosiglitazone and pioglitazone.  In C57BL/6J-ob/ob mice, ED50 values of FK614 and pioglitazone for hypoinsulinemic effect were 1.3 and 11.8 mg/kg, resp.  FK614 also improved the impaired glucose tolerance in ob/ob mice.  In normal rats, FK614 did not influence plasma glucose and insulin levels but significantly decreased both plasma triglyceride and nonesterified fatty acid levels.  FK614 was found to activate peroxisome proliferator-activated receptor (PPAR)γ-mediated transcriptional activity in the reporter gene assay as well as thiazolidinedione derivs., although its max. effect was less than that of thiazolidinedione derivs.  In rat toxicity studies, hemodilution effects for FK614 were less than that for rosiglitazone.  Overall, these studies suggest that FK614 improves insulin resistance in such animal models through activation of PPARγ-mediated transcriptional activity and that it would be a new therapeutic candidate with potential for the treatment of type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2s56d1biBbVg90H21EOLACvtfcHk0li3dR_wqohg4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVGhtrk%253D&md5=7d7e9992b40f865e53d63eae95f25a4a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DMinoura%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DIta%26aufirst%3DM.%26aulast%3DHirosumi%26aufirst%3DJ.%26aulast%3DMabuchi%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DI.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DNakayama%26aufirst%3DO.%26aulast%3DKayakiri%26aufirst%3DH.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DOhkubo-Suzuki%26aufirst%3DA.%26aulast%3DFukagawa%26aufirst%3DM.%26aulast%3DKojo%26aufirst%3DH.%26aulast%3DHanioka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DN.%26aulast%3DImoto%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DMutoh%26aufirst%3DS.%26atitle%3DPharmacological%2520characteristics%2520of%2520a%2520novel%2520nonthiazolidinedione%2520insulin%2520sensitizer%252C%2520FK614%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D494%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Burgermeister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoebelen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flament, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gsell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, H. P.</span><span> </span><span class="NLM_article-title">A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1210%2Fme.2005-0171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=16373399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=809-830&author=E.+Burgermeisterauthor=A.+Schnoebelenauthor=A.+Flamentauthor=J.+Benzauthor=M.+Stihleauthor=B.+Gsellauthor=A.+Ruferauthor=B.+Kuhnauthor=H.+P.+Marki&title=A+Novel+Partial+Agonist+of+Peroxisome+Proliferator-Activated+Receptor-%CE%B3+%28PPAR%CE%B3%29+Recruits+PPAR%CE%B3-Coactivator-1%CE%B1%2C+Prevents+Triglyceride+Accumulation%2C+and+Potentiates+Insulin+Signaling+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span></div><div class="casAuthors">Burgermeister, Elke; Schnoebelen, Astride; Flament, Angele; Benz, Jorg; Stihle, Martine; Gsell, Bernard; Rufer, Arne; Ruf, Armin; Kuhn, Bernd; Marki, Hans Peter; Mizrahi, Jacques; Sebokova, Elena; Niesor, Eric; Meyer, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-830</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Partial agonists of peroxisome proliferator-activated receptor-γ (PPARγ), also termed selective PPARγ modulators, are expected to uncouple insulin sensitization from triglyceride (TG) storage in patients with type 2 diabetes mellitus.  These agents shall thus avoid adverse effects, such as body wt. gain, exerted by full agonists such as thiazolidinediones.  In this context, we describe the identification and characterization of the isoquinoline deriv. PA-082, a prototype of a novel class of non-thiazolidinedione partial PPARγ ligands.  In a cocrystal with PPARγ it was bound within the ligand-binding pocket without direct contact to helix 12.  The compd. displayed partial agonism in biochem. and cell-based transactivation assays and caused preferential recruitment of PPARγ-co-activator-1α (PGC1α) to the receptor, a feature shared with other selective PPARγ modulators.  It antagonized rosiglitazone-driven transactivation and TG accumulation during de novo adipogenic differentiation of murine C3H10T1/2 mesenchymal stem cells.  The latter effect was mimicked by overexpression of wild-type PGC1α but not its LXXLL-deficient mutant.  Despite failing to promote TG loading, PA-082 induced mRNAs of genes encoding components of insulin signaling and adipogenic differentiation pathways.  It potentiated glucose uptake and inhibited the neg. cross-talk of TNFα on protein kinase B (AKT) phosphorylation in mature adipocytes and HepG2 human hepatoma cells.  PGC1α is a key regulator of energy expenditure and down-regulated in diabetics.  We thus propose that selective recruitment of PGC1α to favorable PPARγ-target genes provides a possible mol. mechanism whereby partial PPARγ agonists dissoc. TG accumulation from insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgK6uihTKnsLVg90H21EOLACvtfcHk0lgzw8qQrEc48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D&md5=da885be2866f262e5728fc2042e4b66f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0171%26sid%3Dliteratum%253Aachs%26aulast%3DBurgermeister%26aufirst%3DE.%26aulast%3DSchnoebelen%26aufirst%3DA.%26aulast%3DFlament%26aufirst%3DA.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DRufer%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMarki%26aufirst%3DH.%2BP.%26atitle%3DA%2520Novel%2520Partial%2520Agonist%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor-%25CE%25B3%2520%2528PPAR%25CE%25B3%2529%2520Recruits%2520PPAR%25CE%25B3-Coactivator-1%25CE%25B1%252C%2520Prevents%2520Triglyceride%2520Accumulation%252C%2520and%2520Potentiates%2520Insulin%2520Signaling%2520in%2520Vitro%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26spage%3D809%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Acton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Benzoyl 2-methyl indoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-362&author=J.+J.+Actonauthor=R.+M.+Blackauthor=A.+B.+Jonesauthor=D.+E.+Mollerauthor=L.+Colwellauthor=T.+W.+Doebberauthor=K.+L.+MacNaulauthor=J.+Bergerauthor=H.+B.+Wood&title=Benzoyl+2-methyl+indoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DBenzoyl%25202-methyl%2520indoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, J. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Selective PPARγ modulators with improved pharmacological profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2437</span><span class="NLM_x">–</span> <span class="NLM_lpage">2440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2437-2440&author=K.+Liuauthor=R.+M.+Blackauthor=J.+A.+Actonauthor=R.+Mosleyauthor=S.+Debenhamauthor=R.+Abolaauthor=M.+Yangauthor=R.+Tschirret-Guthauthor=L.+Colwellauthor=C.+Liuauthor=M.+Wuauthor=C.+F.+Wangauthor=K.+L.+MacNaulauthor=M.+E.+McCannauthor=D.+E.+Mollerauthor=J.+P.+Bergerauthor=P.+T.+Meinkeauthor=A.+B.+Jonesauthor=H.+B.+Wood&title=Selective+PPAR%CE%B3+modulators+with+improved+pharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DActon%26aufirst%3DJ.%2BA.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DDebenham%26aufirst%3DS.%26aulast%3DAbola%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DSelective%2520PPAR%25CE%25B3%2520modulators%2520with%2520improved%2520pharmacological%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2437%26epage%3D2440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriota, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span> </span><span class="NLM_article-title">The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological Activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=62-74&author=M.+Einsteinauthor=T.+E.+Akiyamaauthor=G.+A.+Castriotaauthor=C.+F.+Wangauthor=B.+McKeeverauthor=R.+T.+Mosleyauthor=J.+W.+Beckerauthor=D.+E.+Mollerauthor=P.+T.+Meinkeauthor=H.+B.+Woodauthor=J.+P.+Berger&title=The+Differential+Interactions+of+Peroxisome+Proliferator-Activated+Receptor+%CE%B3+Ligands+with+Tyr473+Is+a+Physical+Basis+for+Their+Unique+Biological+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DCastriota%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Differential%2520Interactions%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3%2520Ligands%2520with%2520Tyr473%2520Is%2520a%2520Physical%2520Basis%2520for%2520Their%2520Unique%2520Biological%2520Activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T.</span><span> </span><span class="NLM_article-title">Minimizing metabolic activation during pharmaceutical lead optimization: Progress, knowledge gaps and future directions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=18175266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=43-52&issue=1&author=S.+Kumarauthor=K.+Kelemauthor=R.+Tschirret-Guthauthor=K.+Mitraauthor=T.+Baillie&title=Minimizing+metabolic+activation+during+pharmaceutical+lead+optimization%3A+Progress%2C+knowledge+gaps+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions</span></div><div class="casAuthors">Kumar, Sanjeev; Kassahun, Kelem; Tschirret-Guth, Richard A.; Mitra, Kaushik; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Minimizing the potential for drug candidates to form chem. reactive metabolites that can covalently modify cellular macromols. represents a rational strategy to reduce the risk of drug-induced idiosyncratic toxicity in humans.  In this review, the approaches that are currently available for addressing this issue during the lead optimization phase of drug discovery, their limitations, and future scientific directions that have the potential to address these limitations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovdpkocC2pgrVg90H21EOLACvtfcHk0lgw4VYR4G3fkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFehs78%253D&md5=2befdc730eb26d56eefef1a157e145a9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKelem%26aufirst%3DK.%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DBaillie%26aufirst%3DT.%26atitle%3DMinimizing%2520metabolic%2520activation%2520during%2520pharmaceutical%2520lead%2520optimization%253A%2520Progress%252C%2520knowledge%2520gaps%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26issue%3D1%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muise, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span> </span><span class="NLM_article-title">A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2Fj.ejphar.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=18346728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2008&pages=192-201&author=C.+H.+Changauthor=L.+A.+McNamaraauthor=M.+S.+Wuauthor=E.+S.+Muiseauthor=Y.+Tanauthor=H.+B.+Woodauthor=P.+T.+Meinkeauthor=J.+R.+Thompsonauthor=T.+W.+Doebberauthor=J.+P.+Bergerauthor=M.+E.+McCann&title=A+novel+selective+peroxisome+proliferator-activator+receptor-gamma+modulator-SPPAR%CE%B3M5+improves+insulin+sensitivity+with+diminished+adverse+cardiovascular+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective peroxisome proliferator-activator receptor-γ modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span></div><div class="casAuthors">Chang, Ching H.; McNamara, Lesley A.; Wu, Margaret S.; Muise, Eric S.; Tan, Yejun; Wood, Harold B.; Meinke, Peter T.; Thompson, John R.; Doebber, Tom W.; Berger, Joel P.; McCann, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of the thiazolidinedione insulin sensitizers rosiglitazone and pioglitazone for the treatment of type 2 diabetes mellitus in recent years has proven to be effective in helping patients resume normal glycemic control.  However, their use is often assocd. with undesirable side effects including peripheral edema, congestive heart failure and wt. gain.  Here, we report the identification and characterization of a novel selective PPARγ modulator, SPPARγM5 ((2S)-2-(2-chloro-5-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl} phenoxy)propionic acid), which has notable insulin sensitizing properties and a superior tolerability profile to that of rosiglitazone.  SPPARγM5 is a potent ligand of human PPARγ with high selectivity vs. PPARα or PPARδ in receptor competitive binding assays.  In cell-based transcriptional activation assays, SPPARγM5 was a potent partial agonist of human PPARγ in comparison to the PPARγ full agonist rosiglitazone.  Compared to rosiglitazone or the PPARγ full agonist COOH (2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid), SPPARγM5 induced an attenuated PPARγ-regulated gene expression profile in fully differentiated 3T3-L1 adipocytes and white adipose tissue of chronically treated db/db mice.  SPPARγM5 treatment also reduced the insulin resistance index by homeostasis model assessment (HOMA), suggesting an improvement in insulin resistance in these db/db mice.  Treatment of obese Zucker rats with either rosiglitazone or SPPARγM5 resulted in an improvement in selected parameters that serve as surrogate indicators of insulin resistance and hyperlipidemia.  However, unlike rosiglitazone, SPPARγM5 did not cause significant fluid retention or cardiac hypertrophy in these rats.  Thus, compds. such as SPPARγM5 may offer beneficial effects on glycemic control with significantly attenuated adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxeoOWfrT3IbVg90H21EOLACvtfcHk0lgw4VYR4G3fkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D&md5=68ac4e15e57b5d7e97807c80ae823b3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DMuise%26aufirst%3DE.%2BS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520selective%2520peroxisome%2520proliferator-activator%2520receptor-gamma%2520modulator-SPPAR%25CE%25B3M5%2520improves%2520insulin%2520sensitivity%2520with%2520diminished%2520adverse%2520cardiovascular%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D584%26spage%3D192%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gassman, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bergen, T. J.</span><span> </span><span class="NLM_article-title">Simple method for the conversion of anilines into 2-substituted indoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00783a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=590-591&author=P.+G.+Gassmanauthor=T.+J.+van+Bergen&title=Simple+method+for+the+conversion+of+anilines+into+2-substituted+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00783a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00783a049%26sid%3Dliteratum%253Aachs%26aulast%3DGassman%26aufirst%3DP.%2BG.%26aulast%3Dvan%2BBergen%26aufirst%3DT.%2BJ.%26atitle%3DSimple%2520method%2520for%2520the%2520conversion%2520of%2520anilines%2520into%25202-substituted%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D590%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Acton, J. J.; Debenham, S. D.; Liu, K.; Meinke, P. T.; Wood, H. B.</span><span> </span><span class="NLM_article-title">Indoles having anti-diabetic activity</span> . Patent WO2004/020408 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+J.+Acton&author=S.+D.+Debenham&author=K.+Liu&author=P.+T.+Meinke&author=H.+B.+Wood&title=Indoles+having+anti-diabetic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26atitle%3DIndoles%2520having%2520anti-diabetic%2520activity%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibowitz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullinan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Novel Peroxisome Proliferator-Activated Receptor (PPAR)γ and PPARδ Ligands Produce Distinct Biological Effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">6718</span><span class="NLM_x">–</span> <span class="NLM_lpage">6725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=6718-6725&author=J.+B.+Bergerauthor=M.+D.+Leibowitzauthor=T.+D.+Doebberauthor=A.+Elbrechtauthor=B.+Zhangauthor=G.+Zhouauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=N.+S.+Hayesauthor=Y.+Liauthor=M.+Tanenauthor=J.+Ventreauthor=M.+S.+Wuauthor=G.+D.+Bergerauthor=R.+Mosleyauthor=R.+Marquisauthor=C.+Santiniauthor=S.+P.+Sahooauthor=R.+L.+Tolmanauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Novel+Peroxisome+Proliferator-Activated+Receptor+%28PPAR%29%CE%B3+and+PPAR%CE%B4+Ligands+Produce+Distinct+Biological+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26aulast%3DDoebber%26aufirst%3DT.%2BD.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DR.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNovel%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%2528PPAR%2529%25CE%25B3%2520and%2520PPAR%25CE%25B4%2520Ligands%2520Produce%2520Distinct%2520Biological%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D6718%26epage%3D6725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tugwoog, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montegue, C. T.</span><span> </span><span class="NLM_article-title">Biology and toxicology of PPARgamma ligands</span> <span class="citation_source-journal">Hum. Exp. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1191%2F0960327102ht282oa" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=12412636" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=429-437&author=J.+D.+Tugwoogauthor=C.+T.+Montegue&title=Biology+and+toxicology+of+PPARgamma+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1191%2F0960327102ht282oa&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1191%252F0960327102ht282oa%26sid%3Dliteratum%253Aachs%26aulast%3DTugwoog%26aufirst%3DJ.%2BD.%26aulast%3DMontegue%26aufirst%3DC.%2BT.%26atitle%3DBiology%2520and%2520toxicology%2520of%2520PPARgamma%2520ligands%26jtitle%3DHum.%2520Exp.%2520Toxicol.%26date%3D2002%26volume%3D21%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cillinana, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in <i>db</i>/<i>db</i> mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cillinanaauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Liebowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-gamma%3A+binding+and+activation+correlate+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCillinana%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLiebowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-gamma%253A%2520binding%2520and%2520activation%2520correlate%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of the inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzyme reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+the+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzyme+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520the%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzyme%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Carrington, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Insulin- and mitogen-activated protein kinase mediated phosphorylation and activation of peroxisome proliforator-activated receptor-γ</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31771</span><span class="NLM_x">–</span> <span class="NLM_lpage">31774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31771-31774&author=B.+Zhangauthor=J.+B.+Bergerauthor=G.+Zhouauthor=A.+Elbrechtauthor=S.+Biswasauthor=S.+White-Carringtonauthor=D.+Szalkowskiauthor=D.+E.+Moller&title=Insulin-+and+mitogen-activated+protein+kinase+mediated+phosphorylation+and+activation+of+peroxisome+proliforator-activated+receptor-%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DWhite-Carrington%26aufirst%3DS.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DInsulin-%2520and%2520mitogen-activated%2520protein%2520kinase%2520mediated%2520phosphorylation%2520and%2520activation%2520of%2520peroxisome%2520proliforator-activated%2520receptor-%25CE%25B3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31771%26epage%3D31774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hughs, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephaniants, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoughton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsley, P. S.</span><span> </span><span class="NLM_article-title">Expression profiling usng microarrays fabricated by ink-jet oligonucleotide synthesizer</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=342-347&author=T.+R.+Hughsauthor=M.+Maoauthor=A.+R.+Jonesauthor=J.+Burchardauthor=M.+J.+Martonauthor=K.+W.+Shannonauthor=S.+M.+Lefkowitzauthor=M.+Zimanauthor=J.+M.+Schelterauthor=M.+R.+Meyerauthor=S.+Kobayashiauthor=C.+Davisauthor=H.+Daiauthor=Y.+D.+Heauthor=S.+B.+Stephaniantsauthor=G.+Cavetauthor=W.+L.+Walkerauthor=A.+Westauthor=E.+Coffeyauthor=D.+D.+Shoemakerauthor=R.+Stoughtonauthor=A.+P.+Blanchardauthor=S.+H.+Friendauthor=P.+S.+Linsley&title=Expression+profiling+usng+microarrays+fabricated+by+ink-jet+oligonucleotide+synthesizer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughs%26aufirst%3DT.%2BR.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DA.%2BR.%26aulast%3DBurchard%26aufirst%3DJ.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DShannon%26aufirst%3DK.%2BW.%26aulast%3DLefkowitz%26aufirst%3DS.%2BM.%26aulast%3DZiman%26aufirst%3DM.%26aulast%3DSchelter%26aufirst%3DJ.%2BM.%26aulast%3DMeyer%26aufirst%3DM.%2BR.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3DStephaniants%26aufirst%3DS.%2BB.%26aulast%3DCavet%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DW.%2BL.%26aulast%3DWest%26aufirst%3DA.%26aulast%3DCoffey%26aufirst%3DE.%26aulast%3DShoemaker%26aufirst%3DD.%2BD.%26aulast%3DStoughton%26aufirst%3DR.%26aulast%3DBlanchard%26aufirst%3DA.%2BP.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DLinsley%26aufirst%3DP.%2BS.%26atitle%3DExpression%2520profiling%2520usng%2520microarrays%2520fabricated%2520by%2520ink-jet%2520oligonucleotide%2520synthesizer%26jtitle%3DNat.%2520Biotechnol.%26date%3D2001%26volume%3D19%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cornish, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jebb, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elia, M.</span><span> </span><span class="NLM_article-title">Evaluation of multiple frequency bioelectrical impedance and Cole−Cole analysis for the assessment of body water volumes in healthy humans</span> <span class="citation_source-journal">Eur. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=8654329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaK283kt1Gqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=159-164&author=B.+H.+Cornishauthor=L.+C.+Wardauthor=B.+J.+Tonasauthor=S.+A.+Jebbauthor=M.+Elia&title=Evaluation+of+multiple+frequency+bioelectrical+impedance+and+Cole%E2%88%92Cole+analysis+for+the+assessment+of+body+water+volumes+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans</span></div><div class="casAuthors">Cornish B H; Ward L C; Thomas B J; Jebb S A; Elia M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-64</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the application of a Cole-Cole analysis of multiple frequency bioelectrical impedance analysis (MFBIA) measurements to predict total body water (TBW) and extracellular water (ECW) in humans.  This technique has previously been shown to produce accurate and reliable estimates in both normal and abnormal animals.  DESIGN:  The whole body impedance of 60 healthy humans was measured at 496 frequencies (ranging from 4 kHz to 1 MHz) and the impedance at zero frequency, Ro, and at the characteristic frequency, Zc, were determined from the impedance spectrum, (Cole-Cole plot).  TBW and ECW were independently determined using deuterium and bromide tracer dilution techniques.  SETTING:  At the Dunn Clinical Nutrition Centre and The Department of Biochemistry, University of Queensland.  SUBJECTS:  60 healthy adult volunteers (27 men and 33 women, aged 18-45 years).  RESULTS:  The results presented suggest that the swept frequency bioimpedance technique estimates total body water, (SEE = 5.2%), and extracellular water, (SEE = 10%), only slightly better in normal, healthy subjects than a method based on single frequency bioimpedance or anthropometric estimates based on weight, height and gender.  CONCLUSIONS:  This study has undertaken the most extensive analysis to date of relationships between TBW (and ECW) and individual impedances obtained at different frequencies ( > 400 frequencies), and has shown marginal advantages of using one frequency over another, even if values predicted from theoretical bioimpedance models are used in the estimations.  However in situations where there are disturbances of fluid distribution, values predicted from the Cole-Cole analysis of swept frequency bioimpedance measurements could prove to be more useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI8ivmZxDTlWK_SFaaT9INfW6udTcc2ebLsXwa6n6RvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283kt1Gqsw%253D%253D&md5=ed62bc1b57f28e2a6a8741050b665438</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornish%26aufirst%3DB.%2BH.%26aulast%3DWard%26aufirst%3DL.%2BC.%26aulast%3DTonas%26aufirst%3DB.%2BJ.%26aulast%3DJebb%26aufirst%3DS.%2BA.%26aulast%3DElia%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520multiple%2520frequency%2520bioelectrical%2520impedance%2520and%2520Cole%25E2%2588%2592Cole%2520analysis%2520for%2520the%2520assessment%2520of%2520body%2520water%2520volumes%2520in%2520healthy%2520humans%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D1996%26volume%3D50%26spage%3D159%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Rutter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennoste, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. J.</span><span> </span><span class="NLM_article-title">Bioelectrical impedance analysis for the estimation of body composition in rats</span> <span class="citation_source-journal">Lab. Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1258%2F002367798780559356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=9481696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaK1c7kt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=65-71&author=K.+Rutterauthor=L.+Hennosteauthor=L.+C.+Wardauthor=B.+H.+Cornishauthor=B.+J.+Thomas&title=Bioelectrical+impedance+analysis+for+the+estimation+of+body+composition+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bioelectrical impedance analysis for the estimation of body composition in rats</span></div><div class="casAuthors">Rutter K; Hennoste L; Ward L C; Cornish B H; Thomas B J</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">Bioelectrical impedance analysis (BIA) was used to assess body composition in rats fed on either standard laboratory diet or on high-fat diet designed to induce obesity.  Bioelectrical impedance analysis predictions of total body water and thus fat-free mass (FFM) for the group mean values were generally within 5% of the measured values by tritiated water (3H2O) dilution.  The limits of agreement for the procedure were, however, large, approximately +/- 25%, limiting the applicability of the technique for measurement of body composition in individual animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFQijWPC5cNuxsqfvU0ziafW6udTcc2ebLsXwa6n6RvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7kt1Kqtw%253D%253D&md5=8100b5d69bd9160bd655b4288ca6a6b9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1258%2F002367798780559356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367798780559356%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DK.%26aulast%3DHennoste%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DL.%2BC.%26aulast%3DCornish%26aufirst%3DB.%2BH.%26aulast%3DThomas%26aufirst%3DB.%2BJ.%26atitle%3DBioelectrical%2520impedance%2520analysis%2520for%2520the%2520estimation%2520of%2520body%2520composition%2520in%2520rats%26jtitle%3DLab.%2520Anim.%26date%3D1998%26volume%3D32%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Belcher, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriss, E. B.</span><span> </span><span class="NLM_article-title">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=13481897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1957&pages=64-78&author=E.+H.+Belcherauthor=E.+B.+Harriss&title=Studies+of+plasma+volume%2C+red+cell+volume+and+total+blood+volume+in+young+growing+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span></div><div class="casAuthors">BELCHER E H; HARRISS E B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-78</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4s_zNGAgMIC6Ufuk_1xoTfW6udTcc2eYNzVFpcrKAZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D&md5=dd122772ec2175d6f23b9b3c758bddb3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcher%26aufirst%3DE.%2BH.%26aulast%3DHarriss%26aufirst%3DE.%2BB.%26atitle%3DStudies%2520of%2520plasma%2520volume%252C%2520red%2520cell%2520volume%2520and%2520total%2520blood%2520volume%2520in%2520young%2520growing%2520rats%26jtitle%3DJ.%2520Physiol.%26date%3D1957%26volume%3D139%26spage%3D64%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Asteian</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Blayo</span>, <span class="hlFld-ContribAuthor ">Yuanjun  He</span>, <span class="hlFld-ContribAuthor ">Marcel  Koenig</span>, <span class="hlFld-ContribAuthor ">Youseung  Shin</span>, <span class="hlFld-ContribAuthor ">Dana S.  Kuruvilla</span>, <span class="hlFld-ContribAuthor ">Cesar A.  Corzo</span>, <span class="hlFld-ContribAuthor ">Michael D.  Cameron</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>, <span class="hlFld-ContribAuthor ">Claudia  Ruiz</span>, <span class="hlFld-ContribAuthor ">Susan  Khan</span>, <span class="hlFld-ContribAuthor ">Naresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Scott  Busby</span>, <span class="hlFld-ContribAuthor ">David P.  Marciano</span>, <span class="hlFld-ContribAuthor ">Ruben D.  Garcia-Ordonez</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Griffin</span>, and <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (9)
                                     , 998-1003. <a href="https://doi.org/10.1021/acsmedchemlett.5b00218" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BIndole%252BBiphenylcarboxylic%252BAcids%252Bas%252BPPAR%2525CE%2525B3%252BAntagonists%26aulast%3DAsteian%26aufirst%3DAlice%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D30052015%26date%3D04082015%26date%3D05082015%26date%3D10092015%26date%3D04082015%26volume%3D6%26issue%3D9%26spage%3D998%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Céline  Pirat</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">Nicolas  Lebègue</span>, <span class="hlFld-ContribAuthor ">Nicolas  Renault</span>, <span class="hlFld-ContribAuthor ">Christophe  Furman</span>, <span class="hlFld-ContribAuthor ">Régis  Millet</span>, <span class="hlFld-ContribAuthor ">Saı̈d  Yous</span>, <span class="hlFld-ContribAuthor ">Silvia  Speca</span>, <span class="hlFld-ContribAuthor ">Pascal  Berthelot</span>, <span class="hlFld-ContribAuthor ">Pierre  Desreumaux</span>, and <span class="hlFld-ContribAuthor ">Philippe  Chavatte</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (9)
                                     , 4027-4061. <a href="https://doi.org/10.1021/jm101360s" title="DOI URL">https://doi.org/10.1021/jm101360s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101360s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101360s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BPeroxisome%252BProliferator-Activated%252BReceptors%252B%252528PPARs%252529%25253A%252BDevelopment%252Bof%252BModulators%26aulast%3DPirat%26aufirst%3DC%25C3%25A9line%26date%3D2012%26date%3D2012%26date%3D2010%26date%3D19102010%26date%3D27022012%26date%3D10052012%26date%3D19012012%26volume%3D55%26issue%3D9%26spage%3D4027%26epage%3D4061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Fiona  Lau</span>, <span class="hlFld-ContribAuthor ">Kun  Liu</span>, <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>, <span class="hlFld-ContribAuthor ">Gaochao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuli  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Taro E.  Akiyama</span>, <span class="hlFld-ContribAuthor ">Gino  Castriota</span>, <span class="hlFld-ContribAuthor ">Monica  Einstein</span>, <span class="hlFld-ContribAuthor ">Chualin  Wang</span>, <span class="hlFld-ContribAuthor ">Margaret E.  McCann</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Doebber</span>, <span class="hlFld-ContribAuthor ">Margaret  Wu</span>, <span class="hlFld-ContribAuthor ">Ching H.  Chang</span>, <span class="hlFld-ContribAuthor ">Lesley  McNamara</span>, <span class="hlFld-ContribAuthor ">Brian  McKeever</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, <span class="hlFld-ContribAuthor ">Joel P.  Berger</span>, and <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8541-8554. <a href="https://doi.org/10.1021/jm201061j" title="DOI URL">https://doi.org/10.1021/jm201061j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201061j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201061j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazolones%25253A%252BA%252BNew%252BClass%252Bof%252BSelective%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252B%252528PPAR%2525CE%2525B3%252529%252BModulators%26aulast%3DLiu%26aufirst%3DWeiguo%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D07082011%26date%3D28112011%26date%3D22122011%26date%3D09112011%26volume%3D54%26issue%3D24%26spage%3D8541%26epage%3D8554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Seto</span>, <span class="hlFld-ContribAuthor ">Kyoko  Okada</span>, <span class="hlFld-ContribAuthor ">Koichi  Kiyota</span>, <span class="hlFld-ContribAuthor ">Shigeki  Isogai</span>, <span class="hlFld-ContribAuthor ">Maki  Iwago</span>, <span class="hlFld-ContribAuthor ">Takehiro  Shinozaki</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Kitamura</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kohno</span> and <span class="hlFld-ContribAuthor ">Koji  Murakami</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure−Activity Relationship Studies of Novel 2,4,6-Trisubstituted-5-pyrimidinecarboxylic Acids as Peroxisome Proliferator-Activated Receptor γ (PPARγ) Partial Agonists with Comparable Antidiabetic Efficacy to Rosiglitazone. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (13)
                                     , 5012-5024. <a href="https://doi.org/10.1021/jm100443s" title="DOI URL">https://doi.org/10.1021/jm100443s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100443s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100443s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BStudies%252Bof%252BNovel%252B2%25252C4%25252C6-Trisubstituted-5-pyrimidinecarboxylic%252BAcids%252Bas%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252B%252528PPAR%2525CE%2525B3%252529%252BPartial%252BAgonists%252Bwith%252BComparable%252BAntidiabetic%252BEfficacy%252Bto%252BRosiglitazone%26aulast%3DSeto%26aufirst%3DShigeki%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11042010%26date%3D09062010%26date%3D08072010%26volume%3D53%26issue%3D13%26spage%3D5012%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amalia  Gastaldelli</span>, <span class="hlFld-ContribAuthor ">Norbert  Stefan</span>, <span class="hlFld-ContribAuthor ">Hans-Ulrich  Häring</span>. </span><span class="cited-content_cbyCitation_article-title">Liver-targeting drugs and their effect on blood glucose and hepatic lipids. </span><span class="cited-content_cbyCitation_journal-name">Diabetologia</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 1461-1479. <a href="https://doi.org/10.1007/s00125-021-05442-2" title="DOI URL">https://doi.org/10.1007/s00125-021-05442-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00125-021-05442-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00125-021-05442-2%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetologia%26atitle%3DLiver-targeting%252Bdrugs%252Band%252Btheir%252Beffect%252Bon%252Bblood%252Bglucose%252Band%252Bhepatic%252Blipids%26aulast%3DGastaldelli%26aufirst%3DAmalia%26date%3D2021%26date%3D2021%26volume%3D64%26issue%3D7%26spage%3D1461%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter T.W.  Cheng</span>, <span class="hlFld-ContribAuthor ">Ellen  Kick</span>, <span class="hlFld-ContribAuthor ">Ranjan  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear Hormone Receptor Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-117. <a href="https://doi.org/10.1002/0471266949.bmc191.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc191.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc191.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc191.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DNuclear%252BHormone%252BReceptor%252BMedicinal%252BChemistry%26aulast%3DCheng%26aufirst%3DPeter%2BT.W.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D117%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluca  Svegliati-Baroni</span>, <span class="hlFld-ContribAuthor ">Bárbara  Patrício</span>, <span class="hlFld-ContribAuthor ">Gessica  Lioci</span>, <span class="hlFld-ContribAuthor ">Maria Paula  Macedo</span>, <span class="hlFld-ContribAuthor ">Amalia  Gastaldelli</span>. </span><span class="cited-content_cbyCitation_article-title">Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (16)
                                     , 5820. <a href="https://doi.org/10.3390/ijms21165820" title="DOI URL">https://doi.org/10.3390/ijms21165820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21165820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21165820%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DGut-Pancreas-Liver%252BAxis%252Bas%252Ba%252BTarget%252Bfor%252BTreatment%252Bof%252BNAFLD%25252FNASH%26aulast%3DSvegliati-Baroni%26aufirst%3DGianluca%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D16%26spage%3D5820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji  Zhang</span>, <span class="hlFld-ContribAuthor ">Eric S.  Muise</span>, <span class="hlFld-ContribAuthor ">Seongah  Han</span>, <span class="hlFld-ContribAuthor ">Peter S.  Kutchukian</span>, <span class="hlFld-ContribAuthor ">Philippe  Costet</span>, <span class="hlFld-ContribAuthor ">Yonghua  Zhu</span>, <span class="hlFld-ContribAuthor ">Yanqing  Kan</span>, <span class="hlFld-ContribAuthor ">Haihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Vinit  Shah</span>, <span class="hlFld-ContribAuthor ">Yongcheng  Huang</span>, <span class="hlFld-ContribAuthor ">Ashmita  Saigal</span>, <span class="hlFld-ContribAuthor ">Taro E.  Akiyama</span>, <span class="hlFld-ContribAuthor ">Xiao-Lan  Shen</span>, <span class="hlFld-ContribAuthor ">Tian-Quan  Cai</span>, <span class="hlFld-ContribAuthor ">Kashmira  Shah</span>, <span class="hlFld-ContribAuthor ">Ester  Carballo-Jane</span>, <span class="hlFld-ContribAuthor ">Emanuel  Zycband</span>, <span class="hlFld-ContribAuthor ">Lan  Yi</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Imbriglio</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Smith</span>, <span class="hlFld-ContribAuthor ">Kristine  Devito</span>, <span class="hlFld-ContribAuthor ">James  Conway</span>, <span class="hlFld-ContribAuthor ">Li-Jun  Ma</span>, <span class="hlFld-ContribAuthor ">Maarten  Hoek</span>, <span class="hlFld-ContribAuthor ">Iyassu K.  Sebhat</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Peier</span>, <span class="hlFld-ContribAuthor ">Saswata  Talukdar</span>, <span class="hlFld-ContribAuthor ">David G.  McLaren</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Previs</span>, <span class="hlFld-ContribAuthor ">Kristian K.  Jensen</span>, <span class="hlFld-ContribAuthor ">Shirly  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports Medicine</span><span> <strong>2020,</strong> <em>1 </em>
                                    (4)
                                     , 100056. <a href="https://doi.org/10.1016/j.xcrm.2020.100056" title="DOI URL">https://doi.org/10.1016/j.xcrm.2020.100056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xcrm.2020.100056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xcrm.2020.100056%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%2520Medicine%26atitle%3DMolecular%252BProfiling%252BReveals%252Ba%252BCommon%252BMetabolic%252BSignature%252Bof%252BTissue%252BFibrosis%26aulast%3DZhang%26aufirst%3DJi%26date%3D2020%26volume%3D1%26issue%3D4%26spage%3D100056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Holli-Joi  Sullivan</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Shaina  Nogle</span>, <span class="hlFld-ContribAuthor ">Siyan  Liao</span>, <span class="hlFld-ContribAuthor ">Chun  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">PPAR Research</span><span> <strong>2020,</strong> <em>2020 </em>, 1-24. <a href="https://doi.org/10.1155/2020/5314187" title="DOI URL">https://doi.org/10.1155/2020/5314187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/5314187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F5314187%26sid%3Dliteratum%253Aachs%26jtitle%3DPPAR%2520Research%26atitle%3DTo%252BProbe%252BFull%252Band%252BPartial%252BActivation%252Bof%252BHuman%252BPeroxisome%252BProliferator-Activated%252BReceptors%252Bby%252BPan-Agonist%252BChiglitazar%252BUsing%252BMolecular%252BDynamics%252BSimulations%26aulast%3DSullivan%26aufirst%3DHolli-Joi%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalyzed Synthesis of Antidiabetic Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 349-436. <a href="https://doi.org/10.1201/9780429353116-11" title="DOI URL">https://doi.org/10.1201/9780429353116-11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/9780429353116-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2F9780429353116-11%26sid%3Dliteratum%253Aachs%26atitle%3DBiocatalyzed%252BSynthesis%252Bof%252BAntidiabetic%252BDrugs%26aulast%3DAlc%25C3%25A1ntara%26aufirst%3DAndr%25C3%25A9s%2BR.%26date%3D2019%26spage%3D349%26epage%3D436%26pub%3DJenny%2520Stanford%2520Publishing%26atitle%3DPharmaceutical%252BBiocatalysis%26aulast%3DGrunwald%26aufirst%3DPeter%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yujing  Hu</span>, <span class="hlFld-ContribAuthor ">Jiajie  Fan</span>, <span class="hlFld-ContribAuthor ">Mamatjan  Arkin</span>, <span class="hlFld-ContribAuthor ">Danyang  Li</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Peng</span>, <span class="hlFld-ContribAuthor ">Weihua  Xu</span>, <span class="hlFld-ContribAuthor ">Xianfu  Lin</span>, <span class="hlFld-ContribAuthor ">Qi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Light‐Driven Kinetic Resolution of α‐Functionalized Carboxylic Acids Enabled by an Engineered Fatty Acid Photodecarboxylase. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (25)
                                     , 8474-8478. <a href="https://doi.org/10.1002/anie.201903165" title="DOI URL">https://doi.org/10.1002/anie.201903165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201903165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201903165%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DLight%2525E2%252580%252590Driven%252BKinetic%252BResolution%252Bof%252B%2525CE%2525B1%2525E2%252580%252590Functionalized%252BCarboxylic%252BAcids%252BEnabled%252Bby%252Ban%252BEngineered%252BFatty%252BAcid%252BPhotodecarboxylase%26aulast%3DXu%26aufirst%3DJian%26date%3D2019%26volume%3D58%26issue%3D25%26spage%3D8474%26epage%3D8478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yujing  Hu</span>, <span class="hlFld-ContribAuthor ">Jiajie  Fan</span>, <span class="hlFld-ContribAuthor ">Mamatjan  Arkin</span>, <span class="hlFld-ContribAuthor ">Danyang  Li</span>, <span class="hlFld-ContribAuthor ">Yongzhen  Peng</span>, <span class="hlFld-ContribAuthor ">Weihua  Xu</span>, <span class="hlFld-ContribAuthor ">Xianfu  Lin</span>, <span class="hlFld-ContribAuthor ">Qi  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Light‐Driven Kinetic Resolution of α‐Functionalized Carboxylic Acids Enabled by an Engineered Fatty Acid Photodecarboxylase. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>52 </em><a href="https://doi.org/10.1002/ange.201903165" title="DOI URL">https://doi.org/10.1002/ange.201903165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201903165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201903165%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DLight%2525E2%252580%252590Driven%252BKinetic%252BResolution%252Bof%252B%2525CE%2525B1%2525E2%252580%252590Functionalized%252BCarboxylic%252BAcids%252BEnabled%252Bby%252Ban%252BEngineered%252BFatty%252BAcid%252BPhotodecarboxylase%26aulast%3DXu%26aufirst%3DJian%26date%3D2019%26date%3D2019%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Cesar  Corzo</span>, <span class="hlFld-ContribAuthor ">Mi Ra  Chang</span>, <span class="hlFld-ContribAuthor ">Jinsai  Shang</span>, <span class="hlFld-ContribAuthor ">Vinh Q.  Lam</span>, <span class="hlFld-ContribAuthor ">Richard  Brust</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Blayo</span>, <span class="hlFld-ContribAuthor ">John B.  Bruning</span>, <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Kojetin</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Griffin</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 1431-1439.e6. <a href="https://doi.org/10.1016/j.str.2018.07.007" title="DOI URL">https://doi.org/10.1016/j.str.2018.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2018.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2018.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DChemical%252BCrosslinking%252BMass%252BSpectrometry%252BReveals%252Bthe%252BConformational%252BLandscape%252Bof%252Bthe%252BActivation%252BHelix%252Bof%252BPPAR%2525CE%2525B3%25253B%252Ba%252BModel%252Bfor%252BLigand-Dependent%252BAntagonism%26aulast%3DZheng%26aufirst%3DJie%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D1431%26epage%3D1439.e6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  Shinozuka</span>, <span class="hlFld-ContribAuthor ">Tomoharu  Tsukada</span>, <span class="hlFld-ContribAuthor ">Kunihiko  Fujii</span>, <span class="hlFld-ContribAuthor ">Eri  Tokumaru</span>, <span class="hlFld-ContribAuthor ">Kousei  Shimada</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Onishi</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Satoko  Wakimoto</span>, <span class="hlFld-ContribAuthor ">Masanori  Kuroha</span>, <span class="hlFld-ContribAuthor ">Tsuneaki  Ogata</span>, <span class="hlFld-ContribAuthor ">Kazushi  Araki</span>, <span class="hlFld-ContribAuthor ">Jun  Ohsumi</span>, <span class="hlFld-ContribAuthor ">Ryoko  Sawamura</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hideki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kazunori  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Tani</span>, <span class="hlFld-ContribAuthor ">Makoto  Mori</span>, <span class="hlFld-ContribAuthor ">Jun  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5099-5117. <a href="https://doi.org/10.1016/j.bmc.2018.09.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDS-6930%25252C%252Ba%252Bpotent%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulator.%252BPart%252BII%25253A%252BLead%252Boptimization%26aulast%3DShinozuka%26aufirst%3DTsuyoshi%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5099%26epage%3D5117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  Shinozuka</span>, <span class="hlFld-ContribAuthor ">Tomoharu  Tsukada</span>, <span class="hlFld-ContribAuthor ">Kunihiko  Fujii</span>, <span class="hlFld-ContribAuthor ">Eri  Tokumaru</span>, <span class="hlFld-ContribAuthor ">Kousei  Shimada</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Onishi</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Satoko  Wakimoto</span>, <span class="hlFld-ContribAuthor ">Masanori  Kuroha</span>, <span class="hlFld-ContribAuthor ">Tsuneaki  Ogata</span>, <span class="hlFld-ContribAuthor ">Kazushi  Araki</span>, <span class="hlFld-ContribAuthor ">Jun  Ohsumi</span>, <span class="hlFld-ContribAuthor ">Ryoko  Sawamura</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hideki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kazunori  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Yoshiro  Tani</span>, <span class="hlFld-ContribAuthor ">Makoto  Mori</span>, <span class="hlFld-ContribAuthor ">Jun  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 5079-5098. <a href="https://doi.org/10.1016/j.bmc.2018.09.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.09.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.09.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDS-6930%25252C%252Ba%252Bpotent%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulator.%252BPart%252BI%25253A%252BLead%252Bidentification%26aulast%3DShinozuka%26aufirst%3DTsuyoshi%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D5079%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina M.  Alcántara</span>, <span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalyzed synthesis of antidiabetic drugs: A review. </span><span class="cited-content_cbyCitation_journal-name">Biocatalysis and Biotransformation</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 12-46. <a href="https://doi.org/10.1080/10242422.2017.1323887" title="DOI URL">https://doi.org/10.1080/10242422.2017.1323887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10242422.2017.1323887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10242422.2017.1323887%26sid%3Dliteratum%253Aachs%26jtitle%3DBiocatalysis%2520and%2520Biotransformation%26atitle%3DBiocatalyzed%252Bsynthesis%252Bof%252Bantidiabetic%252Bdrugs%25253A%252BA%252Breview%26aulast%3DAlc%25C3%25A1ntara%26aufirst%3DCristina%2BM.%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D1%26spage%3D12%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bowen  Tang</span>, <span class="hlFld-ContribAuthor ">Boqun  Li</span>, <span class="hlFld-ContribAuthor ">Yuqin  Qian</span>, <span class="hlFld-ContribAuthor ">Mingtao  Ao</span>, <span class="hlFld-ContribAuthor ">Kaiqiang  Guo</span>, <span class="hlFld-ContribAuthor ">Meijuan  Fang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">The molecular mechanism of hPPARα activation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (28)
                                     , 17193-17201. <a href="https://doi.org/10.1039/C6RA27740C" title="DOI URL">https://doi.org/10.1039/C6RA27740C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA27740C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA27740C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DThe%252Bmolecular%252Bmechanism%252Bof%252BhPPAR%2525CE%2525B1%252Bactivation%26aulast%3DTang%26aufirst%3DBowen%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D28%26spage%3D17193%26epage%3D17201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonie  Gellrich</span>, <span class="hlFld-ContribAuthor ">Daniel  Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Receptor Research</span><span> <strong>2017,</strong> <em>4 </em><a href="https://doi.org/10.11131/2017/101310" title="DOI URL">https://doi.org/10.11131/2017/101310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.11131/2017/101310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.11131%2F2017%2F101310%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Receptor%2520Research%26atitle%3DTherapeutic%252BPotential%252Bof%252BPeroxisome%252BProliferator-Activated%252BReceptor%252BModulation%252Bin%252BNon-Alcoholic%252BFatty%252BLiver%252BDisease%252Band%252BNon-Alcoholic%252BSteatohepatitis%26aulast%3DGellrich%26aufirst%3DLeonie%26date%3D2017%26date%3D2017%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christelle  Doebelin</span>, <span class="hlFld-ContribAuthor ">Rémi  Patouret</span>, <span class="hlFld-ContribAuthor ">Ruben D.  Garcia-Ordonez</span>, <span class="hlFld-ContribAuthor ">Mi Ra  Chang</span>, <span class="hlFld-ContribAuthor ">Venkatasubramanian  Dharmarajan</span>, <span class="hlFld-ContribAuthor ">Dana S.  Kuruvilla</span>, <span class="hlFld-ContribAuthor ">Scott J.  Novick</span>, <span class="hlFld-ContribAuthor ">Li  Lin</span>, <span class="hlFld-ContribAuthor ">Michael D.  Cameron</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Griffin</span>, <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>. </span><span class="cited-content_cbyCitation_article-title">N
              -Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (23)
                                     , 2607-2620. <a href="https://doi.org/10.1002/cmdc.201600491" title="DOI URL">https://doi.org/10.1002/cmdc.201600491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600491%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DN%252B-Arylsulfonyl%252BIndolines%252Bas%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor%2525E2%252580%252585%2525CE%2525B3%252B%252528ROR%2525CE%2525B3%252529%252BAgonists%26aulast%3DDoebelin%26aufirst%3DChristelle%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D23%26spage%3D2607%26epage%3D2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilia  Goltsman</span>, <span class="hlFld-ContribAuthor ">Emad E.  Khoury</span>, <span class="hlFld-ContribAuthor ">Joseph  Winaver</span>, <span class="hlFld-ContribAuthor ">Zaid  Abassi</span>. </span><span class="cited-content_cbyCitation_article-title">Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2016,</strong> <em>168 </em>, 75-97. <a href="https://doi.org/10.1016/j.pharmthera.2016.09.007" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2016.09.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2016.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2016.09.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DDoes%252BThiazolidinedione%252Btherapy%252Bexacerbate%252Bfluid%252Bretention%252Bin%252Bcongestive%252Bheart%252Bfailure%25253F%26aulast%3DGoltsman%26aufirst%3DIlia%26date%3D2016%26volume%3D168%26spage%3D75%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Xian-Bin  Xie</span>, <span class="hlFld-ContribAuthor ">Xian-Chao  Cheng</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Multitargeted bioactive ligands for PPARs discovered in the last decade. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>88 </em>
                                    (5)
                                     , 635-663. <a href="https://doi.org/10.1111/cbdd.12806" title="DOI URL">https://doi.org/10.1111/cbdd.12806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12806%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DMultitargeted%252Bbioactive%252Bligands%252Bfor%252BPPARs%252Bdiscovered%252Bin%252Bthe%252Blast%252Bdecade%26aulast%3DZhang%26aufirst%3DJun%26date%3D2016%26date%3D2016%26volume%3D88%26issue%3D5%26spage%3D635%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peiyuan  Yao</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Cui</span>, <span class="hlFld-ContribAuthor ">Shanshan  Yu</span>, <span class="hlFld-ContribAuthor ">Yuncheng  Du</span>, <span class="hlFld-ContribAuthor ">Jinhui  Feng</span>, <span class="hlFld-ContribAuthor ">Qiaqing  Wu</span>, <span class="hlFld-ContribAuthor ">Dunming  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Biosynthesis of (
              R
              )- or (
              S
              )-2-Hydroxybutyrate from
              l
              -Threonine through a Synthetic Biology Approach. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (18)
                                     , 2923-2928. <a href="https://doi.org/10.1002/adsc.201600468" title="DOI URL">https://doi.org/10.1002/adsc.201600468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600468%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BBiosynthesis%252Bof%252B%252528%252BR%252B%252529-%252Bor%252B%252528%252BS%252B%252529-2-Hydroxybutyrate%252Bfrom%252Bl%252B-Threonine%252Bthrough%252Ba%252BSynthetic%252BBiology%252BApproach%26aulast%3DYao%26aufirst%3DPeiyuan%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D18%26spage%3D2923%26epage%3D2928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shun-Jiang  Yao</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Ren</span>, <span class="hlFld-ContribAuthor ">Zheng-Hui  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on the synthesis of acylindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (35)
                                     , 3892-3901. <a href="https://doi.org/10.1016/j.tetlet.2016.07.063" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.07.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.07.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.07.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRecent%252Badvances%252Bon%252Bthe%252Bsynthesis%252Bof%252Bacylindoles%26aulast%3DYao%26aufirst%3DShun-Jiang%26date%3D2016%26volume%3D57%26issue%3D35%26spage%3D3892%26epage%3D3901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Gassman Indole Synthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 116-120. <a href="https://doi.org/10.1002/9781118695692.ch3" title="DOI URL">https://doi.org/10.1002/9781118695692.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118695692.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118695692.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DGassman%252BIndole%252BSynthesis%26date%3D2016%26date%3D2016%26spage%3D116%26epage%3D120%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DIndole%252BRing%252BSynthesis%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2016%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong Uk  Song</span>, <span class="hlFld-ContribAuthor ">Jae Wan  Jang</span>, <span class="hlFld-ContribAuthor ">Tae Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Heuisul  Park</span>, <span class="hlFld-ContribAuthor ">Wan Su  Park</span>, <span class="hlFld-ContribAuthor ">Sang-Hun  Jung</span>, <span class="hlFld-ContribAuthor ">Geun Tae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 950-954. <a href="https://doi.org/10.1016/j.bmcl.2015.12.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B2-%252528indol-2-yl%252529%252Bthiazole%252Bderivatives%252Bas%252Bxanthine%252Boxidase%252Binhibitors%26aulast%3DSong%26aufirst%3DJeong%2BUk%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D950%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>, <span class="hlFld-ContribAuthor ">K. Bhaskara  Rao</span>, <span class="hlFld-ContribAuthor ">Ravi  Sonkar</span>, <span class="hlFld-ContribAuthor ">Ram K.  Modukuri</span>, <span class="hlFld-ContribAuthor ">Yashpal S.  Chhonker</span>, <span class="hlFld-ContribAuthor ">Pragati  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Hardik  Chandasana</span>, <span class="hlFld-ContribAuthor ">A. K.  Khanna</span>, <span class="hlFld-ContribAuthor ">Rabi S.  Bhatta</span>, <span class="hlFld-ContribAuthor ">Gitika  Bhatia</span>, <span class="hlFld-ContribAuthor ">Manish Kumar  Suthar</span>, <span class="hlFld-ContribAuthor ">Jitendra Kumar  Saxena</span>, <span class="hlFld-ContribAuthor ">Vikash  Kumar</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of coumarin–indole: design, synthesis and biological evaluation in Triton WR-1339 and high-fat diet induced hyperlipidemic rat models. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 1858-1869. <a href="https://doi.org/10.1039/C6MD00283H" title="DOI URL">https://doi.org/10.1039/C6MD00283H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00283H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00283H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DHybrids%252Bof%252Bcoumarin%2525E2%252580%252593indole%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bin%252BTriton%252BWR-1339%252Band%252Bhigh-fat%252Bdiet%252Binduced%252Bhyperlipidemic%252Brat%252Bmodels%26aulast%3DSashidhara%26aufirst%3DKoneni%2BV.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D1858%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin P.  Fauber</span>, <span class="hlFld-ContribAuthor ">Alberto  Gobbi</span>, <span class="hlFld-ContribAuthor ">Kirk  Robarge</span>, <span class="hlFld-ContribAuthor ">Aihe  Zhou</span>, <span class="hlFld-ContribAuthor ">Adrian  Barnard</span>, <span class="hlFld-ContribAuthor ">Jianhua  Cao</span>, <span class="hlFld-ContribAuthor ">Yuzhong  Deng</span>, <span class="hlFld-ContribAuthor ">Céline  Eidenschenk</span>, <span class="hlFld-ContribAuthor ">Christine  Everett</span>, <span class="hlFld-ContribAuthor ">Arunima  Ganguli</span>, <span class="hlFld-ContribAuthor ">Julie  Hawkins</span>, <span class="hlFld-ContribAuthor ">Adam R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Hank  La</span>, <span class="hlFld-ContribAuthor ">Maxine  Norman</span>, <span class="hlFld-ContribAuthor ">Gary  Salmon</span>, <span class="hlFld-ContribAuthor ">Susan  Summerhill</span>, <span class="hlFld-ContribAuthor ">Wenjun  Ouyang</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Harvey  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (15)
                                     , 2907-2912. <a href="https://doi.org/10.1016/j.bmcl.2015.05.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bimidazo%25255B1%25252C5-a%25255Dpyridines%252Band%252B-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BRORc%252Binverse%252Bagonists%26aulast%3DFauber%26aufirst%3DBenjamin%2BP.%26date%3D2015%26volume%3D25%26issue%3D15%26spage%3D2907%26epage%3D2912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Murad  Hossain</span>, <span class="hlFld-ContribAuthor ">Abdul  Mukheem</span>, <span class="hlFld-ContribAuthor ">Tunku  Kamarul</span>. </span><span class="cited-content_cbyCitation_article-title">The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2015,</strong> <em>135 </em>, 55-67. <a href="https://doi.org/10.1016/j.lfs.2015.03.010" title="DOI URL">https://doi.org/10.1016/j.lfs.2015.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2015.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2015.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DThe%252Bprevention%252Band%252Btreatment%252Bof%252Bhypoadiponectinemia-associated%252Bhuman%252Bdiseases%252Bby%252Bup-regulation%252Bof%252Bplasma%252Badiponectin%26aulast%3DHossain%26aufirst%3DMd.%2BMurad%26date%3D2015%26volume%3D135%26spage%3D55%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sridevi  Chigurupati</span>, <span class="hlFld-ContribAuthor ">Sokkalingam A.  Dhanaraj</span>, <span class="hlFld-ContribAuthor ">Pitchai  Balakumar</span>. </span><span class="cited-content_cbyCitation_article-title">A step ahead of PPARγ full agonists to PPARγ partial agonists: Therapeutic perspectives in the management of diabetic insulin resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2015,</strong> <em>755 </em>, 50-57. <a href="https://doi.org/10.1016/j.ejphar.2015.02.043" title="DOI URL">https://doi.org/10.1016/j.ejphar.2015.02.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2015.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2015.02.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bstep%252Bahead%252Bof%252BPPAR%2525CE%2525B3%252Bfull%252Bagonists%252Bto%252BPPAR%2525CE%2525B3%252Bpartial%252Bagonists%25253A%252BTherapeutic%252Bperspectives%252Bin%252Bthe%252Bmanagement%252Bof%252Bdiabetic%252Binsulin%252Bresistance%26aulast%3DChigurupati%26aufirst%3DSridevi%26date%3D2015%26volume%3D755%26spage%3D50%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong Uk  Song</span>, <span class="hlFld-ContribAuthor ">Sung Pil  Choi</span>, <span class="hlFld-ContribAuthor ">Tae Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Cheol-Kyu  Jung</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Sang-Hun  Jung</span>, <span class="hlFld-ContribAuthor ">Geun Tae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (6)
                                     , 1254-1258. <a href="https://doi.org/10.1016/j.bmcl.2015.01.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.01.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.01.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.01.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B2-%252528indol-5-yl%252529thiazole%252Bderivatives%252Bas%252Bxanthine%252Boxidase%252Binhibitors%26aulast%3DSong%26aufirst%3DJeong%2BUk%26date%3D2015%26volume%3D25%26issue%3D6%26spage%3D1254%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ichiro  Takada</span>, <span class="hlFld-ContribAuthor ">Makoto  Makishima</span>. </span><span class="cited-content_cbyCitation_article-title">PPARγ ligands and their therapeutic applications: a patent review (2008 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (2)
                                     , 175-191. <a href="https://doi.org/10.1517/13543776.2014.985206" title="DOI URL">https://doi.org/10.1517/13543776.2014.985206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.985206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.985206%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPPAR%2525CE%2525B3%252Bligands%252Band%252Btheir%252Btherapeutic%252Bapplications%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DTakada%26aufirst%3DIchiro%26date%3D2015%26date%3D2014%26volume%3D25%26issue%3D2%26spage%3D175%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  Wright</span>, <span class="hlFld-ContribAuthor ">Michele  Bortolini</span>, <span class="hlFld-ContribAuthor ">Moh  Tadayyon</span>, <span class="hlFld-ContribAuthor ">Martin  Bopst</span>. </span><span class="cited-content_cbyCitation_article-title">Minireview: Challenges and Opportunities in Development of PPAR Agonists. </span><span class="cited-content_cbyCitation_journal-name">Molecular Endocrinology</span><span> <strong>2014,</strong> <em>28 </em>
                                    (11)
                                     , 1756-1768. <a href="https://doi.org/10.1210/me.2013-1427" title="DOI URL">https://doi.org/10.1210/me.2013-1427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/me.2013-1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fme.2013-1427%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Endocrinology%26atitle%3DMinireview%25253A%252BChallenges%252Band%252BOpportunities%252Bin%252BDevelopment%252Bof%252BPPAR%252BAgonists%26aulast%3DWright%26aufirst%3DMatthew%2BB.%26date%3D2014%26volume%3D28%26issue%3D11%26spage%3D1756%26epage%3D1768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veera R.  Konda</span>, <span class="hlFld-ContribAuthor ">Anuradha  Desai</span>, <span class="hlFld-ContribAuthor ">Gary  Darland</span>, <span class="hlFld-ContribAuthor ">Neile  Grayson</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Bland</span>, . </span><span class="cited-content_cbyCitation_article-title">KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (1)
                                     , e87848. <a href="https://doi.org/10.1371/journal.pone.0087848" title="DOI URL">https://doi.org/10.1371/journal.pone.0087848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0087848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0087848%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DKDT501%25252C%252Ba%252BDerivative%252Bfrom%252BHops%25252C%252BNormalizes%252BGlucose%252BMetabolism%252Band%252BBody%252BWeight%252Bin%252BRodent%252BModels%252Bof%252BDiabetes%26aulast%3DKonda%26aufirst%3DVeera%2BR.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D1%26spage%3De87848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas P.  Burris</span>, <span class="hlFld-ContribAuthor ">Laura A.  Solt</span>, <span class="hlFld-ContribAuthor ">Yongjun  Wang</span>, <span class="hlFld-ContribAuthor ">Christine  Crumbley</span>, <span class="hlFld-ContribAuthor ">Subhashis  Banerjee</span>, <span class="hlFld-ContribAuthor ">Kristine  Griffett</span>, <span class="hlFld-ContribAuthor ">Thomas  Lundasen</span>, <span class="hlFld-ContribAuthor ">Travis  Hughes</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Kojetin</span>, . </span><span class="cited-content_cbyCitation_article-title">Nuclear Receptors and Their Selective Pharmacologic Modulators. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2013,</strong> <em>65 </em>
                                    (2)
                                     , 710-778. <a href="https://doi.org/10.1124/pr.112.006833" title="DOI URL">https://doi.org/10.1124/pr.112.006833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.112.006833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.112.006833%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DNuclear%252BReceptors%252Band%252BTheir%252BSelective%252BPharmacologic%252BModulators%26aulast%3DBurris%26aufirst%3DThomas%2BP.%26date%3D2013%26date%3D2013%26volume%3D65%26issue%3D2%26spage%3D710%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akihiro  Furukawa</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Arita</span>, <span class="hlFld-ContribAuthor ">Takehiro  Fukuzaki</span>, <span class="hlFld-ContribAuthor ">Makoto  Mori</span>, <span class="hlFld-ContribAuthor ">Takeshi  Honda</span>, <span class="hlFld-ContribAuthor ">Susumu  Satoh</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Kenji  Wakabayashi</span>, <span class="hlFld-ContribAuthor ">Shinko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Kouichi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Kazushi  Araki</span>, <span class="hlFld-ContribAuthor ">Masanori  Kuroha</span>, <span class="hlFld-ContribAuthor ">Jun  Tanaka</span>, <span class="hlFld-ContribAuthor ">Satoko  Wakimoto</span>, <span class="hlFld-ContribAuthor ">Osamu  Suzuki</span>, <span class="hlFld-ContribAuthor ">Jun  Ohsumi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 522-533. <a href="https://doi.org/10.1016/j.ejmech.2012.05.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.05.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.05.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B%252528%2525E2%252588%252592%252529-cercosporamide%252Bderivatives%252Bas%252Bpotent%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulators%26aulast%3DFurukawa%26aufirst%3DAkihiro%26date%3D2012%26volume%3D54%26spage%3D522%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pitchai  Balakumar</span>, <span class="hlFld-ContribAuthor ">Sonam  Kathuria</span>. </span><span class="cited-content_cbyCitation_article-title">Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>166 </em>
                                    (7)
                                     , 1981-1992. <a href="https://doi.org/10.1111/j.1476-5381.2012.01938.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2012.01938.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2012.01938.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2012.01938.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DSubmaximal%252BPPAR%2525CE%2525B3%252Bactivation%252Band%252Bendothelial%252Bdysfunction%25253A%252Bnew%252Bperspectives%252Bfor%252Bthe%252Bmanagement%252Bof%252Bcardiovascular%252Bdisorders%26aulast%3DBalakumar%26aufirst%3DPitchai%26date%3D2012%26date%3D2012%26volume%3D166%26issue%3D7%26spage%3D1981%26epage%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yejun  Tan</span>, <span class="hlFld-ContribAuthor ">Eric S.  Muise</span>, <span class="hlFld-ContribAuthor ">Hongyue  Dai</span>, <span class="hlFld-ContribAuthor ">Richard  Raubertas</span>, <span class="hlFld-ContribAuthor ">Kenny K.  Wong</span>, <span class="hlFld-ContribAuthor ">G. Marie  Thompson</span>, <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>, <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>, <span class="hlFld-ContribAuthor ">Pek Yee  Lum</span>, <span class="hlFld-ContribAuthor ">John R.  Thompson</span>, <span class="hlFld-ContribAuthor ">Joel P.  Berger</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Transcriptome Profiling Analyses Demonstrate that Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators Display Attenuated and Selective Gene Regulatory Activity in Comparison with PPARγ Full Agonists. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2012,</strong> <em>82 </em>
                                    (1)
                                     , 68-79. <a href="https://doi.org/10.1124/mol.111.076679" title="DOI URL">https://doi.org/10.1124/mol.111.076679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.111.076679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.111.076679%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DNovel%252BTranscriptome%252BProfiling%252BAnalyses%252BDemonstrate%252Bthat%252BSelective%252BPeroxisome%252BProliferator-Activated%252BReceptor%252B%2525CE%2525B3%252B%252528PPAR%2525CE%2525B3%252529%252BModulators%252BDisplay%252BAttenuated%252Band%252BSelective%252BGene%252BRegulatory%252BActivity%252Bin%252BComparison%252Bwith%252BPPAR%2525CE%2525B3%252BFull%252BAgonists%26aulast%3DTan%26aufirst%3DYejun%26date%3D2012%26date%3D2012%26volume%3D82%26issue%3D1%26spage%3D68%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. J.  Verspohl</span>, . </span><span class="cited-content_cbyCitation_article-title">Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2012,</strong> <em>64 </em>
                                    (2)
                                     , 188-237. <a href="https://doi.org/10.1124/pr.110.003319" title="DOI URL">https://doi.org/10.1124/pr.110.003319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.110.003319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.110.003319%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DNovel%252BPharmacological%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BType%252B2%252BDiabetes%26aulast%3DVerspohl%26aufirst%3DE.%2BJ.%26date%3D2012%26date%3D2012%26volume%3D64%26issue%3D2%26spage%3D188%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akihiro  Furukawa</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Arita</span>, <span class="hlFld-ContribAuthor ">Takehiro  Fukuzaki</span>, <span class="hlFld-ContribAuthor ">Susumu  Satoh</span>, <span class="hlFld-ContribAuthor ">Makoto  Mori</span>, <span class="hlFld-ContribAuthor ">Takeshi  Honda</span>, <span class="hlFld-ContribAuthor ">Yumi  Matsui</span>, <span class="hlFld-ContribAuthor ">Kenji  Wakabayashi</span>, <span class="hlFld-ContribAuthor ">Shinko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Kazushi  Araki</span>, <span class="hlFld-ContribAuthor ">Jun  Ohsumi</span>. </span><span class="cited-content_cbyCitation_article-title">Substituents at the naphthalene C3 position of (−)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARγ partial agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (3)
                                     , 1348-1351. <a href="https://doi.org/10.1016/j.bmcl.2011.12.066" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.12.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.12.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.12.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSubstituents%252Bat%252Bthe%252Bnaphthalene%252BC3%252Bposition%252Bof%252B%252528%2525E2%252588%252592%252529-Cercosporamide%252Bderivatives%252Bsignificantly%252Baffect%252Bthe%252Bmaximal%252Befficacy%252Bas%252BPPAR%2525CE%2525B3%252Bpartial%252Bagonists%26aulast%3DFurukawa%26aufirst%3DAkihiro%26date%3D2012%26volume%3D22%26issue%3D3%26spage%3D1348%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Dong-Hun  Lee</span>, <span class="hlFld-ContribAuthor ">Eun Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Jee-young  Lee</span>, <span class="hlFld-ContribAuthor ">Jeong-Woo  Kang</span>, <span class="hlFld-ContribAuthor ">Jong Hwan  Song</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>, <span class="hlFld-ContribAuthor ">Yangmi  Kim</span>, <span class="hlFld-ContribAuthor ">Jin-Tae  Hong</span>, <span class="hlFld-ContribAuthor ">Do-Young  Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2011,</strong> <em>358 </em>
                                    (1-2)
                                     , 75-83. <a href="https://doi.org/10.1007/s11010-011-0923-1" title="DOI URL">https://doi.org/10.1007/s11010-011-0923-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-011-0923-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-011-0923-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DNovel%252BPPAR%2525CE%2525B3%252Bpartial%252Bagonists%252Bwith%252Bweak%252Bactivity%252Band%252Bno%252Bcytotoxicity%25253B%252Bidentified%252Bby%252Ba%252Bsimple%252BPPAR%2525CE%2525B3%252Bligand%252Bscreening%252Bsystem%26aulast%3DCho%26aufirst%3DMin-Chul%26date%3D2011%26date%3D2011%26volume%3D358%26issue%3D1-2%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilia  Goltsman</span>, <span class="hlFld-ContribAuthor ">Xinkang  Wang</span>, <span class="hlFld-ContribAuthor ">Edward R.  LaVallie</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  DiBlasio-Smith</span>, <span class="hlFld-ContribAuthor ">Elena  Ovcharenko</span>, <span class="hlFld-ContribAuthor ">Aaron  Hoffman</span>, <span class="hlFld-ContribAuthor ">Zaid  Abassi</span>, <span class="hlFld-ContribAuthor ">Giora Z.  Feuerstein</span>, <span class="hlFld-ContribAuthor ">Joseph  Winaver</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Chronic Rosiglitazone Treatment on Renal Handling of Salt and Water in Rats With Volume-Overload Congestive Heart Failure. </span><span class="cited-content_cbyCitation_journal-name">Circulation: Heart Failure</span><span> <strong>2011,</strong> <em>4 </em>
                                    (3)
                                     , 345-354. <a href="https://doi.org/10.1161/CIRCHEARTFAILURE.110.960179" title="DOI URL">https://doi.org/10.1161/CIRCHEARTFAILURE.110.960179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCHEARTFAILURE.110.960179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCHEARTFAILURE.110.960179%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%253A%2520Heart%2520Failure%26atitle%3DEffects%252Bof%252BChronic%252BRosiglitazone%252BTreatment%252Bon%252BRenal%252BHandling%252Bof%252BSalt%252Band%252BWater%252Bin%252BRats%252BWith%252BVolume-Overload%252BCongestive%252BHeart%252BFailure%26aulast%3DGoltsman%26aufirst%3DIlia%26date%3D2011%26volume%3D4%26issue%3D3%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter T.W.  Cheng</span>, <span class="hlFld-ContribAuthor ">Ellen  Kick</span>, <span class="hlFld-ContribAuthor ">Ranjan  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear Hormone Receptor Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 77-188. <a href="https://doi.org/10.1002/0471266949.bmc191" title="DOI URL">https://doi.org/10.1002/0471266949.bmc191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc191%26sid%3Dliteratum%253Aachs%26atitle%3DNuclear%252BHormone%252BReceptor%252BMedicinal%252BChemistry%26aulast%3DCheng%26aufirst%3DPeter%2BT.W.%26date%3D2010%26date%3D2010%26spage%3D77%26epage%3D188%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lalit S  Doshi</span>, <span class="hlFld-ContribAuthor ">Manoja Kumar  Brahma</span>, <span class="hlFld-ContribAuthor ">Umakant A  Bahirat</span>, <span class="hlFld-ContribAuthor ">Amol V  Dixit</span>, <span class="hlFld-ContribAuthor ">Kumar VS  Nemmani</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2010,</strong> <em>19 </em>
                                    (4)
                                     , 489-512. <a href="https://doi.org/10.1517/13543781003640169" title="DOI URL">https://doi.org/10.1517/13543781003640169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543781003640169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543781003640169%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulators%252Bas%252Bsafe%252Band%252Beffective%252Bantidiabetic%252Bagents%26aulast%3DDoshi%26aufirst%3DLalit%2BS%26date%3D2010%26date%3D2010%26volume%3D19%26issue%3D4%26spage%3D489%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yann  Lamotte</span>, <span class="hlFld-ContribAuthor ">Paul  Martres</span>, <span class="hlFld-ContribAuthor ">Nicolas  Faucher</span>, <span class="hlFld-ContribAuthor ">Alain  Laroze</span>, <span class="hlFld-ContribAuthor ">Didier  Grillot</span>, <span class="hlFld-ContribAuthor ">Nicolas  Ancellin</span>, <span class="hlFld-ContribAuthor ">Yannick  Saintillan</span>, <span class="hlFld-ContribAuthor ">Véronique  Beneton</span>, <span class="hlFld-ContribAuthor ">Robert T.  Gampe</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of novel indole derivatives as potent and selective PPARγ modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (4)
                                     , 1399-1404. <a href="https://doi.org/10.1016/j.bmcl.2009.12.107" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.12.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.12.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.12.107%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bnovel%252Bindole%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BPPAR%2525CE%2525B3%252Bmodulators%26aulast%3DLamotte%26aufirst%3DYann%26date%3D2010%26volume%3D20%26issue%3D4%26spage%3D1399%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Summary of SAR of the indolyl SPPARγMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>N</i>-Acyl indoles are metabolically labile in vivo.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of rosiglitazone, COOH, and SPPARγM <b>6</b> gene expression heat map of 4619 reporter genes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of SPPARγM <b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of TG, insulin, and FFA lowering between rosiglitazone and SPPARγM <b>6</b> in Zucker <i>fa</i>/<i>fa</i> rats. * <i>P</i> < 0.05 compared to vehicle controls (Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/medium/jm-2009-00097m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of PV, ECF, and HW increases between rosiglitazone and SPPARγM <b>6</b> in Zucker <i>fa</i>/<i>fa</i> rats. * <i>P</i> < 0.05, ** <i>P</i> < 0.01 compared to vehicle controls (Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900097m/production/images/large/jm-2009-00097m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900097m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Plosker, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds, D.</span><span> </span><span class="NLM_article-title">Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=409-438&author=G.+L.+Ploskerauthor=D.+Faulds&title=Troglitazone%3A+A+Review+of+its+Use+in+the+Management+of+Type+2+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26aulast%3DFaulds%26aufirst%3DD.%26atitle%3DTroglitazone%253A%2520A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Type%25202%2520Diabetes%2520Mellitus%26jtitle%3DDrugs%26date%3D1999%26volume%3D57%26spage%3D409%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Balfour, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plosker, G. L.</span> <span class="citation_source-journal">Rosiglitazone Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.2165%2F00003495-199957060-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10400405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1GnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balfour%2C+J.+A.%3B+Plosker%2C+G.+L.Rosiglitazone+Drugs+1999%2C+57%2C+921%E2%80%93930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone</span></div><div class="casAuthors">Balfour, Julia A. Barman; Plosker, Greg L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">921-930</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review with 66 refs. Rosiglitazone, a thiazolidinedione antidiabetic agent, improves insulin resistance, a key metabolic abnormality in most patients with type 2 (non-insulin-dependent) diabetes mellitus.  In animal models of insulin resistance, rosiglitazone decreased plasma glucose, insulin and triglyceride levels and also attenuated or prevented diabetic nephropathy and pancreatic islet cell degeneration.  In contrast to troglitazone, rosiglitazone does not induce cytochrome P 4503A4 metab.  It does not interact significantly with nifedipine, oral contraceptives, metformin, digoxin, ranitidine or acarbose.  In clin. trials in patients with type 2 diabetes mellitus, rosiglitazone at 2-12 mg/day (as a single daily dose or 2 divided daily doses) improved glycemic control, as shown by decreases in fasting plasma glucose and glycosylated Hb (HbA1c).  Addn. of rosiglitazone at 2-8 mg/day to existing sulfonylurea, metformin or insulin therapy achieved further redns. in fasting plasma glucose and HbA1c.  Oral combinations improved insulin sensitivity and β-cell function according to a homeostasis model assessment.  Consistent with its mechanism of action, rosiglitazone appears to be assocd. with a low risk of hypoglycemia (<2% of patients receiving monotherapy).  There is no evidence to date that rosiglitazone shares the hepatotoxicity of troglitazone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqijoPBeWdDCbVg90H21EOLACvtfcHk0lhyhgU3TVgwxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1GnsL0%253D&md5=74eb65e8e17cb6187b6e6be22ac30d9d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F00003495-199957060-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-199957060-00007%26sid%3Dliteratum%253Aachs%26aulast%3DBalfour%26aufirst%3DJ.%2BA.%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26jtitle%3DRosiglitazone%2520Drugs%26date%3D1999%26volume%3D57%26spage%3D921%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nesto, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonow, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenkovich, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span> </span><span class="NLM_article-title">Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=256-263&author=R.+W.+Nestoauthor=D.+Bellauthor=R.+O.+Bonowauthor=V.+Fonsecaauthor=S.+M.+Grundyauthor=E.+S.+Hortonauthor=M.+L.+Winterauthor=D.+Porteauthor=C.+F.+Semenkovichauthor=S.+Smithauthor=L.+H.+Youngauthor=R.+Kahn&title=Thiazolidinedione+Use%2C+Fluid+Retention%2C+and+Congestive+Heart+Failure%3A+A+Consensus+Statement+from+the+American+Heart+Association+and+American+Diabetes+Association"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNesto%26aufirst%3DR.%2BW.%26aulast%3DBell%26aufirst%3DD.%26aulast%3DBonow%26aufirst%3DR.%2BO.%26aulast%3DFonseca%26aufirst%3DV.%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26aulast%3DHorton%26aufirst%3DE.%2BS.%26aulast%3DWinter%26aufirst%3DM.%2BL.%26aulast%3DPorte%26aufirst%3DD.%26aulast%3DSemenkovich%26aufirst%3DC.%2BF.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DL.%2BH.%26aulast%3DKahn%26aufirst%3DR.%26atitle%3DThiazolidinedione%2520Use%252C%2520Fluid%2520Retention%252C%2520and%2520Congestive%2520Heart%2520Failure%253A%2520A%2520Consensus%2520Statement%2520from%2520the%2520American%2520Heart%2520Association%2520and%2520American%2520Diabetes%2520Association%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D256%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pickavance, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckingham, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilding, J. P. H.</span><span> </span><span class="NLM_article-title">Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1570</span><span class="NLM_x">–</span> <span class="NLM_lpage">1576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1038%2Fsj.bjp.0702932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10602338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXotFSit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=1570-1576&author=L.+C.+Pickavanceauthor=M.+Tadayonauthor=P.+S.+Widdowsonauthor=R.+E.+Buckinghamauthor=J.+P.+H.+Wilding&title=Therapeutic+index+for+rosiglitazone+in+dietary+obese+rats%3A+separation+of+efficacy+and+haemodilution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and hemodilution</span></div><div class="casAuthors">Pickavance, L. C.; Tadayyon, M.; Widdowson, P. S.; Buckingham, R. E.; Wilding, J. P. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1570-1576</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The blood glucose-lowering efficacy of rosiglitazone (RSG) and the mechanisms of assocd. wt. gain were detd. in dietary obese rats (DIOs).  DIO and chow-fed rats received RSG 0.3-30 mg kg-1 daily for 21 days.  In DIOs, plasma glucose and insulin concns. were reduced by RSG at dosages of 3 and 10 mg kg-1, resp.  Homeostasis model assessment (HOMA) indicated the threshold for a redn. of insulin resistance was 1 mg kg-1.  Neither glucose nor insulin levels were affected by treatment in chow-fed rats.  RSG 0.3 mg kg-1 lowered free fatty acids (FFAs) in DIOs, whereas for plasma triglycerides (TGs), the threshold was 3 mg kg-1.  By contrast, the threshold for reducing packed red cell vol. (PCV) and increasing cardiac mass was 10 mg kg-1.  Thus, the therapeutic index for RSG in DIOs was >3 and ≤10.  Energy intake and wt. gain increased in treated DIOs (by 20% and 50 g, at 30 mg kg-1) and chow-fed rats (by 25% and 35 g, at 30 mg kg-1).  In DIOs, these increases coincided with falls in plasma leptin (40% lower at 30 mg kg-1) and insulin (43% lower at 30 mg kg-1).  By contrast, in chow-fed rats, wt. gain and hyperphagia occurred without changes in either leptin or insulin.  However, redns. in FFAs below 0.4-0.3 mM were assocd. with hyperphagia and wt. gain in DIO and chow-fed rats.  We conclude that increased energy intake and body wt. did not attenuate the improved metab. evoked by RSG in DIO rats, and that insulin action was enhanced at a dose >3 fold below the threshold for causing hemodilution and cardiac hypertrophy in DIO rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgoMcAqt0bEbVg90H21EOLACvtfcHk0lgJ8CD41ehR0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotFSit78%253D&md5=599c8b440388e50a4083e3868fceb223</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702932%26sid%3Dliteratum%253Aachs%26aulast%3DPickavance%26aufirst%3DL.%2BC.%26aulast%3DTadayon%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DBuckingham%26aufirst%3DR.%2BE.%26aulast%3DWilding%26aufirst%3DJ.%2BP.%2BH.%26atitle%3DTherapeutic%2520index%2520for%2520rosiglitazone%2520in%2520dietary%2520obese%2520rats%253A%2520separation%2520of%2520efficacy%2520and%2520haemodilution%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D1570%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Richter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandeira-Echtler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergerhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahim, S. H.</span><span> </span><span class="NLM_article-title">Rosiglitazone for type 2 diabetes mellitus</span> <span class="citation_source-journal">Cochrane Libr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=1-83&author=B.+Richterauthor=E.+Bandeira-Echtlerauthor=K.+Bergerhoffauthor=C.+Clarauthor=S.+H.+Ebrahim&title=Rosiglitazone+for+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DB.%26aulast%3DBandeira-Echtler%26aufirst%3DE.%26aulast%3DBergerhoff%26aufirst%3DK.%26aulast%3DClar%26aufirst%3DC.%26aulast%3DEbrahim%26aufirst%3DS.%2BH.%26atitle%3DRosiglitazone%2520for%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCochrane%2520Libr.%26date%3D2007%26volume%3D3%26spage%3D1%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’neill, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2427</span><span class="NLM_x">–</span> <span class="NLM_lpage">2443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1056%2FNEJMoa066224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=17145742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12ntrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2427-2443&author=S.+E.+Kahnauthor=S.+M.+Haffnerauthor=M.+A.+Heiseauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=N.+P.+Jonesauthor=B.+G.+Kravitzauthor=J.+M.+Lachinauthor=M.+C.+O%E2%80%99neillauthor=B.+Zinmanauthor=G.+Viberti&title=Glycemic+Durability+of+Rosiglitazone%2C+Metformin%2C+or+Glyburide+Monotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy</span></div><div class="casAuthors">Kahn, Steven E.; Haffner, Steven M.; Heise, Mark A.; Herman, William H.; Holman, Rury R.; Jones, Nigel P.; Kravitz, Barbara G.; Lachin, John M.; O'Neill, Colleen; Zinman, Bernard; Viberti, Giancarlo</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2427-2443</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known.  METHODS: We evaluated rosiglitazone, metformin, and glyburide as initial treatment for recently diagnosed type 2 diabetes in a double-blind, randomized, controlled clin. trial involving 4360 patients.  The patients were treated for a median of 4.0 years.  The primary outcome was the time to monotherapy failure, which was defined as a confirmed level of fasting plasma glucose of more than 180 mg per dL (10.0 mmol per L), for rosiglitazone, as compared with metformin or glyburide.  Prespecified secondary outcomes were levels of fasting plasma glucose and glycated Hb, insulin sensitivity, and β-cell function.  RESULTS: Kaplan-Meier anal. showed a cumulative incidence of monotherapy failure at 5 years of 15% with rosiglitazone, 21% with metformin, and 34% with glyburide.  This represents a risk redn. of 32% for rosiglitazone, as compared with metformin, and 63%, as compared with glyburide (P < 0.001 for both comparisons).  The difference in the durability of the treatment effect was greater between rosiglitazone and glyburide than between rosiglitazone and metformin.  Glyburide was assocd. with a lower risk of cardiovascular events (including congestive heart failure) than was rosiglitazone (P < 0.05), and the risk assocd. with metformin was similar to that with rosiglitazone.  Rosiglitazone was assocd. with more wt. gain and edema than either metformin or glyburide but with fewer gastrointestinal events than metformin and with less hypoglycemia than glyburide (P < 0.001 for all comparisons).  CONCLUSIONS: The potential risks and benefits, the profile of adverse events, and the costs of these three drugs should all be considered to help inform the choice of pharmacotherapy for patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1vXiFiHU6prVg90H21EOLACvtfcHk0lgJ8CD41ehR0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12ntrzF&md5=5d8abeaed5fabbe692d38140a6703c71</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa066224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa066224%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DJones%26aufirst%3DN.%2BP.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DO%25E2%2580%2599neill%26aufirst%3DM.%2BC.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DGlycemic%2520Durability%2520of%2520Rosiglitazone%252C%2520Metformin%252C%2520or%2520Glyburide%2520Monotherapy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2427%26epage%3D2443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kahn, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haffner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravitz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aftring, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viberti, G.</span><span> </span><span class="NLM_article-title">Rosiglitazone-Associated Fractures in Type 2 Diabetes: An Analysis from a Diabetes Outcome Progression Trial (ADOPT)</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=845-851&author=S.+E.+Kahnauthor=B.+Zinmanauthor=J.+M.+Lachinauthor=S.+M.+Haffnerauthor=W.+H.+Hermanauthor=R.+R.+Holmanauthor=B.+G.+Kravitzauthor=D.+Yuauthor=M.+A.+Heiseauthor=R.+P.+Aftringauthor=G.+Viberti&title=Rosiglitazone-Associated+Fractures+in+Type+2+Diabetes%3A+An+Analysis+from+a+Diabetes+Outcome+Progression+Trial+%28ADOPT%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BE.%26aulast%3DZinman%26aufirst%3DB.%26aulast%3DLachin%26aufirst%3DJ.%2BM.%26aulast%3DHaffner%26aufirst%3DS.%2BM.%26aulast%3DHerman%26aufirst%3DW.%2BH.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DKravitz%26aufirst%3DB.%2BG.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DM.%2BA.%26aulast%3DAftring%26aufirst%3DR.%2BP.%26aulast%3DViberti%26aufirst%3DG.%26atitle%3DRosiglitazone-Associated%2520Fractures%2520in%2520Type%25202%2520Diabetes%253A%2520An%2520Analysis%2520from%2520a%2520Diabetes%2520Outcome%2520Progression%2520Trial%2520%2528ADOPT%2529%26jtitle%3DDiabetes%2520Care%26date%3D2008%26volume%3D31%26spage%3D845%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hampton, T.</span><span> </span><span class="NLM_article-title">Diabetes Drugs Tied to Fractures in Women</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">1645</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2007&pages=1645&author=T.+Hampton&title=Diabetes+Drugs+Tied+to+Fractures+in+Women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHampton%26aufirst%3DT.%26atitle%3DDiabetes%2520Drugs%2520Tied%2520to%2520Fractures%2520in%2520Women%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2007%26volume%3D297%26spage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Reginato, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krakow, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-Activated Receptor γ-Activating Properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">32679</span><span class="NLM_x">–</span> <span class="NLM_lpage">32684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32679-32684&author=M.+J.+Reginatoauthor=S.+T.+Baileyauthor=S.+L.+Krakowauthor=C.+Minamiauthor=S.+Ishiiauthor=H.+Tanakaauthor=M.+A.+Lazar&title=A+Potent+Antidiabetic+Thiazolidinedione+with+Unique+Peroxisome+Proliferator-Activated+Receptor+%CE%B3-Activating+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReginato%26aufirst%3DM.%2BJ.%26aulast%3DBailey%26aufirst%3DS.%2BT.%26aulast%3DKrakow%26aufirst%3DS.%2BL.%26aulast%3DMinami%26aufirst%3DC.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DA%2520Potent%2520Antidiabetic%2520Thiazolidinedione%2520with%2520Unique%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3-Activating%2520Properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32679%26epage%3D32684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Oberfield, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goreham, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobb, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull-Ryde, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunket, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliewer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span> </span><span class="NLM_article-title">A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.,</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">6102</span><span class="NLM_x">–</span> <span class="NLM_lpage">6106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1073%2Fpnas.96.11.6102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10339548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADyaK1MXksFKksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=6102-6106&author=J.+L.+Oberfieldauthor=J.+L.+Collinsauthor=C.+P.+Holmesauthor=D.+P.+Gorehamauthor=J.+P.+Cooperauthor=J.+E.+Cobbauthor=J.+M.+Lenhardauthor=E.+A.+Hull-Rydeauthor=C.+P.+Mohrauthor=S.+G.+Blanchardauthor=D.+J.+Parksauthor=L.+B.+Mooreauthor=J.+M.+Lehmannauthor=K.+Plunketauthor=A.+B.+Millerauthor=M.+V.+Milburnauthor=S.+A.+Kliewerauthor=T.+M.+Willson&title=A+peroxisome+proliferator-activated+receptor+%CE%B3+ligand+inhibits+adipocyte+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation</span></div><div class="casAuthors">Oberfield, Jennifer L.; Collins, Jon L.; Holmes, Christopher P.; Goreham, Donna M.; Cooper, Joel P.; Cobb, Jeffery E.; Lenhard, James M.; Hull-Ryde, Emily A.; Mohr, Christopher P.; Blanchard, Steven G.; Parks, Derek J.; Moore, Linda B.; Lehmann, Jurgen M.; Plunket, Kelli; Miller, Ann B.; Milburn, Michael V.; Kliewer, Steven A.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6102-6106</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate glucose and lipid homeostasis.  The PPARγ subtype plays a central role in the regulation of adipogenesis and is the mol. target for the 2,4-thiazolidinedione class of antidiabetic drugs.  Structural studies have revealed that agonist ligands activate the PPARs through direct interactions with the C-terminal region of the ligand-binding domain, which includes the activation function 2 helix.  GW0072 was identified as a high-affinity PPARγ ligand that was a weak partial agonist of PPARγ transactivation.  X-ray crystallog. revealed that GW0072 occupied the ligand-binding pocket by using different epitopes than the known PPAR agonists and did not interact with the activation function 2 helix.  In cell culture, GW0072 was a potent antagonist of adipocyte differentiation.  These results establish an approach to the design of PPAR ligands with modified biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTw2RnV57krLVg90H21EOLACvtfcHk0lhCmSZHdBGPHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFKksrs%253D&md5=8a24d9dc837214ee27b92235410e1164</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.11.6102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.11.6102%26sid%3Dliteratum%253Aachs%26aulast%3DOberfield%26aufirst%3DJ.%2BL.%26aulast%3DCollins%26aufirst%3DJ.%2BL.%26aulast%3DHolmes%26aufirst%3DC.%2BP.%26aulast%3DGoreham%26aufirst%3DD.%2BP.%26aulast%3DCooper%26aufirst%3DJ.%2BP.%26aulast%3DCobb%26aufirst%3DJ.%2BE.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DHull-Ryde%26aufirst%3DE.%2BA.%26aulast%3DMohr%26aufirst%3DC.%2BP.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DLehmann%26aufirst%3DJ.%2BM.%26aulast%3DPlunket%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKliewer%26aufirst%3DS.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DA%2520peroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520ligand%2520inhibits%2520adipocyte%2520differentiation%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%252C%26date%3D1999%26volume%3D96%26spage%3D6102%26epage%3D6106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klatt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-Activated Receptor γ. The Role of CYS313 in Ligand Binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">7913</span><span class="NLM_x">–</span> <span class="NLM_lpage">7922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=7913-7922&author=A.+Elbrechtauthor=Y.+Chenauthor=A.+Adamsauthor=J.+Bergerauthor=P.+Griffinauthor=T.+Klattauthor=B.+Zhangauthor=J.+Menkeauthor=G.+Zhouauthor=R.+G.+Smithauthor=D.+E.+Moller&title=L-764406+Is+a+Partial+Agonist+of+Human+Peroxisome+Proliferator-Activated+Receptor+%CE%B3.+The+Role+of+CYS313+in+Ligand+Binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAdams%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DKlatt%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DL-764406%2520Is%2520a%2520Partial%2520Agonist%2520of%2520Human%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3.%2520The%2520Role%2520of%2520CYS313%2520in%2520Ligand%2520Binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D27%26spage%3D7913%26epage%3D7922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shimaya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirayama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikama, H.</span><span> </span><span class="NLM_article-title">The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic <i>db</i>/<i>db</i> mice</span> <span class="citation_source-journal">Metabolism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2FS0026-0495%2800%2990440-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=10726922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVeqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=411-417&author=A.+Shimayaauthor=E.+Kurosakiauthor=R.+Nakanoauthor=R.+Hirayamaauthor=M.+Shibasakiauthor=H.+Shikama&title=The+novel+hypoglycemic+agent+YM440+normalizes+hyperglycemia+without+changing+body+fat+weight+in+diabetic+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice</span></div><div class="casAuthors">Shimaya, Akiyoshi; Kurosaki, Eiji; Nakano, Ryosuke; Hirayama, Reiko; Shibasaki, Masayuki; Shikama, Hisataka</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-417</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">To det. the relationship between hypoglycemic activity and body wt. gain induced by insulin sensitizers, we compared the effects of thiazolidinedione analogs (troglitazone and pioglitazone) and the oxadiazolidinedione analog (Z)-1,4-bis{4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}but-2-ene (YM440) in diabetic db/db mice.  Oral treatment with YM440 (100 mg/kg) for 28 days decreased the blood glucose concn. (control v YM440, 418 ± 12 v 243 ± 44 mg/dL).  The hypoglycemic activity of this agent was comparable to that of troglitazone (300 mg/kg) and pioglitazone (100 mg/kg).  There were no changes in food intake among the groups.  Troglitazone and pioglitazone, but not YM440, significantly increased body wt. gain during treatment (control, 7.2 ± 0.5 g; YM440, 7.5 ± 0.8 g; troglitazone, 10.9 ± 0.8 g; and pioglitazone, 14.5 ± 1.1 g).  To further assess whether the increase in body wt. by troglitazone or pioglitazone was due to adipogenesis, the wt. of intraabdominal fat tissue (epididymal, retroperitoneal, and perirenal) was detd.  There were no differences in the total wt. of visceral fat between the control and YM440 treatment (3.53 ± 0.23 and 3.60 ± 0.16 g).  In contrast, troglitazone and pioglitazone significantly increased the fat wt. (4.31 ± 0.13 and 4.66 ± 0.19 g).  Thiazolidinediones are known as ligands for peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor responsible for adipogenesis.  Troglitazone and pioglitazone activated PPARγ and increased triglyceride accumulation and mRNA expression of fatty acid-binding protein (FABP) in 3T3-L1 cells.  However, YM440 had no effect on these indexes for adipocyte differentiation.  These results suggest that the mechanism is different for the hypoglycemic action of YM440 vs. the thiazolidinediones.  YM440 ameliorates hyperglycemia without changing PPARγ activity, adipocyte differentiation, or fat wt.  Thus, YM440 could be a useful hypoglycemic agent for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) without affecting body wt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY-djP8VuqO7Vg90H21EOLACvtfcHk0ljqAg94GsZ-5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVeqtLk%253D&md5=53b8085b591bf08c35ac46e5617e4729</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2800%2990440-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252800%252990440-2%26sid%3Dliteratum%253Aachs%26aulast%3DShimaya%26aufirst%3DA.%26aulast%3DKurosaki%26aufirst%3DE.%26aulast%3DNakano%26aufirst%3DR.%26aulast%3DHirayama%26aufirst%3DR.%26aulast%3DShibasaki%26aufirst%3DM.%26aulast%3DShikama%26aufirst%3DH.%26atitle%3DThe%2520novel%2520hypoglycemic%2520agent%2520YM440%2520normalizes%2520hyperglycemia%2520without%2520changing%2520body%2520fat%2520weight%2520in%2520diabetic%2520db%252Fdb%2520mice%26jtitle%3DMetabolism%26date%3D2000%26volume%3D49%26spage%3D411%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rocchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamecq, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poitier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubuquoy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champy, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunket, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desreumaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auwerx, J.</span><span> </span><span class="NLM_article-title">A Unique PPARγ Ligand with Potent Insulin-Sensitizing Yet Weak Adipogenic Activity</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=737-747&author=S.+Rocchiauthor=F.+Picardauthor=J.+Vamecqauthor=L.+Gelmanauthor=N.+Poitierauthor=D.+Zeyerauthor=L.+Dubuquoyauthor=P.+Bacauthor=M.-F.+Champyauthor=K.+D.+Plunketauthor=L.+M.+Leesnitzerauthor=S.+G.+Blanchardauthor=P.+Desreumauxauthor=D.+Morasauthor=J.-P.+Renaudauthor=J.+Auwerx&title=A+Unique+PPAR%CE%B3+Ligand+with+Potent+Insulin-Sensitizing+Yet+Weak+Adipogenic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocchi%26aufirst%3DS.%26aulast%3DPicard%26aufirst%3DF.%26aulast%3DVamecq%26aufirst%3DJ.%26aulast%3DGelman%26aufirst%3DL.%26aulast%3DPoitier%26aufirst%3DN.%26aulast%3DZeyer%26aufirst%3DD.%26aulast%3DDubuquoy%26aufirst%3DL.%26aulast%3DBac%26aufirst%3DP.%26aulast%3DChampy%26aufirst%3DM.-F.%26aulast%3DPlunket%26aufirst%3DK.%2BD.%26aulast%3DLeesnitzer%26aufirst%3DL.%2BM.%26aulast%3DBlanchard%26aufirst%3DS.%2BG.%26aulast%3DDesreumaux%26aufirst%3DP.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DRenaud%26aufirst%3DJ.-P.%26aulast%3DAuwerx%26aufirst%3DJ.%26atitle%3DA%2520Unique%2520PPAR%25CE%25B3%2520Ligand%2520with%2520Potent%2520Insulin-Sensitizing%2520Yet%2520Weak%2520Adipogenic%2520Activity%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D737%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Thor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beierlein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dykes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustovsson, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jendeberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegurier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydow-Bachmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornstrom, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppenberg, J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3565</span><span class="NLM_x">–</span> <span class="NLM_lpage">3567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3565-3567&author=M.+Thorauthor=K.+Beierleinauthor=G.+Dykesauthor=A.-L.+Gustovssonauthor=J.+Heidrichauthor=L.+Jendebergauthor=B.+Lindqvistauthor=C.+Pegurierauthor=P.+Rousselauthor=M.+Slaterauthor=S.+Svenssonauthor=M.+Sydow-Bachmannauthor=U.+Thornstromauthor=J.+Uppenberg&title=Synthesis+and+pharmacological+evaluation+of+a+new+class+of+peroxisome+proliferator-activated+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThor%26aufirst%3DM.%26aulast%3DBeierlein%26aufirst%3DK.%26aulast%3DDykes%26aufirst%3DG.%26aulast%3DGustovsson%26aufirst%3DA.-L.%26aulast%3DHeidrich%26aufirst%3DJ.%26aulast%3DJendeberg%26aufirst%3DL.%26aulast%3DLindqvist%26aufirst%3DB.%26aulast%3DPegurier%26aufirst%3DC.%26aulast%3DRoussel%26aufirst%3DP.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DSydow-Bachmann%26aufirst%3DM.%26aulast%3DThornstrom%26aufirst%3DU.%26aulast%3DUppenberg%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520new%2520class%2520of%2520peroxisome%2520proliferator-activated%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3565%26epage%3D3567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petro, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surwit, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein-γ Selective Modulator</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1210%2Fme.2002-0217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=12554792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=662-676&author=J.+P.+Bergerauthor=A.+E.+Petroauthor=K.+L.+McNaulauthor=L.+J.+Kellyauthor=B.+B.+Zhangauthor=K.+Richardsauthor=A.+Elbrechtauthor=B.+A.+Johnsonauthor=G.+Zhouauthor=T.+W.+Doebberauthor=C.+Biswasauthor=M.+Parikhauthor=N.+Sharmaauthor=M.+R.+Tanenauthor=G.+M.+Thompsonauthor=J.+Ventreauthor=A.+D.+Adamsauthor=R.+Mosleyauthor=R.+S.+Surwitauthor=D.+E.+Moller&title=Distinct+Properties+and+Advantages+of+a+Novel+Peroxisome+Proliferator-Activated+Protein-%CE%B3+Selective+Modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator</span></div><div class="casAuthors">Berger, Joel P.; Petro, Ann E.; Macnaul, Karen L.; Kelly, Linda J.; Zhang, Bei B.; Richards, Karen; Elbrecht, Alex; Johnson, Bruce A.; Zhou, Gaochao; Doebber, Thomas W.; Biswas, Chhabi; Parikh, Mona; Sharma, Neelam; Tanen, Michael R.; Thompson, G. Marie; Ventre, John; Adams, Alan D.; Mosley, Ralph; Surwit, Richard S.; Moller, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">662-676</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antidiabetic thiazolidinediones (TZDs) and non-TZD compds. have been shown to serve as agonists of the peroxisome proliferator-activated receptor γ (PPARγ).  Here, we report the identification and characterization of a novel non-TZD selective PPARγ modulator (nTZDpa).  NTZDpa bound potently to PPARγ with high selectivity vs. PPARα or PPARδ.  In cell-based assays for transcriptional activation, nTZDpa served as a selective, potent PPARγ partial agonist and was able to antagonize the activity of PPARγ full agonists.  NTZDpa also displayed partial agonist effects when its ability to promote adipogenesis in 3T3-L1 cells was evaluated.  Assessment of protein conformation using protease protection or soln. NMR spectroscopy methods showed that nTZDpa produced altered PPARγ conformational stability vs. full agonists, thereby establishing a phys. basis for its obsd. partial agonism.  DNA microarray anal. of RNA from 3T3-L1 adipocytes treated with nTZDpa or several structurally diverse PPARγ full agonists demonstrated qual. differences in the affected gene expression profile for nTZDpa.  Chronic treatment of fat-fed, C57BL/6J mice with nTZDpa or a TZD full agonist ameliorated hyperglycemia and hyperinsulinemia.  However, unlike the TZD, nTZDpa caused redns. in wt. gain and adipose depot size.  Feed efficiency was also substantially diminished.  Unlike TZDs, nTZDpa did not cause cardiac hypertrophy in mice.  When a panel of PPARγ target genes was examd. in white adipose tissue, nTZDpa produced a different in vivo expression pattern vs. the full agonist.  These findings establish that novel selective PPARγ modulators can produce altered receptor conformational stability leading to distinctive gene expression profiles, reduced adipogenic cellular effects, and potentially improved in vivo biol. responses.  Such compds. may lead to preferred therapies for diabetes, obesity, or metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4wmALUo6AMrVg90H21EOLACvtfcHk0ljCLA5Bj6NKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCksr0%253D&md5=d3f877b5b389d84034c98a54e3bbcf06</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1210%2Fme.2002-0217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2002-0217%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DPetro%26aufirst%3DA.%2BE.%26aulast%3DMcNaul%26aufirst%3DK.%2BL.%26aulast%3DKelly%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DRichards%26aufirst%3DK.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DB.%2BA.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DParikh%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DTanen%26aufirst%3DM.%2BR.%26aulast%3DThompson%26aufirst%3DG.%2BM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DA.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DSurwit%26aufirst%3DR.%2BS.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DDistinct%2520Properties%2520and%2520Advantages%2520of%2520a%2520Novel%2520Peroxisome%2520Proliferator-Activated%2520Protein-%25CE%25B3%2520Selective%2520Modulator%26jtitle%3DMol.%2520Endocrinol.%26date%3D2003%26volume%3D17%26spage%3D662%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Schupp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kintscher, U.</span><span> </span><span class="NLM_article-title">Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-γ Activity</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2054</span><span class="NLM_x">–</span> <span class="NLM_lpage">2057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=2054-2057&issue=17&author=M.+Schuppauthor=J.+Jankeauthor=R.+Clasenauthor=T.+Ungerauthor=U.+Kintscher&title=Angiotensin+Type+1+Receptor+Blockers+Induce+Peroxisome+Proliferator-Activated+Receptor-%CE%B3+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchupp%26aufirst%3DM.%26aulast%3DJanke%26aufirst%3DJ.%26aulast%3DClasen%26aufirst%3DR.%26aulast%3DUnger%26aufirst%3DT.%26aulast%3DKintscher%26aufirst%3DU.%26atitle%3DAngiotensin%2520Type%25201%2520Receptor%2520Blockers%2520Induce%2520Peroxisome%2520Proliferator-Activated%2520Receptor-%25CE%25B3%2520Activity%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26issue%3D17%26spage%3D2054%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Minoura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirosumi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayakiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo-Suzuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukagawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, S.</span><span> </span><span class="NLM_article-title">Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">494</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2Fj.ejphar.2004.04.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=15212984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltVGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2004&pages=273-281&author=H.+Minouraauthor=S.+Takeshitaauthor=M.+Itaauthor=J.+Hirosumiauthor=M.+Mabuchiauthor=I.+Kawamuraauthor=S.+Nakajimaauthor=O.+Nakayamaauthor=H.+Kayakiriauthor=T.+Okuauthor=A.+Ohkubo-Suzukiauthor=M.+Fukagawaauthor=H.+Kojoauthor=K.+Haniokaauthor=N.+Yamasakiauthor=T.+Imotoauthor=Y.+Kobayashiauthor=S.+Mutoh&title=Pharmacological+characteristics+of+a+novel+nonthiazolidinedione+insulin+sensitizer%2C+FK614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614</span></div><div class="casAuthors">Minoura, Hideaki; Takeshita, Shigeru; Ita, Makoto; Hirosumi, Jiro; Mabuchi, Miyuki; Kawamura, Ikuo; Nakajima, Satoko; Nakayama, Osamu; Kayakiri, Hiroshi; Oku, Teruo; Ohkubo-Suzuki, Akiko; Fukagawa, Masao; Kojo, Hitoshi; Hanioka, Kenichi; Yamasaki, Noritsugu; Imoto, Takafumi; Kobayashi, Yoshinori; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">273-281</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We evaluated antidiabetic effects of 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide (FK614), a benzimidazole deriv. without a thiazolidinedione structure, which was obtained using C57BL/KsJ-db/db mice.  In db/db mice, the potency of FK614 for hypoglycemic effect was comparable to that of rosiglitazone and approx. 15-fold greater than that of pioglitazone.  FK614 also showed a potent attenuating effect on hypertriglyceridemia in db/db mice, as well as rosiglitazone and pioglitazone.  In C57BL/6J-ob/ob mice, ED50 values of FK614 and pioglitazone for hypoinsulinemic effect were 1.3 and 11.8 mg/kg, resp.  FK614 also improved the impaired glucose tolerance in ob/ob mice.  In normal rats, FK614 did not influence plasma glucose and insulin levels but significantly decreased both plasma triglyceride and nonesterified fatty acid levels.  FK614 was found to activate peroxisome proliferator-activated receptor (PPAR)γ-mediated transcriptional activity in the reporter gene assay as well as thiazolidinedione derivs., although its max. effect was less than that of thiazolidinedione derivs.  In rat toxicity studies, hemodilution effects for FK614 were less than that for rosiglitazone.  Overall, these studies suggest that FK614 improves insulin resistance in such animal models through activation of PPARγ-mediated transcriptional activity and that it would be a new therapeutic candidate with potential for the treatment of type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2s56d1biBbVg90H21EOLACvtfcHk0ljCLA5Bj6NKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltVGhtrk%253D&md5=7d7e9992b40f865e53d63eae95f25a4a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.04.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.04.038%26sid%3Dliteratum%253Aachs%26aulast%3DMinoura%26aufirst%3DH.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DIta%26aufirst%3DM.%26aulast%3DHirosumi%26aufirst%3DJ.%26aulast%3DMabuchi%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DI.%26aulast%3DNakajima%26aufirst%3DS.%26aulast%3DNakayama%26aufirst%3DO.%26aulast%3DKayakiri%26aufirst%3DH.%26aulast%3DOku%26aufirst%3DT.%26aulast%3DOhkubo-Suzuki%26aufirst%3DA.%26aulast%3DFukagawa%26aufirst%3DM.%26aulast%3DKojo%26aufirst%3DH.%26aulast%3DHanioka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DN.%26aulast%3DImoto%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DMutoh%26aufirst%3DS.%26atitle%3DPharmacological%2520characteristics%2520of%2520a%2520novel%2520nonthiazolidinedione%2520insulin%2520sensitizer%252C%2520FK614%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D494%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Burgermeister, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnoebelen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flament, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gsell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, H. P.</span><span> </span><span class="NLM_article-title">A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1210%2Fme.2005-0171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=16373399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=809-830&author=E.+Burgermeisterauthor=A.+Schnoebelenauthor=A.+Flamentauthor=J.+Benzauthor=M.+Stihleauthor=B.+Gsellauthor=A.+Ruferauthor=B.+Kuhnauthor=H.+P.+Marki&title=A+Novel+Partial+Agonist+of+Peroxisome+Proliferator-Activated+Receptor-%CE%B3+%28PPAR%CE%B3%29+Recruits+PPAR%CE%B3-Coactivator-1%CE%B1%2C+Prevents+Triglyceride+Accumulation%2C+and+Potentiates+Insulin+Signaling+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro</span></div><div class="casAuthors">Burgermeister, Elke; Schnoebelen, Astride; Flament, Angele; Benz, Jorg; Stihle, Martine; Gsell, Bernard; Rufer, Arne; Ruf, Armin; Kuhn, Bernd; Marki, Hans Peter; Mizrahi, Jacques; Sebokova, Elena; Niesor, Eric; Meyer, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">809-830</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Partial agonists of peroxisome proliferator-activated receptor-γ (PPARγ), also termed selective PPARγ modulators, are expected to uncouple insulin sensitization from triglyceride (TG) storage in patients with type 2 diabetes mellitus.  These agents shall thus avoid adverse effects, such as body wt. gain, exerted by full agonists such as thiazolidinediones.  In this context, we describe the identification and characterization of the isoquinoline deriv. PA-082, a prototype of a novel class of non-thiazolidinedione partial PPARγ ligands.  In a cocrystal with PPARγ it was bound within the ligand-binding pocket without direct contact to helix 12.  The compd. displayed partial agonism in biochem. and cell-based transactivation assays and caused preferential recruitment of PPARγ-co-activator-1α (PGC1α) to the receptor, a feature shared with other selective PPARγ modulators.  It antagonized rosiglitazone-driven transactivation and TG accumulation during de novo adipogenic differentiation of murine C3H10T1/2 mesenchymal stem cells.  The latter effect was mimicked by overexpression of wild-type PGC1α but not its LXXLL-deficient mutant.  Despite failing to promote TG loading, PA-082 induced mRNAs of genes encoding components of insulin signaling and adipogenic differentiation pathways.  It potentiated glucose uptake and inhibited the neg. cross-talk of TNFα on protein kinase B (AKT) phosphorylation in mature adipocytes and HepG2 human hepatoma cells.  PGC1α is a key regulator of energy expenditure and down-regulated in diabetics.  We thus propose that selective recruitment of PGC1α to favorable PPARγ-target genes provides a possible mol. mechanism whereby partial PPARγ agonists dissoc. TG accumulation from insulin signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgK6uihTKnsLVg90H21EOLACvtfcHk0li0_r4CF5V7kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Oqu7c%253D&md5=da885be2866f262e5728fc2042e4b66f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0171%26sid%3Dliteratum%253Aachs%26aulast%3DBurgermeister%26aufirst%3DE.%26aulast%3DSchnoebelen%26aufirst%3DA.%26aulast%3DFlament%26aufirst%3DA.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DRufer%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMarki%26aufirst%3DH.%2BP.%26atitle%3DA%2520Novel%2520Partial%2520Agonist%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor-%25CE%25B3%2520%2528PPAR%25CE%25B3%2529%2520Recruits%2520PPAR%25CE%25B3-Coactivator-1%25CE%25B1%252C%2520Prevents%2520Triglyceride%2520Accumulation%252C%2520and%2520Potentiates%2520Insulin%2520Signaling%2520in%2520Vitro%26jtitle%3DMol.%2520Endocrinol.%26date%3D2006%26volume%3D20%26spage%3D809%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Acton, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Benzoyl 2-methyl indoles as selective PPARγ modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-362&author=J.+J.+Actonauthor=R.+M.+Blackauthor=A.+B.+Jonesauthor=D.+E.+Mollerauthor=L.+Colwellauthor=T.+W.+Doebberauthor=K.+L.+MacNaulauthor=J.+Bergerauthor=H.+B.+Wood&title=Benzoyl+2-methyl+indoles+as+selective+PPAR%CE%B3+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DBenzoyl%25202-methyl%2520indoles%2520as%2520selective%2520PPAR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Liu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, J. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debenham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNaul, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span> </span><span class="NLM_article-title">Selective PPARγ modulators with improved pharmacological profiles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2437</span><span class="NLM_x">–</span> <span class="NLM_lpage">2440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2437-2440&author=K.+Liuauthor=R.+M.+Blackauthor=J.+A.+Actonauthor=R.+Mosleyauthor=S.+Debenhamauthor=R.+Abolaauthor=M.+Yangauthor=R.+Tschirret-Guthauthor=L.+Colwellauthor=C.+Liuauthor=M.+Wuauthor=C.+F.+Wangauthor=K.+L.+MacNaulauthor=M.+E.+McCannauthor=D.+E.+Mollerauthor=J.+P.+Bergerauthor=P.+T.+Meinkeauthor=A.+B.+Jonesauthor=H.+B.+Wood&title=Selective+PPAR%CE%B3+modulators+with+improved+pharmacological+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DBlack%26aufirst%3DR.%2BM.%26aulast%3DActon%26aufirst%3DJ.%2BA.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DDebenham%26aufirst%3DS.%26aulast%3DAbola%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DColwell%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMacNaul%26aufirst%3DK.%2BL.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DJones%26aufirst%3DA.%2BB.%26aulast%3DWood%26aufirst%3DH.%2BB.%26atitle%3DSelective%2520PPAR%25CE%25B3%2520modulators%2520with%2520improved%2520pharmacological%2520profiles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2437%26epage%3D2440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Einstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castriota, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span> </span><span class="NLM_article-title">The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological Activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=62-74&author=M.+Einsteinauthor=T.+E.+Akiyamaauthor=G.+A.+Castriotaauthor=C.+F.+Wangauthor=B.+McKeeverauthor=R.+T.+Mosleyauthor=J.+W.+Beckerauthor=D.+E.+Mollerauthor=P.+T.+Meinkeauthor=H.+B.+Woodauthor=J.+P.+Berger&title=The+Differential+Interactions+of+Peroxisome+Proliferator-Activated+Receptor+%CE%B3+Ligands+with+Tyr473+Is+a+Physical+Basis+for+Their+Unique+Biological+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEinstein%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%2BE.%26aulast%3DCastriota%26aufirst%3DG.%2BA.%26aulast%3DWang%26aufirst%3DC.%2BF.%26aulast%3DMcKeever%26aufirst%3DB.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520Differential%2520Interactions%2520of%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%25CE%25B3%2520Ligands%2520with%2520Tyr473%2520Is%2520a%2520Physical%2520Basis%2520for%2520Their%2520Unique%2520Biological%2520Activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelem, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschirret-Guth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T.</span><span> </span><span class="NLM_article-title">Minimizing metabolic activation during pharmaceutical lead optimization: Progress, knowledge gaps and future directions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=18175266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=43-52&issue=1&author=S.+Kumarauthor=K.+Kelemauthor=R.+Tschirret-Guthauthor=K.+Mitraauthor=T.+Baillie&title=Minimizing+metabolic+activation+during+pharmaceutical+lead+optimization%3A+Progress%2C+knowledge+gaps+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions</span></div><div class="casAuthors">Kumar, Sanjeev; Kassahun, Kelem; Tschirret-Guth, Richard A.; Mitra, Kaushik; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Minimizing the potential for drug candidates to form chem. reactive metabolites that can covalently modify cellular macromols. represents a rational strategy to reduce the risk of drug-induced idiosyncratic toxicity in humans.  In this review, the approaches that are currently available for addressing this issue during the lead optimization phase of drug discovery, their limitations, and future scientific directions that have the potential to address these limitations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovdpkocC2pgrVg90H21EOLACvtfcHk0lhJVn_XwO3SwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFehs78%253D&md5=2befdc730eb26d56eefef1a157e145a9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DKelem%26aufirst%3DK.%26aulast%3DTschirret-Guth%26aufirst%3DR.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DBaillie%26aufirst%3DT.%26atitle%3DMinimizing%2520metabolic%2520activation%2520during%2520pharmaceutical%2520lead%2520optimization%253A%2520Progress%252C%2520knowledge%2520gaps%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26issue%3D1%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muise, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinke, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span> </span><span class="NLM_article-title">A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1016%2Fj.ejphar.2007.12.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=18346728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2008&pages=192-201&author=C.+H.+Changauthor=L.+A.+McNamaraauthor=M.+S.+Wuauthor=E.+S.+Muiseauthor=Y.+Tanauthor=H.+B.+Woodauthor=P.+T.+Meinkeauthor=J.+R.+Thompsonauthor=T.+W.+Doebberauthor=J.+P.+Bergerauthor=M.+E.+McCann&title=A+novel+selective+peroxisome+proliferator-activator+receptor-gamma+modulator-SPPAR%CE%B3M5+improves+insulin+sensitivity+with+diminished+adverse+cardiovascular+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selective peroxisome proliferator-activator receptor-γ modulator-SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects</span></div><div class="casAuthors">Chang, Ching H.; McNamara, Lesley A.; Wu, Margaret S.; Muise, Eric S.; Tan, Yejun; Wood, Harold B.; Meinke, Peter T.; Thompson, John R.; Doebber, Tom W.; Berger, Joel P.; McCann, Margaret E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">192-201</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The use of the thiazolidinedione insulin sensitizers rosiglitazone and pioglitazone for the treatment of type 2 diabetes mellitus in recent years has proven to be effective in helping patients resume normal glycemic control.  However, their use is often assocd. with undesirable side effects including peripheral edema, congestive heart failure and wt. gain.  Here, we report the identification and characterization of a novel selective PPARγ modulator, SPPARγM5 ((2S)-2-(2-chloro-5-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl} phenoxy)propionic acid), which has notable insulin sensitizing properties and a superior tolerability profile to that of rosiglitazone.  SPPARγM5 is a potent ligand of human PPARγ with high selectivity vs. PPARα or PPARδ in receptor competitive binding assays.  In cell-based transcriptional activation assays, SPPARγM5 was a potent partial agonist of human PPARγ in comparison to the PPARγ full agonist rosiglitazone.  Compared to rosiglitazone or the PPARγ full agonist COOH (2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid), SPPARγM5 induced an attenuated PPARγ-regulated gene expression profile in fully differentiated 3T3-L1 adipocytes and white adipose tissue of chronically treated db/db mice.  SPPARγM5 treatment also reduced the insulin resistance index by homeostasis model assessment (HOMA), suggesting an improvement in insulin resistance in these db/db mice.  Treatment of obese Zucker rats with either rosiglitazone or SPPARγM5 resulted in an improvement in selected parameters that serve as surrogate indicators of insulin resistance and hyperlipidemia.  However, unlike rosiglitazone, SPPARγM5 did not cause significant fluid retention or cardiac hypertrophy in these rats.  Thus, compds. such as SPPARγM5 may offer beneficial effects on glycemic control with significantly attenuated adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxeoOWfrT3IbVg90H21EOLACvtfcHk0lhJVn_XwO3SwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVKrsb0%253D&md5=68ac4e15e57b5d7e97807c80ae823b3b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.12.036%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BH.%26aulast%3DMcNamara%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DMuise%26aufirst%3DE.%2BS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DWood%26aufirst%3DH.%2BB.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DBerger%26aufirst%3DJ.%2BP.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26atitle%3DA%2520novel%2520selective%2520peroxisome%2520proliferator-activator%2520receptor-gamma%2520modulator-SPPAR%25CE%25B3M5%2520improves%2520insulin%2520sensitivity%2520with%2520diminished%2520adverse%2520cardiovascular%2520effects%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D584%26spage%3D192%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gassman, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Bergen, T. J.</span><span> </span><span class="NLM_article-title">Simple method for the conversion of anilines into 2-substituted indoles</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00783a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=590-591&author=P.+G.+Gassmanauthor=T.+J.+van+Bergen&title=Simple+method+for+the+conversion+of+anilines+into+2-substituted+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja00783a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00783a049%26sid%3Dliteratum%253Aachs%26aulast%3DGassman%26aufirst%3DP.%2BG.%26aulast%3Dvan%2BBergen%26aufirst%3DT.%2BJ.%26atitle%3DSimple%2520method%2520for%2520the%2520conversion%2520of%2520anilines%2520into%25202-substituted%2520indoles%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D590%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Acton, J. J.; Debenham, S. D.; Liu, K.; Meinke, P. T.; Wood, H. B.</span><span> </span><span class="NLM_article-title">Indoles having anti-diabetic activity</span> . Patent WO2004/020408 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+J.+Acton&author=S.+D.+Debenham&author=K.+Liu&author=P.+T.+Meinke&author=H.+B.+Wood&title=Indoles+having+anti-diabetic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DJ.%2BJ.%26atitle%3DIndoles%2520having%2520anti-diabetic%2520activity%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leibowitz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullinan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahoo, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Novel Peroxisome Proliferator-Activated Receptor (PPAR)γ and PPARδ Ligands Produce Distinct Biological Effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">6718</span><span class="NLM_x">–</span> <span class="NLM_lpage">6725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=6718-6725&author=J.+B.+Bergerauthor=M.+D.+Leibowitzauthor=T.+D.+Doebberauthor=A.+Elbrechtauthor=B.+Zhangauthor=G.+Zhouauthor=C.+Biswasauthor=C.+A.+Cullinanauthor=N.+S.+Hayesauthor=Y.+Liauthor=M.+Tanenauthor=J.+Ventreauthor=M.+S.+Wuauthor=G.+D.+Bergerauthor=R.+Mosleyauthor=R.+Marquisauthor=C.+Santiniauthor=S.+P.+Sahooauthor=R.+L.+Tolmanauthor=R.+G.+Smithauthor=D.+E.+Moller&title=Novel+Peroxisome+Proliferator-Activated+Receptor+%28PPAR%29%CE%B3+and+PPAR%CE%B4+Ligands+Produce+Distinct+Biological+Effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DLeibowitz%26aufirst%3DM.%2BD.%26aulast%3DDoebber%26aufirst%3DT.%2BD.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCullinan%26aufirst%3DC.%2BA.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DVentre%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%2BS.%26aulast%3DBerger%26aufirst%3DG.%2BD.%26aulast%3DMosley%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DR.%26aulast%3DSantini%26aufirst%3DC.%26aulast%3DSahoo%26aufirst%3DS.%2BP.%26aulast%3DTolman%26aufirst%3DR.%2BL.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DNovel%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520%2528PPAR%2529%25CE%25B3%2520and%2520PPAR%25CE%25B4%2520Ligands%2520Produce%2520Distinct%2520Biological%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D6718%26epage%3D6725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tugwoog, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montegue, C. T.</span><span> </span><span class="NLM_article-title">Biology and toxicology of PPARgamma ligands</span> <span class="citation_source-journal">Hum. Exp. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1191%2F0960327102ht282oa" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=12412636" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=429-437&author=J.+D.+Tugwoogauthor=C.+T.+Montegue&title=Biology+and+toxicology+of+PPARgamma+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1191%2F0960327102ht282oa&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1191%252F0960327102ht282oa%26sid%3Dliteratum%253Aachs%26aulast%3DTugwoog%26aufirst%3DJ.%2BD.%26aulast%3DMontegue%26aufirst%3DC.%2BT.%26atitle%3DBiology%2520and%2520toxicology%2520of%2520PPARgamma%2520ligands%26jtitle%3DHum.%2520Exp.%2520Toxicol.%26date%3D2002%26volume%3D21%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Berger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cillinana, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebber, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saperstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebowitz, M. D.</span><span> </span><span class="NLM_article-title">Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in <i>db</i>/<i>db</i> mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1996&pages=4189-4195&author=J.+Bergerauthor=P.+Baileyauthor=C.+Biswasauthor=C.+A.+Cillinanaauthor=T.+W.+Doebberauthor=N.+S.+Hayesauthor=R.+Sapersteinauthor=R.+G.+Smithauthor=M.+D.+Liebowitz&title=Thiazolidinediones+produce+a+conformational+change+in+peroxisomal+proliferator-activated+receptor-gamma%3A+binding+and+activation+correlate+with+antidiabetic+actions+in+db%2Fdb+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DP.%26aulast%3DBiswas%26aufirst%3DC.%26aulast%3DCillinana%26aufirst%3DC.%2BA.%26aulast%3DDoebber%26aufirst%3DT.%2BW.%26aulast%3DHayes%26aufirst%3DN.%2BS.%26aulast%3DSaperstein%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DLiebowitz%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520produce%2520a%2520conformational%2520change%2520in%2520peroxisomal%2520proliferator-activated%2520receptor-gamma%253A%2520binding%2520and%2520activation%2520correlate%2520with%2520antidiabetic%2520actions%2520in%2520db%252Fdb%2520mice%26jtitle%3DEndocrinology%26date%3D1996%26volume%3D137%26spage%3D4189%26epage%3D4195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the inhibition constant (<i>K</i><sub>i</sub>) and the concentration of the inhibitor which causes 50% inhibition (IC<sub>50</sub>) of an enzyme reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+inhibition+constant+%28Ki%29+and+the+concentration+of+the+inhibitor+which+causes+50%25+inhibition+%28IC50%29+of+an+enzyme+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520inhibition%2520constant%2520%2528Ki%2529%2520and%2520the%2520concentration%2520of%2520the%2520inhibitor%2520which%2520causes%252050%2525%2520inhibition%2520%2528IC50%2529%2520of%2520an%2520enzyme%2520reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Carrington, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szalkowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, D. E.</span><span> </span><span class="NLM_article-title">Insulin- and mitogen-activated protein kinase mediated phosphorylation and activation of peroxisome proliforator-activated receptor-γ</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">31771</span><span class="NLM_x">–</span> <span class="NLM_lpage">31774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=31771-31774&author=B.+Zhangauthor=J.+B.+Bergerauthor=G.+Zhouauthor=A.+Elbrechtauthor=S.+Biswasauthor=S.+White-Carringtonauthor=D.+Szalkowskiauthor=D.+E.+Moller&title=Insulin-+and+mitogen-activated+protein+kinase+mediated+phosphorylation+and+activation+of+peroxisome+proliforator-activated+receptor-%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DBerger%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DElbrecht%26aufirst%3DA.%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DWhite-Carrington%26aufirst%3DS.%26aulast%3DSzalkowski%26aufirst%3DD.%26aulast%3DMoller%26aufirst%3DD.%2BE.%26atitle%3DInsulin-%2520and%2520mitogen-activated%2520protein%2520kinase%2520mediated%2520phosphorylation%2520and%2520activation%2520of%2520peroxisome%2520proliforator-activated%2520receptor-%25CE%25B3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D31771%26epage%3D31774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hughs, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelter, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephaniants, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoughton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsley, P. S.</span><span> </span><span class="NLM_article-title">Expression profiling usng microarrays fabricated by ink-jet oligonucleotide synthesizer</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=342-347&author=T.+R.+Hughsauthor=M.+Maoauthor=A.+R.+Jonesauthor=J.+Burchardauthor=M.+J.+Martonauthor=K.+W.+Shannonauthor=S.+M.+Lefkowitzauthor=M.+Zimanauthor=J.+M.+Schelterauthor=M.+R.+Meyerauthor=S.+Kobayashiauthor=C.+Davisauthor=H.+Daiauthor=Y.+D.+Heauthor=S.+B.+Stephaniantsauthor=G.+Cavetauthor=W.+L.+Walkerauthor=A.+Westauthor=E.+Coffeyauthor=D.+D.+Shoemakerauthor=R.+Stoughtonauthor=A.+P.+Blanchardauthor=S.+H.+Friendauthor=P.+S.+Linsley&title=Expression+profiling+usng+microarrays+fabricated+by+ink-jet+oligonucleotide+synthesizer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughs%26aufirst%3DT.%2BR.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DA.%2BR.%26aulast%3DBurchard%26aufirst%3DJ.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DShannon%26aufirst%3DK.%2BW.%26aulast%3DLefkowitz%26aufirst%3DS.%2BM.%26aulast%3DZiman%26aufirst%3DM.%26aulast%3DSchelter%26aufirst%3DJ.%2BM.%26aulast%3DMeyer%26aufirst%3DM.%2BR.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3DStephaniants%26aufirst%3DS.%2BB.%26aulast%3DCavet%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DW.%2BL.%26aulast%3DWest%26aufirst%3DA.%26aulast%3DCoffey%26aufirst%3DE.%26aulast%3DShoemaker%26aufirst%3DD.%2BD.%26aulast%3DStoughton%26aufirst%3DR.%26aulast%3DBlanchard%26aufirst%3DA.%2BP.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26aulast%3DLinsley%26aufirst%3DP.%2BS.%26atitle%3DExpression%2520profiling%2520usng%2520microarrays%2520fabricated%2520by%2520ink-jet%2520oligonucleotide%2520synthesizer%26jtitle%3DNat.%2520Biotechnol.%26date%3D2001%26volume%3D19%26spage%3D342%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cornish, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonas, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jebb, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elia, M.</span><span> </span><span class="NLM_article-title">Evaluation of multiple frequency bioelectrical impedance and Cole−Cole analysis for the assessment of body water volumes in healthy humans</span> <span class="citation_source-journal">Eur. J. Clin. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=8654329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaK283kt1Gqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=159-164&author=B.+H.+Cornishauthor=L.+C.+Wardauthor=B.+J.+Tonasauthor=S.+A.+Jebbauthor=M.+Elia&title=Evaluation+of+multiple+frequency+bioelectrical+impedance+and+Cole%E2%88%92Cole+analysis+for+the+assessment+of+body+water+volumes+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans</span></div><div class="casAuthors">Cornish B H; Ward L C; Thomas B J; Jebb S A; Elia M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of clinical nutrition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-64</span>
        ISSN:<span class="NLM_cas:issn">0954-3007</span>.
    </div><div class="casAbstract">OBJECTIVE:  To assess the application of a Cole-Cole analysis of multiple frequency bioelectrical impedance analysis (MFBIA) measurements to predict total body water (TBW) and extracellular water (ECW) in humans.  This technique has previously been shown to produce accurate and reliable estimates in both normal and abnormal animals.  DESIGN:  The whole body impedance of 60 healthy humans was measured at 496 frequencies (ranging from 4 kHz to 1 MHz) and the impedance at zero frequency, Ro, and at the characteristic frequency, Zc, were determined from the impedance spectrum, (Cole-Cole plot).  TBW and ECW were independently determined using deuterium and bromide tracer dilution techniques.  SETTING:  At the Dunn Clinical Nutrition Centre and The Department of Biochemistry, University of Queensland.  SUBJECTS:  60 healthy adult volunteers (27 men and 33 women, aged 18-45 years).  RESULTS:  The results presented suggest that the swept frequency bioimpedance technique estimates total body water, (SEE = 5.2%), and extracellular water, (SEE = 10%), only slightly better in normal, healthy subjects than a method based on single frequency bioimpedance or anthropometric estimates based on weight, height and gender.  CONCLUSIONS:  This study has undertaken the most extensive analysis to date of relationships between TBW (and ECW) and individual impedances obtained at different frequencies ( > 400 frequencies), and has shown marginal advantages of using one frequency over another, even if values predicted from theoretical bioimpedance models are used in the estimations.  However in situations where there are disturbances of fluid distribution, values predicted from the Cole-Cole analysis of swept frequency bioimpedance measurements could prove to be more useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI8ivmZxDTlWK_SFaaT9INfW6udTcc2eZ-plsb-d44fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK283kt1Gqsw%253D%253D&md5=ed62bc1b57f28e2a6a8741050b665438</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornish%26aufirst%3DB.%2BH.%26aulast%3DWard%26aufirst%3DL.%2BC.%26aulast%3DTonas%26aufirst%3DB.%2BJ.%26aulast%3DJebb%26aufirst%3DS.%2BA.%26aulast%3DElia%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520multiple%2520frequency%2520bioelectrical%2520impedance%2520and%2520Cole%25E2%2588%2592Cole%2520analysis%2520for%2520the%2520assessment%2520of%2520body%2520water%2520volumes%2520in%2520healthy%2520humans%26jtitle%3DEur.%2520J.%2520Clin.%2520Nutr.%26date%3D1996%26volume%3D50%26spage%3D159%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Rutter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennoste, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. J.</span><span> </span><span class="NLM_article-title">Bioelectrical impedance analysis for the estimation of body composition in rats</span> <span class="citation_source-journal">Lab. Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm900097m&amp;key=10.1258%2F002367798780559356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=9481696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaK1c7kt1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1998&pages=65-71&author=K.+Rutterauthor=L.+Hennosteauthor=L.+C.+Wardauthor=B.+H.+Cornishauthor=B.+J.+Thomas&title=Bioelectrical+impedance+analysis+for+the+estimation+of+body+composition+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Bioelectrical impedance analysis for the estimation of body composition in rats</span></div><div class="casAuthors">Rutter K; Hennoste L; Ward L C; Cornish B H; Thomas B J</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-71</span>
        ISSN:<span class="NLM_cas:issn">0023-6772</span>.
    </div><div class="casAbstract">Bioelectrical impedance analysis (BIA) was used to assess body composition in rats fed on either standard laboratory diet or on high-fat diet designed to induce obesity.  Bioelectrical impedance analysis predictions of total body water and thus fat-free mass (FFM) for the group mean values were generally within 5% of the measured values by tritiated water (3H2O) dilution.  The limits of agreement for the procedure were, however, large, approximately +/- 25%, limiting the applicability of the technique for measurement of body composition in individual animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFQijWPC5cNuxsqfvU0ziafW6udTcc2eZ-plsb-d44fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7kt1Kqtw%253D%253D&md5=8100b5d69bd9160bd655b4288ca6a6b9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1258%2F002367798780559356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252F002367798780559356%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DK.%26aulast%3DHennoste%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DL.%2BC.%26aulast%3DCornish%26aufirst%3DB.%2BH.%26aulast%3DThomas%26aufirst%3DB.%2BJ.%26atitle%3DBioelectrical%2520impedance%2520analysis%2520for%2520the%2520estimation%2520of%2520body%2520composition%2520in%2520rats%26jtitle%3DLab.%2520Anim.%26date%3D1998%26volume%3D32%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Belcher, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriss, E. B.</span><span> </span><span class="NLM_article-title">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm900097m&amp;key=13481897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900097m&amp;key=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1957&pages=64-78&author=E.+H.+Belcherauthor=E.+B.+Harriss&title=Studies+of+plasma+volume%2C+red+cell+volume+and+total+blood+volume+in+young+growing+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies of plasma volume, red cell volume and total blood volume in young growing rats</span></div><div class="casAuthors">BELCHER E H; HARRISS E B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of physiology</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-78</span>
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4s_zNGAgMIC6Ufuk_1xoTfW6udTcc2eZ-plsb-d44fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG1c%252FisVGqsA%253D%253D&md5=dd122772ec2175d6f23b9b3c758bddb3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelcher%26aufirst%3DE.%2BH.%26aulast%3DHarriss%26aufirst%3DE.%2BB.%26atitle%3DStudies%2520of%2520plasma%2520volume%252C%2520red%2520cell%2520volume%2520and%2520total%2520blood%2520volume%2520in%2520young%2520growing%2520rats%26jtitle%3DJ.%2520Physiol.%26date%3D1957%26volume%3D139%26spage%3D64%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900097m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm900097m%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-13" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900097m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9ded3b683d94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
